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CHAPTER I 
 
 
INTRODUCTION 
 
Good nutrition is a prerequisite for human development. Many developing countries still 
have unacceptably high rates of undernutrition and are unlikely to reach their Millennium 
Development Goals by 2015. The wide-spread undernutrition and key vitamin and mineral 
deficiencies in developing countries will continue to be a serious threat to public health and 
to economic and social development in these countries without appropriate attention and 
health policies. The high rates of “hidden hunger” or micronutrient deficiency among 
women in Jordan are caused by many factors including early age at marriage, short birth 
intervals, poor dietary diversification, and lack of national policies on food fortification for 
nutrients such as zinc and vitamin D.  
With abundant sunlight in the Middle East, one would have assumed that the 
populations of these countries would be secured from being vitamin D deficient, but 
research on the vitamin D status of Middle Eastern women has shown the opposite. On 
an average, 5–10 min of direct sunlight exposure of the arms and legs (half the minimal 
erythema dose) will produce about 3000 IU of vitamin D3 (Holick 2007); however, the 
amount of body surface area that is actually exposed to sunlight depends on the 
clothing style, use of sunscreen and lifestyle. A growing body of research suggests
2 
that vitamin D deficiency is widespread among women in the Middle Eastern countries 
(Ghannam et al 1999, Mishal 2001, Moussavi et al 2005, Olmez et al 2006, Siddiqui and 
Kamfar 2007), and limited research has been carried out to determine vitamin D status 
among children in the Middle East. No study has assessed the vitamin D status of both 
women and their preschool children in the region. 
Anemia and iron deficiency are the most common nutritional disorders affecting 
children and women in both industrialized and developing countries. In the Middle East, 
about 47% of pre-school children (0.8 million) have hemoglobin (Hb) below 11 g/dL and 
almost 40 million women of child bearing age (non-pregnant) have Hb below 12 g/dL 
(WHO 2008). The prevalence of anemia in the Eastern Mediterranean region is 
considered to be a severe public health problem among pre-school children and 
moderate among women of child-bearing age (WHO/UNICEF/UNU 2001). In Jordan, it is 
estimated that more than 200,000 children under the age of five and almost 30% of 
non-pregnant women of reproductive age are anemic (WHO 2008). In 2003, the 
Ministry of Health in Jordan estimated the prevalence of anemia, iron deficiency, and 
iron deficiency anemia to be 32%, 40%, and 22%, respectively among non-pregnant 
women of reproductive age, and 20%, 26%, and 10%, respectively among pre-school 
children (Ministry of Health 2003).  
The World Health Organization (WHO) identified the factors contributing most to 
burden of disease in developing countries with high mortality; zinc deficiency was 
ranked as the 5th factor followed by iron deficiency as the 6th (WHO 2002). Globally 
about ½ of the human population is at risk of low zinc intake (Brown and Wuehler 
3 
2000).The high prevalence of anemia in the Middle East North Africa (MENA) region 
despite the fortification of flour with iron supports the fact that there is a need to assess 
zinc status. Anemia is a marker for both iron and zinc deficiency (Shrimpton et al 2005). 
It is likely that iron deficiency exists with other micronutrient deficiencies like zinc 
(Dewey and Brown 2003). By examining the availability of zinc in the local diet in 
Afghanistan, Algeria, Djibouti, Egypt, Iraq, Morocco, Pakistan, Somalia, Sudan, and 
Yemen, the prevalence of zinc deficiency in the Middle East and North Africa region was 
estimated to be 46%, a percentage that makes the region rank third after South Asia 
(79%) and Sub-Saharan Africa (50%) (Caulfield and Black 2004). Currently, there are no 
estimates about the national prevalence and distribution of zinc deficiency in Jordan, 
and there is a serious lack of awareness of the importance of zinc in human nutrition not 
only in Jordan but also in the MENA region. Direct measurement of plasma zinc in a 
representative sample is required, so that knowledge about the prevalence and 
distribution of zinc deficiency can be established before setting steps to eliminate zinc 
deficiency. 
Animal and human studies have suggested an association between iron and zinc 
deficiencies and delayed cognitive and developmental outcomes. There is a 
considerable body of research suggesting poor cognitive, motor, or social functioning in 
iron deficient infants and young children up to 24 months of age (Aukett et al 1986, 
Black et al 2004a, Friel et al 2003, Heywood et al 1989, Idjradinata and Pollitt 1993, 
Lozoff et al 1987, Oski et al 1983, Walter et al 1983, Walter et al 1989, Williams et al 
1999). Longitudinal studies have also shown that infants with chronic iron deficiency fail 
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to catch up with the children with good iron status in developmental tests over time, 
despite correction of iron status (Algarin et al 2003, Corapci et al 2006, Dommergues et 
al 1989, Hurtado et al 1999, Lozoff et al 1991, Lozoff et al 2000, Lozoff et al 2006b, Palti 
et al 1985, Shafir et al 2006, Walter 2003). However, research on developmental 
outcomes and motor and cognitive functioning among iron deficient pre-school children 
is limited. The few available studies showed impaired motor, cognitive, and 
developmental outcomes among iron-deficient pre-school children (Lozoff et al 2007, 
Metallinos-Katsaras et al 2004, Pollitt et al 1983, Pollitt et al 1986, Soewondo et al 1989, 
Stoltzfus et al 2001).  
Many zinc intervention studies that assessed the role of zinc in improving 
diminished cognitive ability and motor functioning have suggested relations between 
motor development in infants, toddlers, and school aged children and zinc 
supplementation (Ashworth et al 1998, Bentley et al 1997, Black et al 2004a, Castillo-
Duran et al 2001, Friel et al 1993, Gardner et al 2005, Kirksey et al 1991, Kirksey et al 
1994, Merialdi et al 1999, Sazawal et al 1996), although more research is needed to 
confirm such a relationship (Black 2003). On the other hand, other studies found no 
impact of zinc supplementation on infant and child mental development and behavior 
(Black et al 2004b, Cavan et al 1993, Gibson et al 1989, Hamadani et al 2001, Hamadani 
et al 2002, Lind et al 2004, Tamura et al 2003, Taneja et al 2005). 
Malnutrition in Jordan should be addressed immediately if sustained economic 
growth will convert the country into a “developed” state, as there is a definite positive 
correlation between health and income per capita. Healthier children have better school 
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performance and higher cognitive capacity. Healthier populations have higher productivity, 
lower mortality rate, and higher national saving rates. It is a two-way causality where health 
improvements lead to economic growth, and economic growth facilitates health 
improvement. 
The overall aim of this study was to examine the extent and causes of 
malnutrition and of selected micronutrient deficiencies (vitamin D, iron, and zinc) in 
women of childbearing age and their preschool children in northern Jordan. 
 
The specific objectives of the study were: 
1. To assess vitamin D status in women of childbearing age and their 
preschool children in Jordan during the summer.  
2. To determine the prevalence of iron and zinc deficiency in mothers and 
their preschool children living in northern Jordan, and to evaluate the 
diagnostic efficiency (i.e., sensitivity and specificity) of serum TfR and 
different TfR/ferritin ratios in identifying iron deficiency in women of 
child-bearing age and preschool children in Jordan. 
3. To examine possible associations between children’s performance on 
cognitive tests, their socioeconomic variables and their iron and zinc 
status indicators. 
The dissertation consists of six chapters that follow this introduction. Chapter 2 
provides an overview of the current literature on vitamin D, iron, and zinc. It also 
presents research on cognitive and developmental outcomes related to zinc and iron 
6 
deficiency. Research methodology is addressed in chapter 3. The vitamin D study is 
presented in chapter 4 as it was published in the European Journal of Clinical Nutrition.  
Chapters 5 and 6 are organized in manuscript format. Chapter 5 assesses the prevalence 
of iron and zinc deficiency among study participants, and chapter 6 examines the 
association between children’s performance on cognitive tests and their iron and zinc 
status indicators. Finally, chapter 7 provides a general discussion of the findings, 
conclusions, and recommendations for future research. 
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CHAPTER II 
 
 
REVIEW OF LITERATURE 
 
VITAMIN D CHEMISTRY, METABOLISM, AND CIRCULATION 
 
The importance of vitamin D to human health began to be clearly understood 
during the 1930s. The chemical structure of vitamin D was identified in Germany by 
Adolf Windaus (Norman and Henry 2006, Windaus et al 1932), a Nobel prize winner in 
Chemistry in 1928 for his work on sterols and their connection to vitamins.  
Vitamin D is derived from sterols. It is a generic term that represents four rings 
with differing side chain structure. Vitamin D contains three intact rings with a break in 
the fourth ring, and that is why it is considered to be a seco-steroid (Bouillon et al 1995). 
The two most important forms of vitamin D are: vitamin D2 (ergocalciferol), and vitamin 
D3 (cholecalciferol). Ergocalciferol is the synthetic form of vitamin D that is produced by 
the UV radiation of ergosterol in plants which leads to the formation of pre-vitamin D2 
(Figure 2.1). Then in a heat dependent process (Holick 2007), it is converted to vitamin 
D2 (ergocalciferol). Vitamin D3 is formed in the plasma membranes of human and animal 
skin (Figure 2.2).
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 When UVB radiation (290-315nm) hits the skin, it converts 7-dehydrocholesterol 
to pre-vitamin D3 , a thermodynamically unstable cis isomer which is rapidly converted 
to vitamin D3  (Bouillon et al 1995, Holick 2007). Approximately 50% of pre-vitamin D3 is 
converted to vitamin D3 within 2 hours (Holick 2005).  Excessive exposure to sun light is 
unlikely to cause vitamin D3 toxicity because once vitamin D3 is made, it enters the 
circulation, and the excess amounts of 7-dehydrochoelsterol and pre-vitamin D3  are 
rapidly converted to inactive photoproducts like tachysterol and lumisterol (Holick 
2005). 
Figure 2.1 
Vitamin D2 synthesis in plants  
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Vitamin D from both sources, the skin and the diet, is metabolized in the liver by 
25-hydroxyvitamin D-24-hydroxylase (Figure 2.3) to [25(OH) D], a term that is used to 
reflect both 25(OH) D2 and 25(OH) D3 (Gascon-Barre 2005). Serum 25(OH) D is the form 
9 
that is used to assess vitamin D status in individuals (Holick 2007, Holick 2009). The 
25(OH) D is the immediate precursor of the active metabolite: 1,25 dihydroxyvitamin D 
[1,25(OH)2D], and the kidney is the primary site for production of 1,25(OH) 2D with the 
action of the enzyme 25-hydroxyvitamin D-1alpha-hydroxylase (Henry 2005). Serum 
1,25 (OH)2D does not reflect vitamin D status, it remains normal or even increased with 
vitamin D deficiency as a result of secondary hyperparathyroidism (Holick 2009) 
 
Figure 2.2 
Vitamin D3 synthesis in skin 
 
 
 
 
 
. 
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Figure 2.3 
Vitamin D metabolism in human 
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ROLE OF 1, 25(OH)2 D IN CALCIUM HOMEOSTASIS  
The production of [1, 25(OH) 2D] in the kidney is tightly regulated by plasma 
parathyroid hormone (PTH) and calcium and phosphorous concentrations (Figure 2.4). 
The initial stimulus to 1, 25(OH) 2D production in the kidneys is the decreased blood 
calcium concentration and the parathyroid hormone. When calcium concentration in 
blood decreases, the parathyroid glands are stimulated to secrete PTH. The PTH acts on 
two major sites: the kidneys and the bone. In kidneys PTH increases renal calcium 
reabsorption, and stimulates 25-hydroxyvitamin D-1alpha-hydroxylase, the enzyme that 
converts 25(OH) D to its active form, 1, 25(OH) 2D. In the bone, both PTH and 1, 25(OH) 
2D act to increase calcium and phosphorous mobilization from bone to increase serum 
levels of calcium. This occurs through activation of osteoblasts (PTH interacts with its 
receptors in osteoblasts), which stimulates the conversion of pre-osteoclasts into 
mature osteoclasts, causing bone resorption and demineralization of the skeleton. A 
negative feedback mechanism is exerted by 1,25(OH) 2D on the kidney to decrease its 
own production. The third site where 1,25(OH) 2D acts is the intestine. The decrease in 
blood calcium stimulates 1,25(OH) 2D to interact with cell membrane vitamin D 
receptors (VDRs) in the intestine to stimulate the absorption of calcium and 
phosphorous, and increase the serum concentrations of both (Holick 2007, Norman and 
Henry 2006). 
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Figure 2.4 
Regulation of calcium homeostasis by 1,25(OH) 2D 
 
 
Kidneys, bone, and intestine are considered the classical targets for 1,25(OH) 2D. 
Recent research had shown that vitamin D receptors (VDRs) are present in different 
tissues in human body, and that 1,25(OH) 2D interacts with VDRs to affect functions 
other than calcium homeostasis. These tissues include: gastrointestinal cells like: 
esophagus, stomach, small intestine, large intestine, and colon; reproductive cells like: 
testis, ovary, placenta, and uterus; immune cells like: thymus, bone marrow, B-cells, and 
T-cells (Adams and Hewison 2008, Nagpal et al 2005, Wesley Pike and Shevde 2005) . 
Vitamin D receptors are also present in cardiac and smooth muscles, breast, brain, 
cancer cells, hair follicles, pancreatic β-cells, and pituitary gland (Norman and Silva 
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2001). Recent research on 1,25(OH) 2D has shown that it has immuno-modulatory 
effects that might be involved in multiple sclerosis, type II diabetes, upper respiratory 
tract infections, psoriasis, rheumatoid arthritis, and inflammatory bowel disease (Chen 
et al 2007, Ginde et al 2009, Holick 2006a, Mathieu and Adorini 2002, Nagpal et al 2005, 
Pittas et al 2006). It is also involved in cardiovascular functions through its effects on 
rennin-angiotensin regulation (Holick 2006a, Wang et al 2008). A recent meta-analysis 
showed vitamin D supplementation to be associated with decrease in total mortality 
rates from any cause (Autier and Gandini 2007).  
 
HOW MUCH VITAMIN D DO WE GET THROUGH SUN EXPOSURE?  
The major source for vitamin D is skin synthesis in response to sunlight exposure, 
specifically to UVB (290-315 nm). The Australian and New Zealand Bone and Mineral 
Society recommends an exposure of hands, face, and arms to 1/3 of a minimal 
erythema dose (the amount of sunlight exposure that causes slight redness of the skin) 
for adequate endogenous synthesis of vitamin D3 (Working Group of the Australian and 
New Zealand Bone and Mineral Society et al 2005). Exposure of the whole body for 10-
15 min to sunlight during summer generates 20,000 IU of vitamin D3 (Hollis 2005). On 
average 5-10 minutes of direct sunlight exposure of the arms and legs (half the minimal 
erythema dose) will produce about 3000 IU of vitamin D3  (Holick 2007). This amount 
varies by several factors including: latitude, time of the year, clothing practice, use of 
sunscreen, skin pigmentation, obesity, and age. 
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At latitudes between 37°N and 37°S, sunlight should be sufficient to produce 
normal levels of 25(OH) D3 (Figure 2.5), and it would be insufficient at latitudes above 
37°N and below 37°S (Holick 2006a). 
 
Figure 2.5 
Map highlighting latitudes between 37°N and 37°S 
 
 
However, amount of body surface area that is actually exposed to sunlight (this 
depends on clothing style, use of sunscreen, and lifestyle, i.e. indoor versus outdoor 
activities) and time of the year influence vitamin D status among individuals living under 
abundant sunlight. In two global studies that evaluated vitamin D status among 
postmenopausal women with osteoporosis from 18 countries at latitudes ranging 64°N-
20°S (Lips et al 2001), and 25 countries on 5 continents (Lips et al 2006), it was found 
that vitamin D deficiency was higher among participants from countries “closer” to the 
equator, like countries in the Middle East, Central and Southern Europe, and Latin 
America. A major factor in the Middle Eastern countries would be the cultural dress 
style and the sedentary lifestyle of women. This is supported by several studies that 
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have been done in the Middle East (Basaran et al 2007, Dawodu et al 1998, Gannage-
Yared et al 2000, Mishal 2001, Moussavi et al 2005, Saadi et al 2006).  
Several studies have found that serum concentrations of 25(OH) D are lower in 
winter compared to the summer (Chapuy et al 1996, Goswami et al 2000, Lips et al 
2001, Pal et al 2003, Pasco et al 2004), and among the elderly (Adami et al 2008, Chapuy 
et al 1996, Kudlacek et al 2003, Vieth et al 2003) due to less efficient cutaneous 
synthesis of vitamin D3 and lack of sunlight exposure (Holick et al 1989, Lips 2001).   
Skin pigmentation is another factor that affects vitamin D synthesis in the skin; 
higher prevalence of vitamin D deficiency was found in black Americans compared to 
white Americans (Looker 2005, Nesby-O'Dell et al 2002, Yanoff et al 2006). High melanin 
pigment concentration in the skin blocks UVB penetration and decreases the cutaneous 
production of vitamin D (Matsuoka et al 1991). People with darker skin needs longer 
duration of sunlight exposure to achieve the same level of vitamin D3 synthesis in the 
skin (Hollis 2005, Matsuoka et al 1991, Nesby-O'Dell et al 2002).  
Obesity is another factor that contributes to low serum 25(OH)D among 
individuals (Holick 2003, Liel et al 1988, Need et al 1993, Parikh et al 2004). 
Bioavailability of vitamin D decreases with obesity   (Wortsman et al 2000), and 
percentage body fat is inversely proportional to serum 25(OH)D in healthy women 
(Arunabh et al 2003). While serum parathyroid hormone was found to be positively 
associated with body mass index (BMI) (Kamycheva et al 2004), total body fat was found 
to have a strong inverse relationship with serum levels of 25(OH)D, and a weaker 
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association was found between body mass index (BMI) and serum 25(OH)D (Snijder et al 
2005). 
 
DIETARY SOURCES OF VITAMIN D 
Populations of developed countries are largely dependent on fortified food and 
dietary supplements to meet their dietary vitamin D requirements. Dietary vitamin D is 
mainly obtained from natural sources like salmon, sardines, tuna, egg yolk, and cod liver 
oil, and from fortified foods which include fortified milk, orange juice, cereals, butter, 
margarine, and yogurt. Natural sources of vitamin D, fortified foods and their vitamin D 
content, and vitamin D supplements are presented in Tables 2.1, 2.2, and 2.3, 
respectively.   
Table 2.1 
Natural sources of vitamin D and their vitamin D content 
 
Food source 
 
Size 
 
Vitamin D content 
 
Reference 
Salmon  
Fresh wild 3.5 oz 600-1000 IU 
(Holick 2007) Farmed 3.5 oz 100-250 IU 
Canned 3.5 oz 300-600 IU 
Sardines 
-Canned in tomato 
sauce, drained solids, 
with bone 
1 can (3.75 oz) 1776 IU 
(U.S. Department 
of Agriculture and 
Agricultural 
Research Service 
2007) 
-Canned in oil, 
drained solids, with 
bone 
1 can (3.75 oz) 250 IU 
Tuna 
 
Tuna light, canned in 
oil 
3.5 oz 234 IU 
 
Cod Liver Oil 
1 tsp 450 IU 
 
Egg yolk 
 
Raw, fresh 
large 18 IU 
 
liver 
 
Lamb liver, raw 
100 gm 16 IU 
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In developing countries sun light exposure is considered the major source for 
vitamin D synthesis for many reasons: foods rich in vitamin D (fatty fish, liver) are not 
commonly consumed, dairy products are rarely fortified with vitamin D, frequent 
consumption of raw milk and dairy products derived from raw milk, and the relatively 
high prices of vitamin D supplements making them unaffordable for the majority. In 
addition, there is little awareness of the importance of vitamin D to health and there is a 
lack of nutrition education related to vitamin D. 
 
Table 2.2 
Fortified foods and their vitamin D content 
Food type  
Estimates 
of fortified 
products in 
the US* 
Size 
Vitamin D 
content 
Reference  
Fortified Milk 
 
1%, 2%, and non 
fat milk  
All 1 cup 98 IU 
 
(U.S. Department of 
Agriculture and 
Agricultural Research 
Service 2007) 
 
dry, non fat, 
instant 
All 1 cup 299 IU 
 
Soy milk 
 
All 1 cup 100 IU 
 
Fortified cereals  
Few 100 gm 74-300 IU 
 
Fortified Orange juice 
Few 1 cup 100 IU 
 
Fortified Yogurt 
Few 1 cup 100 IU 
(Holick 2007) 
 
Fortified butter 
Few 3.5 oz 50 IU 
 
Fortified margarine 
Few 3.5 oz 430 IU 
 
Fortified cheese  
Few 3 oz 100 IU 
*(Calvo et al 2004) 
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Table 2.3 
Vitamin D supplements 
 
Oral vitamin D 
supplement type 
 
Vitamin D content  
per capsule 
 
Reference 
 
Vitamin D3 
 
6, 10, 14, 40, and 80 IU 
 
(Norman and Henry 2006) 
Vitamin D3 400, 800, 1000, 2000 IU 
(Holick 2007) 
Vitamin D2 50,000 IU 
 
 
ADEQUATE INTAKES OF VITAMIN D 
“Adequate intake (AI) refers to a recommended average daily nutrient intake 
level based on observed or experimentally derived approximations or estimates of the 
nutrient intake by a group (or groups) of apparently healthy people” (Institute of 
Medicine 2005). Adequate intake is used when there are insufficient available studies to 
define estimated average requirements (EAR), and therefore set the recommended 
daily allowance (RDA). The lack of accurate estimates for vitamin D dietary intake due to 
the absence of accurate measurements of food composition of vitamin D, and the 
difficulty in assessing the exact amount of vitamin D synthesized in the skin (due to 
variability in age, latitude, skin pigmentation, use of sunscreen, season, etc.) lead to the 
absence of consensus on the vitamin D recommendations for the general population.  
The recommendations for adequate intakes of vitamin D published in 1997 by 
the Institute of Medicine (IOM) in the US as presented in Table 2.4.  
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Table 2.4 
 US vitamin D adequate intakes 
 
Age 
 
AI 
 
Upper limit 
Infants 0-12 months 200 IU or 5 µg/day 1000 IU or 25 µg/day 
Ages (1-50) years  200 IU or 5 µg/day 2000 IU or 50 µg/day 
Adults aged (50-70) years 400 IU or 10 µg/day 2000 IU or 50 µg/day 
Adults aged > 71 years  600 IU or 15 µg/day 2000 IU or 50 µg/day 
Pregnancy & Lactation 200 IU or 5 µg/day 2000 IU or 50 µg/day 
Source: (Institute of Medicine 2005) 
 
The more recently published “Dietary Guidelines for American 2005” stressed 
those values and recommends higher dietary vitamin D for specific population groups: 
elderly, individuals with dark skin, and those with limited cutaneous production of 
vitamin D due to insufficient exposure to UVB radiation (e.g., housebound individuals). 
The recommended vitamin D daily intake for this “high risk group” is 1000 IU (U.S. 
Department of Health and Human Services and U.S. Department of Agriculture 2005). 
The report suggests the daily intake of: 3 cups of vitamin D-fortified milk (300 IU), 1 cup 
of vitamin D-fortified orange juice (100 IU), and 600 IU of vitamin D supplement to reach 
the vitamin D intake recommendation of 1000 IU. 
Similar vitamin D adequate intakes are suggested in Australia and New Zealand. 
The minimum daily dietary intake of vitamin D that is required to prevent vitamin D 
deficiency is 200 IU for ages < 50 years, and 600 IU for age >70 years (Working Group of 
the Australian and New Zealand Bone and Mineral Society et al 2005). A vitamin D 
supplement of 400 IU is recommended when sun exposure is limited. The World Health 
20 
Organization and Food and Agricultural Organization of the United Nations recommend 
200 IU of vitamin D as a minimum requirement for children and adults, 400 IU for older 
adults (51-65 years old) and 600 IU for ages >65 years (WHO/FAO 2002). Table 2.5 
summarizes recommended vitamin D intakes by different organizations along with the 
term used by each country.   
Unfortunately until now, there are no recommended dietary guidelines 
concerning vitamin D intake in the Middle East and North Africa region (MENA), despite 
the high prevalence of vitamin D deficiency. Recently, the Middle East and North Africa 
consensus on  osteoporosis recommended a daily intake of 400 IU of vitamin D for 
women 50-70 years old, and 600 IU for women older than 70 years old (Maalouf et al 
2007). There are no dietary guidelines for vitamin D intake for the remainder of the 
population, there are insufficient data to assess the dietary intake of vitamin D, and 
most importantly, there are no studies that assess the amount of vitamin D that is 
actually produced through sun exposure. One might assume that the abundant sunlight 
in the region would secure the population from being vitamin D deficient, but this may 
not be the case in the MENA region.  
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Table 2.5 
Vitamin D intakes recommended by different organizations   
WHO 
Source: (WHO/FAO 2002) 
 
Term used 
 
Age Groups (years) for both males and females 
 
Pregnancy & 
Lactation Recommended 
Nutrient Intake 
(RNI) of vitamin D/ 
day 
 
0-50 51-65 >65 
 
200 IU 
(5µg) 
 
400 IU 
(10µg) 
 
600 IU 
(15µg) 
 
200 IU (5µg) 
United States & Canada, Australia and New Zealand 
Sources: (U.S. Department of Health and Human Services and U.S. Department of Agriculture 2005) and 
(National Health and Medical Research Council in Australia and New Zealand 2005) 
 
Term used 
 
Age Groups (years) for both males and females 
 
Pregnancy & 
Lactation Adequate Intake 
(AI) of vitamin D/ 
day 
0-50 51-70 >70 
 
200 IU 
(5µg) 
 
 
400 IU 
(10µg) 
 
600 IU 
(15µg) 
 
200 IU (5µg) 
Ireland 
Source: (Food Safety Authority of Ireland 1999) 
 
Term used 
 
Age Groups (years) for both males and females 
 
Pregnancy & 
Lactation Recommended 
Dietary Allowance 
(RDA) of vitamin 
D/ day 
1-3 4-10 11-17 18-64 65+ 
 
400 IU 
(10µg) 
 
0- 400 IU 
(0-10µg) 
 
0-600 IU 
(0-15µg) 
 
0- 400 IU 
(0-10µg) 
 
400 IU 
(10µg) 
 
400 IU 
(10µg) 
 
Netherlands 
Source: (Health Council of the Netherlands 2008)  
 
Term used 
 
Age Groups (years) for both males and females 
 
Pregnancy & 
Lactation Adequate Intake 
(AI) of vitamin D/ 
day 
 0-3 4-50 51-70 >70 
With no 
exposure 
to sunlight 
 
400 IU 
(10µg) 
 
200 IU 
(5µg) 
 
400 IU 
(10µg) 
 
600 IU 
(15µg) 
 
400 IU 
(10µg) 
Light-colored skin, and remain 
outdoors for at least 15 minutes 
a day with at least hands and 
face uncovered 
 
200 IU 
(5µg) 
 
100 IU 
(2.5µg) 
 
200 IU 
(5µg) 
 
500 IU 
(12.5µg) 
 
300 IU 
(7.5µg) 
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Table 2.5 (continued) 
Vitamin D intakes recommended by different organizations   
Commission of the European Communities 
Source:(Commission of the European Communities 1993) 
   
 
Term used 
 
Age Groups for both males and females 
 
Pregnancy 
& 
Lactation 
A population 
Reference Intake 
(PRI) of vitamin 
D/ day 
6-11 
months 
1-10  
years 
11-17 
years 
18-64 
 years 
65+ 
years 
>400 IU 
(>10µg) 
Max: 900 IU 
(25 µg)  
0-400 IU 
(0-10µg) 
0- 600 IU 
(0-15µg) 
0-400 IU 
(0-10µg) 
400 IU 
(10µg) 
400 IU 
(10µg) 
       
European Society for Pediatric Endocrinology (ESPE) Bone Club Recommendations 
Source: (Hochberg et al 2002) 
 
Term used 
 
Age Groups (years) for both males and females 
 
3
rd
 trimester 
Pregnancy & 
Lactation 
Adequate 
Intake (AI) 
of vitamin 
D/ day 
Premature 
infants 
Term-1
st
 
year 
Childhood Adolescence Chronic 
disease 
200-400 IU 200-800 IU 0-400 IU 0-1000 IU 400 IU 400-1000 IU 
 
The higher doses are recommended when sun exposure is limited and for dark skin 
 
 
VITAMIN D TOXICITY 
Although excessive exposure to sunlight has the risk of causing skin cancer, there 
is no risk of vitamin D intoxication, as the sunlight destroys excess vitamin D and convert 
it into inactive photoproducts (Webb et al 1989). The tolerable upper intake level (UL) 
that is set by Food and Nutrition Board is 2,000 IU (50µg) per day (Institute of Medicine 
2005) . A recent study that reviewed a set of well-designed human clinical trials, and 
applied a risk assessment based on the absence of toxicity, suggested a vitamin D UL 
dose of 10,000 IU (250µg) per day (Hathcock et al 2007). 
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MEASURING VITAMIN D STATUS 
The major circulating metabolite of vitamin D is 25(OH) D; it is the most 
abundant and has the longest half-life of all vitamin D metabolites (Holick 2006b, Lips 
2004). It reflects the total synthesis of 25(OH) D from the two sources, sunlight exposure 
and dietary intake (Holick 2006b). 
As noted earlier, vitamin D along with parathyroid hormone plays a major role in 
the homeostatic regulation of serum calcium and phosphorous concentrations.  “When 
calcium levels fall even slightly, levels are returned to normal by a PTH/vitamin D-
controlled increase in calcium absorption, increase in renal tubular reabsorption, and 
bone resorption” (Connie 2006). Calcium absorption is reduced at lower concentrations 
of 25(OH)D, even within a normal reference range of 25(OH)D (Heaney et al 2003). 
Calcium levels were significantly reduced at serum 25(OH) D concentrations of 50 
nmol/L relative to a mean serum concentration of 25(OH)D of 86 nmol/L. When serum 
calcium is reduced in response to vitamin D deficiency; hyperparathyroidism is triggered 
and PTH secretion is increased. 
An inverse relationship between PTH level and serum 25(OH)D has been 
reported in many studies (Guillemant et al 1999, Holick et al 2005, Lamberg-Allardt et al 
2001, Outila et al 2001, Vieth et al 2003), and it is suggested that the optimal range for 
25(OH)D is the range where the PTH concentrations will be reduced to the minimum 
and theoretically attain the plateau value based on an exponential function. Different 
research groups have found similar but slightly different 25(OH)D concentration when 
PTH starts to plateau. The PTH plateau was reached at serum 25(OH) D concentration of 
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70 nmol/L (Vieth et al 2003), 75nmol/L (Holick et al 2005), 80 nmol/L (Lamberg-Allardt 
et al 2001), and 83 nmol/L (Guillemant et al 1999). 
 
DEFINING VITAMIN D DEFICIENCY 
There is an absence of consensus on the cut-off point that defines vitamin D 
deficiency. Even the term deficiency is not used consistently by researchers; other terms 
like vitamin D inadequacy, vitamin D insufficiency, and mild, moderate, or severe 
deficiency are also used. The absence of consensus is due to three main reasons; first, 
there is a great variation of serum 25(OH) D among different countries. Populations of 
many developed countries tend to have higher levels of serum 25(OH) D (due to 
fortification, use of supplements, and nutrition education), and therefore higher serum 
25(OH) concentrations are used as cut-off points for deficiency. In countries where 
there is a high prevalence of low serum 25(OH) D, lower cut-off points are used.  
Secondly, there are differences in the assay methods used to measure serum 
25(OH) D between different laboratories. A cross calibration of three serum 25(OH) D 
assays: competitive protein binding (CPB), high-performance liquid chromatography 
(HPLC), and radioimmunoassay (RIA) administered by five international laboratories 
showed that although the assays were able to consistently identify low and high values 
of serum 25(OH) D, reported serum 25(OH) D was higher when measured by CPB than 
by HPLC, and intermediate vales were reported using RIA (Lips et al 1999). The highest 
correlation was found between HPLC and RIA (r=.84, p<.01).  
25 
A third reason for the absence of consensus on the cut-offs for vitamin D 
deficiency, is the differences in the impact of low serum 25(OH)D on the biomarkers 
that are used to define an adequate level of serum 25(OH)D. These biomarkers include: 
serum PTH, calcium absorption, bone mineral density (BMD), and fractures. For 
example, as noted in the previous section the threshold of serum 25(OH) D that will 
suppress high serum concentrations of PTH has varied from 70-83 nmol/L in different 
studies.  
An evidence report on vitamin D status and bone health reviewed 167 studies 
and concluded that although there is a fair amount of evidence for some association 
between serum 25(OH) D and bone health outcomes (rickets, PTH, falls, fractures) in 
infants and children, women of reproductive age, postmenopausal women, and elderly, 
“it was difficult to define specific thresholds of circulating 25(OH)D for optimal bone 
health”(Cranney et al 2007). 
Table 2.6 shows that the cut-off points for an optimal concentration of 25(OH) D 
in U.S. and Canada [ 25(OH)D > 75-80 nmol/L] are higher than the cut-off points used in 
most studies in European countries [ 25 (OH) D >50]  and what is proposed by the Bone 
and Mineral Society, Endocrine Society, and Osteoporosis in Australia and New Zealand.  
In the Middle East; most of the studies set a lower cut-off point to define deficiency, 
such as 25(OH) D <30-37.5 nmol/L. 
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Table 2.6 
Cut-off points used to define low serum 25(OH) D in different countries 
USA & Canada     
USA 2007 vitamin D sufficiency  ≥ 75 nmol/L 
(Holick 2007) vitamin D insufficiency 52-74 nmol/L 
vitamin D deficiency < 50 nmol/L 
 2005 Optimal vitamin D concentration >80 nmol/L 
(Heaney 2004, Heaney 2005) Osteoporosis 20-80 nmol/L 
Osteomalacia and rickets <20 nmol/L 
Canada 2006 Optimal vitamin D concentration >75 nmol/L (Vieth 2006) 
Europe     
Netherlands 2004 Vitamin D replete >50 nmol/L 
(Lips 2004) 
Mild vitamin D deficiency 25-50 nmol/L 
Moderate vitamin D deficiency 12.5-25 nmol/L 
Severe vitamin D deficiency <12.5 nmol/L 
 2006 Vitamin D deficiency <25 nmol/L (van der Meer et al 2006) 
Germany 2006 Vitamin D adequacy 70-100 to 250 nmol/L 
(Zittermann et al 2006) 
Hypovitaminosis D >50-70 to 100 nmol/L 
Vitamin D insufficiency >25-50 nmol/L 
Vitamin D deficiency 0-25 nmol/L 
Irland 2008 Vitamin D in adequacy <50 nmol/L 
(Hill et al 2008) 
Vitamin D deficiency <25 nmol/L 
Finland 2006 Vitamin D insufficiency <40 nmol/L (Laaksi et al 2006) 
Vitamin D deficiency <25 nmol/L  
Australia & Newzealand 
 2005 Mild vitamin D deficiency 25-50 nmol/L (Working Group of the 
Australian and New Zealand 
Bone and Mineral Society et 
al 2005) 
Moderate vitamin D deficiency 12.5-25 nmol/L 
Severe vitamin d deficiency <12.5 nmol/L 
Middle East     
Lebanon 2000 Hypovitaminosis D <30nmol/L 
(Gannage-Yared et al 2000) 
 Severe hypovitaminosis D < 12.5 nmol/L 
Turkey 2005 Vitamin D deficiency <37.5 nmol/L (Hatun et al 2005) 
2006 Vitamin insufficiency <37.5 nmol/L (Olmez et al 2006) 
2007 Optimal levels ≥ 75 nmol/L 
(Basaran et al 2007) 
 Suboptimal < 75 nmol/L 
 Vitamin D insufficiency < 50 nmol/L 
 Vitamin D deficiency < 30 nmol/L 
Jordan 2001 Vitamin D insufficiency >12.5-30 nmol/L 
(Mishal 2001) 
 Severe vitamin D deficiency <12.5 nmol/L 
UAE 2006 Vitamin D insufficiency >80 nmol/L 
(Saadi et al 2006)  Moderately severe vitamin D 
deficiency 
<20 nmol/L 
Iran 2004 Mild vitamin D deficiency 25- ≤ 35 nmol/L 
(Hashemipour et al 2004)  Moderate vitamin D deficiency 12.5- ≤ 25 nmol/L 
 Severe vitamin D deficiency ≤12.5 nmol/L 
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PREVALENCE OF VITAMIN D DEFICIENCY AMONG HEALTHY YOUNG WOMEN – AN 
INTERNATIONAL OVERVIEW 
In the United States, hypovitaminosis D among nonpregnant African women and 
White women of reproductive age (15-49 years) was examined in data obtained from 
the Third National Health and Nutrition Examination Survey, 1988-1994 (NHANES III) 
(Nesby-O'Dell et al 2002). Mean serum 25(OH) D measured by radioimmunoassay was 
44.2 ± 1.1 nmol/L among African American women, and 82.5 ± 1.5 nmol/L among white 
women. The prevalence of hypovitaminosis D (defined as serum 25(OH) D ≤ 37.5 
nmol/L) was 42.4% among African Americans (n= 1546), and 4.2% among whites (n= 
1426). When serum 25(OH)D cut-off point was defined as 25.0 nmol/L, the prevalence 
of vitamin D deficiency was 12.5% among African American women. 
Scragg and colleagues (2007) examined the association between serum 25(OH)D 
and blood pressure among 12, 644 people aged ≥ 20 years in NHANES III (Scragg et al 
2007). Mean serum 25(OH) D (measured by radioimmunoassay) was 78 nmol/L in males 
(n= 6097), and it varied in females (n= 6547) according to different age groups (Table 
2.7). The concentration of 25(OH)D was lower with higher BMI values, and it was lowest 
in the non-Hispanic black 
Another study assessed the association of 25(OH)D and the risk of cancer in 
16818 participants (age > 17 years) in NHANES III (Freedman et al 2007). Mean serum 
25(OH)D and the prevalence of low serum 25(OH)D are presented in Table 2.8. 
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Table 2.7 
Serum 25(OH) D by age, ethnicity, and BMI in NHANES III 
 
Females’ age group 
(year) 
n 
Mean serum 25(OH)D 
(nmol/L) 
20-29 3127 81 
30-39 2901 78 
40-49 2128 73 
50-59 1295 72 
60-69 1434 70 
≥ 70 1759 67 
Ethnicity (males & females) 
 
  
Non-Hispanic black 3479 49 
Mexican American 3866 68 
Non-Hispanic white 5299 79 
BMI (males & females) 
 
  
≤ 22.1 2499 80 
22.2-24.6 2511 79 
24.7-27.1 2528 75 
≥ 30.7 2523 67 
Source: adapted from (Scragg et al 2007) 
 
Table 2.8 
Serum 25(OH) D by age, sex, and race in NHANES III 
 
 
 
Range of serum 25(OH)D (nmol/L) 
 
Characteristics  <50 50- <62.5 62.5- <80 ≥80 
n  5744 3143 3713 4218 
Age (years)  45.2 45.9 44.1 40.8 
Serum 25(OH)D (nmol/L)  38.3 56.6 71.3 104.4 
Sex (%) Men 34.7 46.5 49.7 55.3 
 Women 65.3 53.5 50.3 44.7 
Race (%) Non- Hispanic white 51.6 69.7 81.2 90.4 
 Non- Hispanic black 29.0 12.4 5.9 2.4 
 Mexican American 7.2 7.4 5.4 2.9 
 Other 12.2 10.5 7.6 4.3 
Source: adapted from (Freedman et al 2007) 
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Vitamin D status of 200 black and 200 white pregnant women residing in 
northern United States and their neonates was assessed in Pittsburg, Pennsylvania 
(Bodnar et al 2007). Serum 25(OH)D was measured using ELISA and validated by HPLC. 
Two serum samples were taken from the mothers one at < 21 week of gestation and 
one before delivery, as well as a cord serum sample. Black women had lower serum 
25(OH)D than white women, and both had high prevalence of vitamin D insufficiency 
before 21st week of gestation and before delivery. Black neonates had lower serum 
25(OH) D  compared to white neonates, and both had high levels of vitamin D 
insufficiency (Table 2.9). 
Table 2.9 
25(OH) D in pregnant women and their neonates in Pennsylvania 
 
 serum 25(OH)D (nmol/L) 
 Mean < 37.5 37.8-80 > 80 
4-21 wk gestation     
White women 73.1 2.0% 60.3% 37.3% 
Black women 40.2 44.9% 51.0% 4.1% 
37-42 wk gestation     
White women 80.4 5.0% 41.2% 53.8% 
Black women 49.4 29.2 54.1% 16.7% 
Cord Blood 67.4 9.7% 56.4% 33.9% 
 39.0 45.6% 46.8% 7.6% 
Source: (Bodnar et al 2007) 
In Canada; vitamin D insufficiency was assessed in 796 young women (age: 18-35 
years) from Oct. 1995-Mar. 1997 (Vieth et al 2001). Serum 25(OH) D (measured by 
radioimmunoassay) was highest in August and lowest in February (Table 2.10). The 
prevalence of low serum 25(OH) D (less than 40 nmol/L) was higher in non-white (Asian, 
and Indo-Asian), and non-black subjects than in white women (although sample size for 
the black women was small).  
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Table 2.10 
Serum 25(OH) D in young women in Canada 
 
Women’s 
group 
n Mean 25(OH)D 
 (nmol/L) 
Prevalence of serum 25(OH)D < 40 nmol/L 
during winter 
White 380 58± 24 21.3% 
Non-white 47 51± 22 31.9% 
Black 8 68 ± 40 25 
Women’s 
group 
n Mean 25(OH)D 
 (nmol/L) 
Prevalence of serum 25(OH)D < 40 nmol/L 
during summer 
White 322 76± 28 7.1% 
Non-white 35 68± 33 17.1% 
Black 4 68 ± 15 0 
Source: (Vieth et al 2001) 
 
Vitamin D status of a white British population was assessed from the 1958 British 
birth cohort (Hypponen and Power 2007). Vitamin D, measured by enzyme-linked 
immunosorbent assay, was assessed in 7437 whites (at 45 years of age) in four seasons 
between Sep. 2002 and Apr. 2004. Seasons were classified as: winter (December - 
February); spring (March - May); summer (June -August); and fall (September - 
November), and four geographical regions were: south, middle, north, and Scotland. 
Mean 25(OH) D was higher in summer and fall, and the prevalence of vitamin D 
deficiency was higher during winter and spring. Men had higher 25(OH) D 
concentrations than women during the summer and the fall but not during the winter 
and the spring (Table 2.11).  
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Table 2.11 
25(OH) D in a British population 
 
 25(OH)D (nmol/L) 
Characteristics n mean <25 <40 <75 
All      
Winter & Spring 2850 41.1 15.5% 46.6% 87.1% 
Summer & Fall 4587 60.3 3.2% 15.4% 60.9% 
Winter & Spring      
Men 1413 41.1 13.9% 47.0% 88.7% 
Women 1437 41.2 17.1% 46.3% 85.4% 
Summer & Fall      
Men 2312 61.9 2.2% 13.4% 58.1% 
Women 2275 58.6 4.3% 17.4% 63.7% 
Source: (Hypponen and Power 2007) 
 
Mean concentration of 25(OH) D was also lowest in Scotland compared to other 
regions in winter and spring (35.4 nmol/L in Scotland compared to 41.2, 40.6, and 42.6 
nmol/L in south, middle, and north, respectively), and in summer and fall (45.6 nmol/L 
in Scotland compared to 62.4, 60.4, and 60.9 nmol/L in south, middle, and north, 
respectively). 
In France, vitamin D status was assessed in 1569 adults selected from 20 French 
cities grouped into 9 geographical regions (Chapuy et al 1997) between November 1994 
and April 1995. The mean serum 25(OH) D measured by radioimmunoassay was 62 ± 30 
nmol/L in men (n= 765, aged 45-65 years) and 60 ± 30 nmol/L in women (n= 804, aged 
35-60 years), with the lowest values in the North and the greatest in the South. The 
prevalence of low serum 25(OH)D (values ≤ 30 nmol/L) was 14% among all participants.  
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In Italy, a longitudinal study was performed to assess vitamin D status of healthy 
subjects in southern Italy (Carnevale et al 2001). Serum 25(OH) D was measured twice 
(in February and in August) by radioimmunoassay for a total of 90 participants (32 men, 
and 58 women). Mean age was 39.4 years for men and 36.9 for women. The prevalence 
of hypovitaminosis D (defined as serum 25(OH) D < 30 nmol/L) was 17.8% in winter and 
2.2% in summer for all participants. Hypovitaminosis D among women was 27.6% in 
winter and 3.4% in summer. When 50 nmol/L was used as a cut-off for deficiency; the 
prevalence of vitamin D deficiency among women was 81% during winter, and 6.9% 
during summer.  
In Germany, seasonal variation in vitamin D status was assessed in 38 women 
(mean age= 24.5 years) in winter (collected in February), and 38 females of the same 
age (mean age= 24.7 years) in summer (collected between July - October) in Bonn at 
latitude: 51°N (Zittermann et al 1998). Mean serum 25(OH) D measured by 
radioimmunoassay was 30.3 ± 19.1 nmol/L in winter and 69.8 ± 27.0 nmol/L in summer. 
In Finland, vitamin D deficiency was assessed in healthy young adults in winter in the 
southern area at 60°N latitude (Lamberg-Allardt et al 2001). Serum 25(OH) D was 
measured by radioimmunoassay in 202 women and 126 men (age: 31-43 years). Mean 
serum 25(OH) D was 47 ± 34 and 45 ± 35 in women and men, respectively. The 
prevalence of low serum 25(OH) D with a cut point value of 25 nmol/L was 26.2% (n=53) 
in women and 28.6% (n=36) in men. Another study in Finland (Helsinki, 60°N) assessed 
vitamin D in 178 female adolescents (aged 14-16 years) during winter (Outila et al 2001). 
Mean serum 25(OH)D measured by radioimmunoassay was 39.0 ± 14 nmol/L, and 
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vitamin D deficiency (defined as serum 25(OH)D ≤ 25.0 nmol/L) was prevalent among 
13.5% of participants (n= 24).  
In Austria, vitamin D was assessed in 654 women (age range: 21-74 years) and 
435 men (age range: 26-76 years) (Kudlacek et al 2003). Mean serum 25(OH) D 
measured by enzyme-based protein binding assay was 52.3 ± 33.3 nmol/L with no 
significant difference between the two sexes. The prevalence of vitamin D deficiency 
(defined as serum 25(OH)D < 30.0 nmol/L) was 26% (n=271)  among participants.  
In India, vitamin D deficiency was assessed in healthy urban (n=943, mean 
age=46 ± 0.43 years) and suburban (n=205, mean age= 43 ± 1.01) subjects in southern 
India (13.4°N) (Harinarayan et al 2007). Serum 25(OH) D measured by competitive 
radioimmunoassay was assessed in 141 men, and 572 women. Mean serum 25(OH) D 
was higher in men compared to women, and it was higher in rural subjects in both men 
(59.3 nmol/L in rural subjects vs. 46.4 nmol/L in urban subjects), and women (47.5 
nmol/L in rural subjects vs. 38.75 nmol/L in urban subjects). Vitamin D deficiency 
(defined as serum 25(OH) D < 50.0 nmol/L) was prevalent among 44% of men, and 70% 
of women in rural areas, and among 62% of men and 75% of women in urban areas.  
Plasma 25(OH) D was assessed in young and old women and men using 
radioimmunoassay in north-east of China in Shenyang (Yan et al 2000). Participants 
were 48 young women and 48 young men (age: 25-35 years), and 48 old women and 50 
old men (age; 65-75 years). Vitamin D deficiency (defined as plasma 25(OH) D < 25 
nmol/L) was prevalent among 48%, 29%, 15%, and 13% of old men, young men, old 
women, and young women, respectively. A recent study in China has examined vitamin 
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D status of 441 young nonpregnant women (age: 20-35 years) in two Chinese cities 
(Beijing and Hong Kong) in the spring between February and June 2006 (Woo et al 
2007). Mean serum 25(OH) D measured by radioimmunoassay was 32 nmol/L, and the 
prevalence of vitamin D insufficiency (defined as 25(OH)D concentration ≤ 50 nmol/L 
was 93% among all participants.   
Vitamin D insufficiency among 77 healthy young women (aged 19-66 years) was 
assessed in Japan (Nakamura et al 2001a) during the winter of 1999-2000. Mean serum 
25(OH)D measured by HPLC was 42.0 nmol/L for all subjects. The mean serum 25(OH)D 
for women aged <30 years (n=38) was 34.0 ± 11.0 nmol/L, and it was significantly lower 
than that for women aged 30 years or above (n=39) with a mean 25(OH) D of 50.0 ± 14.4 
nmol/L.  In another study that assessed serum 25(OH) D in 77 Japanese female college 
students (age: 19-24 years) (Nakamura et al 2001b). The mean serum 25(OH)D 
measured by HPLC was 34.2 ± 12.1  nmol/L, and 40.3% (n=31) of females had serum 
25(OH)D less than 30.0 nmol/L.  
Vitamin D status of nonpregnant women was assessed in 504 women (18-40 
years old) living in two Asian cities: Jakarta (6°S) in Indonesia and Kuala Lumpur (2°N) in 
Malaysia (Green et al 2008). Mean plasma 25(OH) D measured by radioimmunoassay 
was 48nmol/L for all participants. Less than 1% of women had plasma 25(OH) D < 17.5 
nmol/L, and over 60% of women had 25(OH) D less than 50 nmol/L (Table 2.12).  
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Table 2.12 
25(OH) D of non-pregnant women in Indonesia and Malaysia 
 
Group  n Mean age Mean 25(OH)D 
 (nmol/L) 
Prevalence of serum  
25(OH)D < 50 nmol/L 
All  504  48 61% 
Jakarta  126 30 46 63% 
Kuala Lumpur:      
Malay  133 26 43 74% 
Chinese  123 23 58 38% 
Indian  122 27 45 68% 
All Kuala Lumpur  378 25 49 60% 
Source: (Green et al 2008) 
 
In Australia, a comparison of vitamin D status in women < 60 years of age from 
three regions across Australia was performed using data from three cross-sectional 
studies (van der Mei et al 2007). The authors reviewed three population studies 
[McGrath et al. 2001; Pasco et al. 2001; van der Mei et al. 2007]. Serum 25(OH) D was 
measured by radioimmunoassay in the three studies. Participants included in the 
analysis were 167 women from Southeast Queensland (27°S), 561 women from Geelong 
region (38°S), and 432 women from Tasmania (43°S). Samples were collected over all 
seasons for the three studies; summer (December - February), autumn (March - May), 
winter (January -August), and spring (September – November). In the three studies; 
vitamin D insufficiency was common in winter and spring. The prevalence of vitamin D 
deficiency in spring is shown in Table 2.13: 
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Table 2.13 
Prevalence of vitamin D deficiency in Australia 
 
  Mean 25(OH)D 
 (nmol/L) 
Prevalence of serum 25(OH)D during Spring 
Region n < 25 nmol/L  < 50 nmol/L 
Southeast 
Queensland 
167 67.0 7.1% 40.5% 
Geelong 561 75.5 7.9% 37.4% 
Tasmania 432 51.1 13.0% 67.3% 
Source: (van der Mei et al 2007) 
 
PREVALENCE OF VITAMIN D DEFICIENCY IN THE MIDDLE EAST AND NORTH AFRICA 
The unexpected vitamin D deficiency in the Middle East came into view during 
the 1980s when a few studies in Saudi Arabia reported low concentrations of serum 
25(OH)D among Saudi women (Fonseca et al 1984), Saudi mothers and their newborn 
infants (Serenius et al 1984, Taha et al 1984), men (Sedrani 1984) , and the elderly (Al-
Arabi et al 1984). Plasma 25(OH)D was assessed in 31 adult Saudi women; the range was 
5-45 nmol/L, with median of 15 nmol/L (Fonseca et al 1984), and significantly lower 
plasma 25(OH)D was found in women whose average sunlight exposure was less than 
30 minutes per day.  
Vitamin D status was assessed in 119 pregnant women at term and their 
newborns in Saudi Arabia (Serenius et al 1984); serum 25(OH)D was undetectable (< 7.5 
nmol/L) in 11 of 119 maternal samples, and in 50 of 119 umbilical samples. It was 
extremely low (< 10 nmol/l) in a further 19 maternal and 31 umbilical samples. 
Significantly higher serum 25(OH) D was found in higher socioeconomic groups, and in 
mothers who had been given vitamin D supplementation during pregnancy.  
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In another study, plasma 25(OH) D was assessed in 100 Saudi mothers and their 
neonates within 24 hours after delivery (Taha et al 1984). Low plasma 25(OH) D (< 25 
nmol/L) was found in 59 mothers and 70 neonates.  
In 1999; serum 25(OH) D was assessed using radioimmunoassay in 321 healthy 
Saudi females (age: 10 - >50 years) with the majority between 20-50 years of age. Fifty-
two percent of participants had severe hypovitaminosis D (25(OH) D ≤ 20 nmol/L) and 
parathyroid hormone (PTH) was correlated significantly (r=-0.28) with 25(OH) D. 
(Ghannam et al 1999). 
 Serum 25(OH)D was assessed in the western region of Saudi Arabia (Jeddah) 
using a competitive binding radioimmunoassay in 739 infants and pre-school children 
(aged 4-72 months).  Serum 25(OH) D correlation with dietary intake of vitamin D and 
duration and frequency of sunlight exposure was determined (Bahijri 2001). Serum 
25(OH)D ranged between 6.5-192 nmol/L. Infants and children were grouped by age 
into five groups: group 1, n= 110 (4 - < 6 months old); group 2, n= 170 (6 - < 12 months 
old); group 3, n= 166 (12 - < 24 months old); group 4, n= 166 (24 - < 36 months old); and 
group 5, n= 221 (36 - 72 months old). Prevalence of vitamin D deficiency, defined as 
serum 25(OH)D < 25 nmol/L, was: 16.4%, 15.3%, 16.3%, 2.4%, and 8.6%  in the groups 1, 
2, 3, 4, and 5, respectively.  
The prevalence of vitamin D deficiency among women in United Arab Emirates 
(UAE) has been assessed in a few studies. The effect of duration of sunshine exposure 
weighted against the magnitude of clothing on serum 25(OH)D was assessed in 3 groups 
of women of child-bearing age. Women groups were: UAE nationals (n=33), non-gulf 
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Arabs (n=25), and Europeans (n=17) who lived in UAE (Dawodu et al 1998). Serum 
25(OH) D was measured by HLPC, and PTH was measured by immunoradiometric assay. 
Lowest serum 25(OH) D was found among UAE nationals and non-gulf Arabs (21.5 
nmol/L, and 31.5 nmol/L, respectively). Both values were significantly lower than serum 
25(OH) D found in European women (160.8 nmol/L). PTH values were lower with lower 
serum 25(OH) D but without a significant difference between the three groups. UV 
exposure score was significantly lower in UAE nationals and non-gulf Arabs compared to 
European women. Nationality, clothing, and UV exposure score were major predictors 
of vitamin D status. 
Serum 25(OH) D was measured in exclusively breast feeding infants and their 
mothers during summer in UAE (Dawodu et al 2003).  Their 25(OH) D was assessed by 
HLPC in 90 mothers and 78 infants. Infants ranged in age from 4 to 16 weeks, and they 
were Arab (n=23) or South Asian (n=67). Fifty-five mothers (61%), and 64 infants (82%) 
had serum 25(OH) D < 25nmol/L. The median serum 25(OH)D was 21.5 nmol/L in 
women and 11.5 nmol/L in infants. 
Serum 25(OH) D was assessed in 259 Emirati women (age range: 20-85 years) 
(Saadi et al 2006). All women had vitamin D deficiency (serum 25(OH)D < 80 nmol/L), 
and 35.1% of women had serum 25(OH)D < 20 nmol/L. Vitamin D was assessed in two 
groups [pre-menopausal (n= 175), and postmenopausal (n=84)] between Jan 1, 2003 
and June 30, 2005. Mean serum 25(OH) D was significantly lower in pre-menopausal 
women (24.3 ± 10.4 nmol/L) compared to postmenopausal women (27.3 ± 11.2 nmol/L). 
There was no significant difference between serum 25(OH)D in women who covered all 
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their body except for face and hands (24.8 ± 11.1 nmol/L), and those who covered their 
whole body (25.7 ± 10.6 nmol/L). However mean serum 25(OH) D was significantly 
higher in women wearing western dress style (63.3 ± 26.2 nmol/L). Mean serum 
25(OH)D was highest in April (29.2 ± 13.0 nmol/L) and lowest in August (18.2 ± 5.9 
nmol/L).  
A study in Kuwait has compared plasma 25(OH) D in 50 veiled and 22 unveiled 
women between 14-45 years of age (El-Sonbaty and Abdul-Ghaffar 1996). Mean plasma 
25(OH) D was significantly lower in veiled women (14.4 nmol/L) compared to non veiled 
women (30.2 nmol/L). Another study in Kuwait assessed serum 25(OH) D by 
radioimmuniassay in 214 full-term pregnant mothers and their neonates (Molla et al 
2005). Mean serum 25(OH) D was 36.5 nmol/L in mothers and 20.5 nmol/L in neonates. 
Eighty-six mothers (40%) and 142 neonates (66%) had serum 25(OH) D < 25nmol/L. 
Prevalence of vitamin D deficiency was assessed in 318 (153 boys and 165 girls) 
high school students (aged 14-18 years) in Iran (Moussavi et al 2005). Serum 25(OH) D 
was < 50 nmol/L in 46.2 % of participants (18.3% in males, and 72.1% in females), and it 
was < 82 nmol/L in 72.2% of participants (49% in males, and 95.2% in females). 
Serum 25(OH)D was measured by HLPC in 73 early postmenopausal Iranian women in 
Tehran (Rassouli et al 2001). Mean age was 55.7 ± 3.6 years, and samples were collected 
during February -June 2000. Mean serum 25(OH) D was 42.8 ± 28.3 nmol/L. There was 
no significant difference between serum 25(OH) D levels measured in winter (33.3 ±12.5 
nmol/L, n = 17) and spring (45 ± 30 nmol/L, n = 56). Overall, prevalence of vitamin D 
deficiency (defined as serum 25(OH) D < 30 nmol/L) was 36% (n= 26). 
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In Turkey, vitamin D deficiency was found in pre-menopausal women (Alagol et 
al 2000), early infancy (Hatun et al 2005), elderly (Atli et al 2005), healthy female 
adolescents (Olmez et al 2006), and among women with osteoporosis (Basaran et al 
2007). 
Alagol and colleagues (2000) assessed the vitamin D status among 48 pre-
menopausal women (14-44 years of age) during summer. Women were grouped into 
three groups; group I: women wearing western dress style; group II: women wearing full 
covering clothing showing hands and face; and group III: women wearing full covering 
clothing including face and hands. (Alagol et al 2000). Mean serum 25(OH)D was : 56 ± 
41.3 nmol/L, 31.9 ± 24.4 nmol/L, and 9 ± 5.7 nmol/L for the groups I, II, and III, 
respectively. Another study evaluated serum 25(OH) D in a total of 42 mothers who 
were diagnosed with vitamin D deficiency and their infants (27 boys and 15 girls) in two 
medical centers in Turkey (Hatun et al 2005). Serum 25(OH) D was measured only in 29 
infants and 15 mothers by radioimmunoassay, and serum 25(OH) D <37.5 nmol/L was 
prevalent in all of the infants and the mothers, with mean serum 25(OH)D of 17.5 
nmol/L in infants and 19.5 nmol/L in mothers.  
Serum 25(OH)D was assessed by radioimmunoassay in 64 healthy female 
adolescents (14-18 years of age) from low and high socioeconomic settlements at the 
end of summer (September -October) and at the end of winter (February - March) in 
Turkey (Olmez et al 2006). Serum 25(OH) was higher at the end of summer compared to 
winter, and higher for the girls from the high socioeconomic settlement compared to 
the girls from the low socioeconomic settlement. Mean serum 25(OH) D was 65.3 
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nmol/L at the end of summer compared to 59.5 nmol/L at the end of winter for girls 
from the higher socioeconomic settlement, and it was 51.6 nmol/L at the end of 
summer compared to 34.3 nmol/L at the end of winter for girls from the lower 
socioeconomic settlement. The prevalence of vitamin D insufficiency (25(OH)D < 37.5 
nmol/L) among girls from the higher socioeconomic settlement was 15.6% at the end of 
both seasons, and it was 59.4% at the end of winter, and 25% at the end of summer for 
girls from the lower socioeconomic settlement. 
Serum 25(OH) D was assessed by HLPC in 259 women with osteoporosis in 
Turkey (Basaran et al 2007). Mean age was 61 ± 8.9 years. Mean 25(OH)D was 56.75 ± 
31.5 nmol/L. Thirty-five women (13.5%) had serum 25(OH)D < 30 nmol/L, ninety-seven 
women (37.5%) had serum 25(OH)D between 30-50 nmol/L, seventy-nine women 
(30.5%) had serum 25(OH)D between 50-75 nmol/L, and forty-eight women (18.5%) had 
serum 25(OH)D more than 75 nmol/L. Quality of  Life (QOL) was assessed using QOL 
Questionnaire of the European Foundation of Osteoporosis (QUALEFFO), and it was 
found that concentration of 25(OH)D is significantly associated with QOL.  
The prevalence of vitamin D deficiency was assessed in an elderly Turkish 
population (Atli et al 2005). Serum 25(OH)D was measured by radioimmunoassay for 
138 female and 87 male participants living in old age homes (OAH), and 171 female and 
24 male participants living in own homes (OH). Elderly individuals were in good health. 
Concentrations of 25(OH) D < 37.5 nmol/L were observed among 33.4% of total 
participants. Low 25(OH) D concentrations were higher among women and among 
elderly living in an old age home (54.1% vs. 18.4% for females and males, respectively) 
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compared to those who lived in their own homes (27.9% and 4.2% for females and 
males, respectively). Mean serum 25(OH) D was 24.8 nmol/L for females and 37.6 
nmol/L for males living in an old age home, and it was 41.3 nmol/L for females and 63.2 
nmol/L for males living in their own home.  
Prevalence of vitamin D inadequacy in Lebanon and Turkey was reported in an 
international study that investigated serum 25(OH)D among 2589 postmenopausal 
women with osteoporosis from 18 countries in 5 continents (Lips et al 2006). Serum 
25(OH) D was measured by competitive binding immunoassay in 150 women from 
Turkey (mean age = 61 years), and in 251 women from Lebanon (mean age = 67.5 
years). Mean serum 25(OH) D was the lowest among women in Turkey (54.5 nmol/L) 
and Lebanon (48.8 nmol/L) compared to the whole population study. Prevalence of 
vitamin D deficiency was measured at different cut-off points: 37.5 nmol/L, 50 nmol/L, 
62.5 nmol/L, and 75 nmol/L. In Turkey the prevalence of vitamin D deficiency was 
31.3%, 57.3%, 68%, and 76.7%, respectively with these cut offs. In Lebanon, the 
prevalence of vitamin D deficiency was 34.3%, 58.2 %, 76.5%, and 84.9% using these cut 
offs. 
In Lebanon, hypovitaminosis D was examined in 99 men and 217 women (aged 
30-50 years) between January and April 1999 (Gannage-Yared et al 2000). One hundred 
and fifty-six of participants were from five different rural centers, and 160 were from 
urban centers. Fifty-one of the women selected were veiled. Serum 25(OH) D was 
measured by radioimmunoassay. Mean serum 25(OH) D was 24.3 nmol/L for all 
participants (35.8 nmol/L in men, and 19.0 nmol/L in women). Serum 25(OH) D was < 30 
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nmol/L in 72.8% of all participants, and low 25(OH) D was more prevalent in women 
(83.9%) compared to men (48.5%). Severe hypovitaminosis D (25(OH)D < 12.5 nmol/L) 
was observed in 30.7% of all participants and was highly prevalent in women (41.5%). 
Style of clothing had a significant impact on 25(OH)D among women. Veiled women had 
a significantly lower 25(OH) D (12.8 nmol/L) compared to non veiled women (24.5 
nmol/L). Women living in rural areas had significantly lower 25(OH)D compared to 
women living in urban areas (16.6, and 21.4 nmol/L, respectively), whereas men living in 
rural areas had significantly higher serum 25(OH)D compared to men living in urban 
areas (40.2, and 31.5 nmol/L, respectively). 
Vitamin D was also assessed in healthy school children (aged 10-16 years) in 
Lebanon (El-Hajj Fuleihan et al 2001). Children participating were from different 
socioeconomic status, and the study was performed twice; at the end of spring 1999 
(n=169), and at the end of summer 1999 (n=177). Overall, mean serum 25(OH) D 
(measured by competitive protein-binding assay) was lower in the spring (42.5 nmol/L) 
compared to the summer (55 nmol/L). Girls had lower serum 25(OH) D in both seasons 
(37.5 and 47.5 nmol/L in spring and summer, respectively) compared to boys (47.5 and 
60.0 nmol/L in spring and summer, respectively). Among all participants, serum 25(OH) 
D < 50 nmol/L was prevalent among 65% in spring and 40% in summer. Socioeconomic 
status had a significant effect on 25(OH)D; in both seasons students in middle 
socioeconomic status had lower 25(OH)D (29.5 and 49.8 nmol/L in spring and summer, 
respectively) compared to students in higher socioeconomic status (53.5 and 57.5 
nmol/L in spring and summer, respectively).  
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Only one study assessed the prevalence of vitamin D deficiency in Jordan (Mishal 
2001). Serum 25(OH) D measured by radioimmunoassay was assessed in 22 men, and 
124 women (18- 45 years of age) in Amman. The study also studied the effect of dress 
styles on 25(OH) D among young women, and it was conducted during two seasons: 
summer (July - September), and winter (January - March). Women were subdivided into 
3 groups based on their dress style; women wearing full-covering clothing including 
hands and face (n= 11 in summer, n= 12 in winter), women wearing full covering 
clothing showing face and hands (n= 31 in summer, n= 49 in winter), and women 
wearing western-type dress style (n= 12 in summer, n=8 in winter). The male group 
included 11 participants in summer, and 11 in winter. In both seasons, there was a 
significant difference between all groups; serum 25(OH) D was highest in men (43.8 and 
34.7 nmol/L in summer and winter, respectively), followed by women with western 
dress-style (36.7 and 30.9 nmol/L in summer and winter, respectively), followed by 
women wearing full covering showing face and hands (28.3 and 24.4 nmol/L in summer 
and winter, respectively), followed by women wearing full covering including face and 
hands (24.3 and 22.7 nmol/L in summer and winter, respectively). Overall, serum 
25(OH) D < 30 nmol/L was prevalent among 72.5 % and 50% of all participants in winter 
and summer, respectively.  
A study in Egypt assessed vitamin D status in 60 female patients (20-50 years) 
with chronic low back pain, matched with a control group of healthy females (n=20) of 
the same age (Lotfi et al 2007). Serum 25(OH) D assessed by radioimmunoassay was 
significantly lower in patients than controls (90.5 and 99.5 nmol/L, respectively). Forty-
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nine patients (81.7%) and 12 controls (60%) had serum 25(OH)D between 50-90 nmol/L. 
Serum 25(OH)D positively correlated with fewer pregnancies, longer duration of sunlight 
exposure, and body area exposed to the sun, and negatively correlated with wearing 
black clothing, and clothing made of synthetic fibers.  
In Tunisia, the first study to assess vitamin D status among a healthy section of 
the Tunisian population (males and females) appeared in 2005 (Meddeb et al 2005). 
Serum 25(OH) D was measured by radioimmunoassay between January and March 2002 
in a total of 389 participants (67% females) aged 20-60 years chosen from an urban area 
near Tunis. More than 70% of women who participated in the study didn’t wear the veil. 
The prevalence of hypovitaminosis D (25(OH) D <37.5 nmol/L) among the whole sample 
was 47.6% (n= 185). Among those with hypovitaminosis D, one case was found to have 
serum 25(OH) D < 12.5 nmol/L, and 66 cases (36%) had serum 25(OH)D  between 12.5-
25.0 nmol/L.  Mean serum 25(OH) D in veiled women was 35.1 nmol/L compared to 42.5 
nmol/L in non veiled women. The prevalence of hypovitaminosis D (25(OH) D <37.5 
nmol/L) was significantly higher in veiled women compared to nonveiled women (70.5% 
and 48.9%, respectively). Having 25(OH) D< 37.5 nmol/L was higher in postmenopausal 
women compared to pre-menopausal women (74.5% and 50%, respectively), and it was 
higher with multiparity (parity ≥ 3) compared to nonparous groups (68.9% and 43.9%, 
respectively). 
It worth mentioning here that the type of veil women wear in Tunisia and in 
Maghreb Countries (Libya, Algeria, Tunisia, and Morocco) is different from the one wore 
by women in the gulf region and Middle Eastern countries. In Tunisia, it is thin, white, 
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and doesn’t cover the whole body (i.e. shows the face, hands, and legs), and the 
majority doesn’t wear it. In Morocco, the veil is not limited to the Islamic code of dress 
style, but also is part of the Moroccan traditional clothing, where even the non-veiled 
women wear the traditional long and hooded garment with long sleeves. In the gulf 
region (UAE, SA, Kuwait, Iran), the veil is the thick, black, and long abayeh that covers 
the whole body, and most women cover their faces and hands. 
 In Morocco a case-control study evaluated the impact of clothing style on bone 
mineral density (BMD) among postmenopausal women (Allali et al 2006). The study 
recruited 178 postmenopausal women living in urban centers of Morocco, and 178 
controls matched by age (mean age= 63.2 years) and body mass index (mean BMI= 32.1 
kg/m2). Veiled women constituted 83.7% of osteoporotic patients and 69.1% of 
nonosteoporotic patients. Wearing the concealing clothing was associated with a high 
risk of osteoporosis: OR= 2.29 (95% CI: 1.38-3.82). authors of the study highly 
recommended the need to assess vitamin D status among the population and 
particularly in women who wear concealing clothing.  
Serum 25(OH) D measured by chemiluminescence was assessed in 415 women 
(aged 24-77 years) during summer in Rabat in Morocco (Allali et al 2008). Women’s 
mean age was 50 ± 9.3 years, all were residing in urban areas, eighty-five percent had 
never practiced sports, and 74% were menopausal. Fifty-six percent of women were 
wearing the veil for a mean duration of 10 years. Mean serum 25(OH) D for all women 
was 46 nmol/L. The prevalence of vitamin D insufficiency (25(OH)D ≤ 75 nmol/L) was 
91%. One hundred seventy-eight women (43%) had serum 25(OH)D < 37.5 nmol/L, and 
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17 women (4% ) had values < 12.5 nmol/L. Prevalence of vitamin D insufficiency 
increased in higher ages with the highest prevalence in women >55 years of age (52%). 
Also, prevalence of vitamin D insufficiency was significantly higher in veiled women 
(47%) compared to non-veiled women (33%), and it was associated with time spent 
outdoors. Women who spent less than 30 minutes per day in outdoor activities had a 
higher prevalence of vitamin D insufficiency (25(OH)D ≤ 75 nmol/L) compared to women 
who spent more than 30 min/day (47% and 33%, respectively).  
It might be relevant here to mention two studies that had assessed vitamin D 
status of Bangladeshi women, given the fact that Bangladesh is a Muslim country. The 
first study assessed the influence of socio-economic status on vitamin D status among 
Bangladeshi women (Islam et al 2002). Serum 25(OH) D was measured by 
radioimmunoassay in a low socioeconomic group (n= 99), and in a high socioeconomic 
group (n= 90). Women’s age ranged between 16-40 years. Median value of serum 
25(OH) D was 36.7 nmol/L and 43.5 nmol/L in the low socio-economic group and high 
socio economic group, respectively. Serum 25(OH)D <25 nmol/L was prevalent among 
17% of women in low socio-economic group compared to 12% in the high socio-
economic group. The prevalence of serum 25(OH) D < 37.5 nmol/L was 50%, and 38% 
among women in the low socio-economic group and high socio-economic group, 
respectively.  
The second study evaluated serum 25(OH) D among three groups of women 
aged 18-60 years (Islam et al 2006). The first group included non-veiled young women 
(n= 36, mean age= 22.3 years), the second group included veiled women (n= 30, mean 
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age = 47.7 years), and the third group included non-veiled diabetic women (n= 55, mean 
age= 50.2 years).  Mean 25(OH) D was not significantly different between the three 
groups. The prevalence of vitamin D deficiency (25(OH) D< 25 nmol/L) was 39%, 30%, 
and 38% among non-veiled young women, veiled women, and diabetic women, 
respectively.  The prevalence of vitamin D insufficiency (25(OH) D< 40 nmol/L) was 78%, 
38%, and 76% among non-veiled young women, veiled women, and diabetic women, 
respectively.  
 
 
SOCIOECONOMIC AND HEALTH STATUS OF WOMEN OF CHILD-BEARING AGE AND CHILDREN 
UNDER-FIVE IN JORDAN 
 
COUNTRY PROFILE 
The population size of Jordan was 5.8 million in 2008, with a population growth 
rate of 2.4% (Population Reference Bureau 2009), and is expected to reach 6.1 million 
by 2010 (Department of Statistics 2008). Jordan is divided into 12 governorates, and the 
population density varies from 206 persons/km² in the middle region, 48 persons/km² in 
the northern region, and 11 persons/km² in southern region (Department of Statistics 
2008). The percent of population living in urban areas reached 83% in 2004, and around 
38% of the population lives in the capital city Amman (Population Reference Bureau 
2009).  
Life expectancy at birth was estimated to be 72 years (Males: 71, Females: 73) 
(United Nations Population Fund 2009). Children under the age of 15 constitute 37% of 
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the population, and the proportion of people over the age of 65 is 3% (Population 
Reference Bureau 2009). 
The gross domestic product (GDP) per capita reached $2,850 in 2007 (World 
Bank 2009). The United Nations Development Programme (UNDP) gave Jordan a rank of 
86th out of 177 countries with data on the Human Development Index (HDI). The HDI for 
Jordan is 0.773 (United Nations Development Programme 2008). The HDI provides a 
composite measure of three dimensions of human development: living a long and 
healthy life (measured by life expectancy), being educated (measured by adult literacy 
and enrolment at the primary, secondary and tertiary level), and having a decent 
standard of living (measured by purchasing power parity, income). With regard to 
education, illiteracy rate has declined during the past ten years to reach 7.9%, and 
females are more likely to be uneducated (Table 2.14). 
Table 2.14 
 Illiteracy rate in Jordan 
  
2003 
 
2004 
 
2005 
 
2006 
 
2007 
Adult male illiteracy rate (% 15+ years of age) 
 
5.1 5.6 4.8 5.1 4.3 
Adult female illiteracy rate (% 15+ years of age) 
 
14.8 15.1 13.1 13.7 11.6 
Total (Males and Females) 9.9 10.3 9 9.3 7.9 
Source: (Ministry of Health 2007) 
 
 
Although female literacy rate is high, only 12% of married women are employed, 
while labor force participation rate for male is 66.4% (United Nations Population Fund 
2009) 
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HEALTH STATUS 
Fertility rate dropped dramatically between 1983 and 2002 (6.6, and 3.7, 
respectively) and remained almost constant over 2002-2007 (Ministry of Health 2007). 
Family wealth seems to influence fertility, women living in poor households have almost 
twice as many children (4.8 children/woman) compared to women who live in wealthier 
households (2.5 children/woman) (Department of Statistics 2008).  
Fifty-percent of women in Jordan are married by age 22.2, but only 18% are 
married by age 18. Childbearing begins at a relatively late age in Jordan compared to 
neighboring countries, half of women have their first birth by age 23.9 and only 8% of 
women had their first birth by age 18 (Department of Statistics 2008). Maternal 
mortality ratio is 41 per 100,000 live births (World Health Organization 2008) which is 
low compared to other countries in the Middle East. 
Infant mortality rate has sharply declined during the last 20 years from 82 deaths 
per 1,000 live births in 1976 to 19 deaths in 2007. Under-five mortality rate is 25 deaths 
per 1,000 live births (UNICEF 2009).  
Mortality rates are slightly higher in rural than urban areas, and they also differ 
by governorate. For example, under-five mortality ranges from 10 in central 
governorates to 39 in southern governorates. Also, as women’s education increases, 
childhood mortality decreases. Under-five mortality rate is twice as high among children 
whose mothers are uneducated compared to children whose mothers have at least a 
high school degree (Department of Statistics 2008).  
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Many factors influence infant mortality rate; mother’s age at birth, birth order, 
and length of previous birth interval. Mother’s age at delivery and infant mortality exhibit 
a U-shaped curve. Mortality rates are higher among infants born to mothers less than 20 
years of age, and those aged 40 and over (Department of Statistics 2008). Birth weight is 
an important indicator for the infant’s susceptibility to the risk of illness. The State of 
the World’s Children 2009 report estimated that 12% of babies born in the year 2006-
2007 in Jordan were born with low birth weight (<2.5 kilogram at birth) (UNICEF 2009).  
 
THE PREVALENCE OF STUNTING AND WASTING AMONG CHILDREN UNDER-FIVE IN JORDAN 
AND THE REGION 
Two major indicators of child malnutrition are stunting and wasting.  Stunting is 
defined as insufficient height relative to age (WHO 1995b). It is an indicator of chronic 
nutritional deprivation, as it results from extended periods of inadequate food intake, poor 
dietary quality, increased morbidity, or a combination of these factors (Gibson 2005) . 
Wasting results from a failure to gain sufficient weight relative to height or from weight loss 
(WHO 1995b).  
The State of the World’s Children 2009 reported (based on the most recent data 
available during the years 2000-2007) a prevalence of 5%, 2%, and 9% for underweight, 
wasting and stunting, respectively among children under five in Jordan (UNICEF 2009). 
Jordan has been successful in reducing the prevalence of stunting from 16% during the 
period 1980-1996 (UNICEF 1996) to 9% during the period 1996-2005 (UNICEF 2006).  
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Figures 2.6 and 2.7 show that protein-energy malnutrition is still a public 
problem in the Middle East North Africa (MENA) region. The prevalence of stunting and 
wasting in some countries (like United Arab Emirates, Saudi Arabia, and Kuwait) is shocking 
given the high GNI per capita for these countries. Poverty and food shortage are not strong 
causes for stunting and wasting among children in these countries. On the other hand, De 
Onis and Blossner (2000) analyzed 92 countries in a standardized way to allow 
comparisons between prevalence of undernutrition and obesity across countries and 
over time; many countries with a high level of obesity still reported significant rates of 
childhood stunting. These countries include: Egypt, Morocco, Bahrain, and Algeria from 
the MENA region (De Onis and Blossner 2000).  
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Figure 2.6 
Percentage of children under-five suffering from wasting in the MENA region (2000-2007) 
 
 
 
Data refer to the most recent year available during 2000-2007, source: (UNICEF 2009) 
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Figure 2.7 
Percentage of children under-five suffering from stunting in the MENA region (2000-2007) 
 
 
Data refer to the most recent year available during 2000-2007, source: (UNICEF 2009) 
 
On the local level, the last estimates of the national prevalence of stunting, 
wasting and underweight were determined in 1997 by the Jordan Population and Family 
Survey.  The nutritional status of children from birth to 59 months was determined using 
three indices: weight-for-height (wasting) reflecting acute growth disturbances, height-
for-age (stunting) reflecting long term faltering and weight-for-age (underweight). The 
national prevalence rates of stunting, wasting, and underweight were 7.8%, 1.9%, and 
5.1%, respectively, (Department of Statistics 1997). There was little difference in stunting 
between boys and girls in the whole sample (8% and 7% for males and females, 
respectively).  Compared to males, a slightly higher proportion of females had wasting 
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(2.0% and 1.2% for females and males, respectively), and underweight (5.5% and 4.6% for 
females and males, respectively).  
The nutritional status of children was better in urban than in rural areas: 13.7% of 
rural children were stunted compared to only 6.7% of urban children. The same trend was 
true in the case of underweight (8.5% and 4.3% for rural and urban children, respectively). 
However, there was no difference regarding wasting (around 2%) in each sector (Khatib et 
al 1998). In 2006, growth pattern was determined in 1695 healthy children (842 boys and 
853 girls) between 3-6 years of age (Ibrahim et al 2008). Two percent of boys and 0.5% of 
girls were below -3 SD of weight for height z-score, and 7.4% of boys and 5.2% of girls fell 
in the group of (-3 SD < -2 SD).  
 
NUTRITIONAL STATUS OF WOMEN OF CHILD-BEARING AGE IN JORDAN 
The 2007 Jordan Population and Health Survey (JPFHS) collected data on the 
height and weight of 7,759 women aged 15-49 years (half of the households sampled). 
Almost 50% of women were overweight or obese (BMI≥  25 kg/m2), and only 4% were 
underweight (Department of Statistics 2008) (Table 2.15).  
Jordan (as many developed and developing countries) is undergoing a “nutrition 
transition”. According to Popkin (2006) this global phenomena is characterized by large 
shifts from traditional diet that is high in fiber, grains, fruits, and vegetables to more modern 
diet that is characterized by high fat, low fiber, and greater percentages of energy derived 
from sugars and animal protein and fats (Popkin 2006). This phenomenon has been 
attributed to the increased urbanization worldwide from 46% in 1965 to 83% in 2004, 
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(Population Reference Bureau 2009), and the health care reforms that decreased infant and 
child mortality rate and increased life expectancy. 
 
Table 2.15 
BMI distribution among Jordanian women 
 
  Percentage of women in each BMI category 
(Total n= 7,759) 
 
 
 
Mean BMI (kg/m
2
) 
 
<18.5 
 
18.5-24.9 
 
25-29.9 
 
≥30.0 
Age (years)      
15-19 23 7.3 71.2 15.7 5.7 
20-29 24.3 3.7 60.9 23.3 12.1 
30-39 26.4 3.4 41.4 33.1 22.2 
40-49 27.3 3.7 38.2 28.4 29.7 
      
Residence      
Urban 25.7 3.9 49.3 27.2 19.7 
Rural 26.3 4.0 45.3 28.2 22.4 
      
Total 25.8 3.9 48.6 27.4 20.1 
Source: (Department of Statistics 2008) 
 
Nutrition transition is accompanied by increase in obesity rates, and chronic 
diseases including diabetes, hypertension, and stroke. The total prevalence of obesity (BMI 
≥ 30kg/m2) was found to be 34.8% among 710 Jordanian adults in 2004 (Table 2.16), and 
obesity was significantly associated  with diabetes, high blood pressure, high cholesterol, 
and asthma (Zindah et al 2008). 
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Table 2.16  
Prevalence of obesity and related non-communicable diseases in a study in Jordan 
 
 Sex Age groups (years) 
 
 
 Male 
% 
Female 
% 
18-34 
 % 
35-49 % 50-64 % ≥65 
% 
Total 
% 
Obesity 21.1 41.5 19.1 42.7 45.3 43.4 34.8 
High blood pressure 36.3 27.3 9.4 28.3 55.2 61.4 30.2 
High cholesterol 25.6 21.9 8.0 25.5 38.0 39.2 23.1 
Diabetes 17.7 16.5 6.1 12.7 32.3 39.0 16.9 
Source: (Zindah et al 2008)  
 
Another recent study assessed the prevalence of metabolic syndrome among 
394 males and 727 females in Northern Jordan (Khader et al 2007). Participants’ age was 
≥ 25 years, and criteria for the metabolic syndrome were met if an individual met 3 or 
more of the following criteria: abdominal obesity, high fasting glucose, high blood 
pressure, hypertriglyceridemia, and low LDL cholesterol. Mean ± SD of BMI for women 
was 31.6 ± 5.8, and the prevalence of metabolic syndrome was 40.9% among women 
compared to 28.7% among men.  
The 2007 Jordan Population and Family Health Survey (JPFHS) shows that most 
mothers of young children consume foods made from grains (92%), foods made with oil, 
fat or butter (88%), meat, fish, shellfish, poultry or eggs (84 %) and cheese or yogurt 
(82%) (Department of Statistics 2008). Two-thirds of mothers consume fruits or 
vegetables rich in vitamin A and three-fourths consume other types of fruits and 
vegetables. Consumption of iron-rich foods was found to be higher among mothers with 
a higher education and among women living in wealthier households. In addition, 50% 
of mothers reported taking iron supplementation for more than three months during 
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their last pregnancy, and 19% of mothers reported not taking any iron supplementation 
during their last pregnancy. Mothers with higher levels of education and those living in 
the wealthiest households were most likely to take at least 90 days worth of iron 
supplements. 
Overall, Jordan has achieved good progress compared to the other countries in 
the region in reducing maternal and infant mortality rate, stunting and wasting among 
children less than five years of age, and in implementing some programs to eliminate 
micronutrient deficiency like fortification and supplementation of some micronutrients. 
Jordan is moving ahead toward the achievement of the Millennium Development Goals 
(Table 2.17). 
Table 2.17 
Examples of health indicators related to Millennium Development Goals (MDGs) in selected 
countries in the Middle East  
  
Jordan 
 
 
Lebanon 
 
Egypt 
    
MDG 1: Eradicate poverty and hunger    
Prevalence of child malnutrition (U5 underweight - %) 4 4 5 
Prevalence of child malnutrition (U5 stunting - %) 9 11 18 
Prevalence of child malnutrition (U5 wasting - %) 2 5 4 
    
MDG 2: Reduce child mortality    
Under 5 mortality rate (per 1,000) 24 29 36 
Infant mortality rate ( per 1,000 live births) 21 26 30 
    
MDG 3:  Improve maternal health    
Maternal mortality ratio (per 100,000 live births) 41 100 84 
Births attended by skilled health staff (%) 99 96 74 
    
Source: The State of the World's Children 2009: Maternal and Newborn Health. (UNICEF 2009)  
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PREVALENCE OF ANEMIA AND IRON DEFICIENCY IN JORDAN AND THE EASTERN 
MEDITERRANEAN REGION 
Anemia and iron deficiency are the most common nutritional disorders affecting 
children and women in both industrialized and developing countries (Table 2.18). 
Globally, forty-seven percent of preschool-age children and 30.2% of non-pregnant 
women are anemic (WHO 2008). About 47% of pre-school children (0.8 million) have 
hemoglobin (Hb) levels below 11 g/dL and almost 40 million women of child bearing age 
(non-pregnant) have Hb levels below 12 g/dL in the Eastern Mediterranean region 
(WHO 2008).  
Table 2.18 
Global prevalence of anemia in WHO regions 
 
 
 
 
Region 
 
Prevalence of anemia (%) 
 
Pre-school 
children 
(0.00-4.99 yrs) 
Hb<11 g/dl 
Pregnant  
women 
(no age range 
defined) 
Hb<11 g/dl 
Non-pregnant 
 women 
(15.00- 49.99 yrs) 
Hb<12 g/dl 
Africa 67.6 57.1 47.5 
Americas 29.3 24.1 17.8 
South-East Asia 65.5 48.2 45.7 
Europe 21.7 25.1 19.0 
Eastern Mediterranean 46.7 44.2 32.4 
Western Pacific 23.1 30.7 21.5 
Global 47.4 41.8 20.2 
Source: adapted from “ Worldwide prevalence of anemia 1993–2005: WHO global database on anemia”, 
(WHO 2008) 
 
 
The WHO classification of public health significance of anemia in populations 
based on prevalence estimated from hemoglobin or hematocrit is presented in Table 
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2.19. According to the WHO classification, the prevalence of anemia in the Eastern 
Mediterranean region is considered a severe public health problem among pre-school 
children and moderate among women of child-bearing age.   
Table 2.19  
WHO classification of public health significance of anemia 
 
Prevalence of anemia (%) 
  
Category of public health significance 
≤ 4.9  Normal 
5.0 - 19.9  Mild 
20.0 - 39.9  Moderate 
≥ 40.0   Severe 
Source: (WHO/UNICEF/UNU 2001) 
 
Anemia is a major nutritional problem among women and children in the 
countries of the Middle East and North Africa region regardless of the variation in the 
socioeconomic status among these countries. The prevalence of anemia among pre-
school children ranges from 22% in Tunisia to almost 70% in Yemen and 85% in Sudan 
(Table 2.20). In Jordan, it is estimated that more than 28.3% children under the age of 
five are anemic (WHO 2008).  
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Table 2.20 
Prevalence of anemia among pre-school children in the Eastern Mediterranean region 
 
   
Date of 
survey 
Age 
range 
(yrs) 
 
Sample 
size 
Prevalence 
 of anemia % 
(Hb<11 g/dl) 
 
Public health 
problem 
Low Income      
Yemen    68.3 Severe 
Sudan 1994-1995 0.5-6.99 1970 84.6 Severe 
Lower Middle Income      
Egypt 2000 0.5-4.99 4708 29.9 Moderate 
Iraq    55.9 Severe 
Morocco 2000 0.5-4.99 1486 31.5 Moderate 
Syria    41.0 Severe 
Jordan 2002 0.5-4.99 2573 28.3 Moderate 
Iran    35.0 Moderate 
Tunisia 1996-1997 0.0-5.99 965 21.7 Moderate 
Lebanon 1997-1998 1.0-4.99 234 28.3 Moderate 
Upper-middle Income      
Oman 1995 0.0-5.99 5015 50.5 Severe 
Libya    33.9 Moderate 
Saudi Arabia    33.1 Moderate 
Bahrain    24.7 Moderate 
High Income      
Qatar 1995 1.0-2.0 1449 26.2 Moderate 
Kuwait 1998-2002 0.5-4.99 3693 32.4 Moderate 
United Arab Emirates    27.7 Moderate 
Source: “WHO Global Database on Anemia: World Wide Prevalence of Anemia 1993-2005” (WHO 2008) 
 
 
The prevalence of anemia among non-pregnant women of reproductive age has 
been classified as a severe public health problem in some countries in the region even in 
countries with higher income like United Arab Emirates and Bahrain with prevalence of 
44% and 51%, respectively (Table 2.21).  
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Table 2.21 
Prevalence of anemia among non-pregnant women of reproductive age in the Eastern 
Mediterranean region 
    
Date of 
survey 
Age 
range 
(yrs) 
 
Sample 
size 
Prevalence of 
Anemia % 
(Hb<11 g/dl) 
 
Public health 
problem 
Lo
w
 
In
co
m
e
       
Yemen    51.0 Severe 
Sudan    43.5 Severe 
      
Lo
w
e
r 
M
id
d
le
  
In
co
m
e
 
Egypt 2000 15-49.99 9210 27.6 Moderate 
Iraq    45.3 Severe 
Morocco 2000 15-49.99 1784 32.6 Moderate 
Syria    33.4 Moderate 
Jordan 2002 15-49.99 2925 28.6 Moderate 
Iran 1994-1995 15-49.99 1351 33.0 Moderate 
Tunisia 1996-1997 17-59.99 1951 26.3 Moderate 
Lebanon 1997-1998 15-49.99 539 25.2 Moderate 
U
p
p
e
r-
M
id
d
le
 
In
co
m
e
 
      
Oman 2000 15-49.99 2766 34.0 Moderate 
Libya    29.9 Moderate 
Saudi Arabia    32.2 Moderate 
Bahrain 2002 14-49.99 384 51.3 Severe 
      
H
ig
h
 
In
co
m
e
 Qatar    36.2 Moderate 
Kuwait 1998-2002  2993 28.7 Moderate 
UAE    43.9 Severe 
      
Source: “WHO Global Database on Anemia: World Wide Prevalence of Anemia 1993-2005” (WHO 2008) 
 
 
Based on the WHO global database almost 30% of non-pregnant women of 
reproductive age in Jordan are anemic but some other studies show that the percentage 
of women with iron deficiency is even higher. The Ministry of Health in Jordan has 
assessed the prevalence of anemia, iron deficiency, and iron deficiency anemia among 
women of reproductive age (Table 2.22), and it was 32%, 40%, and 22%, respectively 
(Ministry of Health 2003).    
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Table 2.22  
Prevalence of anemia, iron deficiency, and iron deficiency anemia among different age groups 
in Jordan, 2003 
  
Anemia 
 
Iron deficiency 
 
Iron deficiency anemia 
 
Non-pregnant women of reproductive age 
 
32% 
 
40% 
 
22% 
 
Pre-school children 
 
20% 
 
26% 
 
10% 
 
School children (6-18 years) 
 
9.3% 
 
- 
 
- 
Source: (Ministry of Health 2003) 
 
 
In 2003, anemia was assessed in 200 pregnant women in northern Jordan 
(Albsoul-Younes et al 2004). Eighty-four women (41%) women were anemic. Increased 
risk of anemia was associated with lower educational level, multiparity, and rural 
residence. Another study assessed the prevalence of anemia in 260 women aged 18-49 
years and found that 40% were anemic (Mawajdeh et al 2003).  
A study on the incidence of iron deficiency anemia in infants was conducted in 
1999. The study examined the relationship between anemia during pregnancy and iron 
deficiency in 232 infants. The iron status of infants born to 107 anemic (Hb<11g/dl) and 
125 non-anemic mothers was reviewed at 3, 6, 9 and 12 months. Indicators to define iron-
deficiency were (Hb<11g/dl) and either plasma ferritin (<12 mg/dl) or zinc protoporphyrin 
(ZPP) (>35mg/dl) whole blood. The results indicate that anemia was significantly higher in 
infants born to anemic mothers (81%) compared with controls (65%). At 12 months of 
age, 72% were anemic, while 57% were identified as iron deficient (Kilbride et al 1999).  
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The prevalence of iron deficiency anemia as well as different types of 
Thalassaemia was investigated in 1020 school children (aged 6-15 years) living in the 
north-eastern Badia region in Jordan (Babiker et al 1999). Iron deficiency anemia was 
diagnosed in 54 children. 
The Ministry of Health in Jordan conducted a national baseline survey on iron 
deficiency anemia along with WHO, UNICEF, and Centers for Disease Control and 
Prevention in 2002. The study found a different prevalence of iron deficiency among 
children based on age groups as well as between children living in urban and rural areas 
as described in Table 2.23 (Ministry of Health et al 2002). 
Table 2.23  
Prevalence of anemia among children by age groups in Jordan, 2002 
 
Children’s Age Group (yrs) n 
Mean Hb 
(g/dl) 
Prevalence of Anemia 
(%) 
1.00-1.99 245 11.2 34.4 
2.00-2.99 258 11.7 23.3 
3.00-3.99 281 11.9 13.2 
4.00-4.99 276 12.0 10.6 
1.00-4.99 (rural) 366 11.6 22.4 
1.00-4.99 (urban) 695 11.7 19.4 
Source: (Ministry of Health et al 2002) 
The high prevalence of anemia among children under- five years of age is due to 
poor dietary intakes of iron, low iron absorption, and mothers’ anemia during 
pregnancy. The high prevalence of anemia among women is caused by many factors 
including early age at marriage, short birth intervals, poor dietary diversification, lack of 
nutrition education, and perhaps by high consumption of tea containing tannins that 
reduce iron availability (Aoyama 1999).  
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PREVALENCE OF ZINC DEFICIENCY IN JORDAN AND THE EASTERN MEDITERRANEAN REGION 
The World Health Organization (WHO) identified the factors contributing most to 
burden of disease in developing countries with high mortality; zinc deficiency was 
ranked as the 5th factor followed by iron deficiency as the 6th (WHO 2002). Globally 
about ½ of the human population is at risk of low zinc intake (Brown and Wuehler 
2000). First cases of zinc deficiency in humans were reported in the Middle Eastern 
region in the sixties, specifically in Iran and Egypt (Prasad et al 1961, Prasad et al 1963), 
and zinc deficiency was highly correlated with severe anemia, growth retardation, and 
delay in sexual maturation. 
In zinc deficiency, the first response is a reduction in growth without an apparent 
reduction in tissue concentration (Cousins 2006). Signs of zinc deficiency include: growth 
retardation, depression of immune function, decreased appetite, skeletal abnormalities, 
and impaired reproductive ability (Cousins 2006). According to a meta-analysis of 33 
randomized-controlled zinc intervention trials in pre-pubertal children, zinc 
interventions have demonstrated that zinc supplementation produced positive 
responses including stunting reduction in children, weight gain, and linear growth 
(Brown et al 2002). Zinc supplementation is also associated with improved reproductive 
functions including fetal growth, increased birth weight, lack of congenital 
malformations, and term delivery (Black 2003). 
According to the World Bank, zinc deficiency accounts for about 800,000 deaths 
annually from diarrhea, pneumonia, and malaria in children under five years of age 
(Caulfield et al 2006). While Sub-Saharan Africa accounts for the malaria burden, the 
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Middle East and North Africa region along with South Asia and Sub-Saharan Africa 
contribute to the other zinc deficiency outcomes: pneumonia and diarrhea.  
 
The high prevalence of anemia in the MENA region despite the fortification of 
flour with iron supports the fact that there is a need to assess zinc status. Anemia is a 
marker for both iron and zinc deficiency (Shrimpton et al 2005), and it is likely that iron 
deficiency exists with other micronutrient deficiencies including zinc and vitamin B12 
(Dewey and Brown 2003). Table 2.24 shows that the prevalence of zinc deficiency in the 
Middle East and North Africa region is estimated to be 46%. This figure was estimated 
by examining the availability of zinc in the local diet in the following countries: 
Afghanistan, Algeria, Djibouti, Egypt, Iraq, Morocco, Pakistan, Somalia, Sudan, and 
Yemen (Caulfield and Black 2004).  
Table 2.24 
Estimated zinc deficiency outcomes among children ages birth through four by region  
 
 
Region 
 
Prevalence  
(%) 
 
Deaths 
(Thousands) 
 
DALYs loss* 
(Thousands) 
East Asia and the Pacific 7 15 1,004 
Eastern Europe and Central Asia 10 4 149 
Latin America and the Caribbean 33 15 587 
Middle East and North Africa 46 94 3,290 
South Asia 79 252 8,510 
Sub-Saharan Africa 50 400 14,094 
High Income Countries 5 0 2 
*DALYs: Disability Adjusted Life Years = the sum of years of potential life lost due to premature mortality 
and the years of productive life lost due to disability. 
Source: Adapted from (Caulfield et al 2006) 
 
Currently, there are no estimates about the national prevalence and distribution 
of zinc deficiency in Jordan, and there is a serious lack of awareness of the importance 
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of zinc in human nutrition not only in Jordan but also in the MENA region. Direct 
measurement of plasma zinc in a representative sample is required, so that knowledge 
about the prevalence and distribution of zinc deficiency can be established before 
setting steps to eliminate zinc deficiency. Gibson (2006) recommended that: “at risk 
countries either national or targeted Zn interventions such as supplementation, 
fortification, dietary diversification or modification, or biofortification should be 
implemented, where appropriate, by incorporating them into pre-existing micronutrient 
intervention programs” (Gibson 2006). 
Diets in the MENA region are characterized by low zinc bioavailability 
contributed to by diets high in phytate that inhibits zinc absorption. The incidence of 
zinc deficiency is similar to that of nutritional iron deficiency because both are caused by 
similar dietary patterns (Sandstead 2000). Zinc deficiency may be the underlying cause 
in the high prevalence of child growth retardation, low birth weight and anemia in the 
MENA region (Aoyama 1999). 
 
 
 
 
 
 
 
 
68 
IRON IN HUMANS 
 OVERVIEW  
The approximate amount of iron in the human body is about 2.5-4.0 gm which is 
about 30-40 mg/kg body weight (Beard 2006). The largest constituent of body iron is in 
the form of functional iron which takes three forms: hemoglobin (about 70%), the 
oxygen carrying pigment of red blood cells, myoglobin (about 4%), the oxygen-binding 
storage protein in muscles; and various iron-containing enzymes like cytochromes which 
act as electron carriers within the cells. About 25% of body iron (0-15 mg/kg) is in the 
form of storage iron that is found primarily in the liver (60%), muscles, and cells of the 
reticuloendothelial system (Beard 2006). Most of the iron stored in the liver is in the 
form of ferritin (95%) and hemosiderin (5%) (Bothwell et al 1979). Finally, iron mobilized 
from tissues carried by the transport protein (transferrin) comprises less than 1% of 
body iron.   
Iron balance in the human body is maintained based on the interrelationship 
between dietary iron intake, iron absorption and bioavailability, and body demand 
(WHO 1996). Disruption in any of these factors like low iron intake due to poverty or 
poor food choices, poor absorption and low iron bioavailability, or increase in body 
demand due to pregnancy, growth or blood loss in menstruation or diseases means that 
the body’s physiological needs are not met by enough iron intake, and iron stores 
diminish leading to iron deficiency.  
Dietary sources provide two forms of iron: heme and non-heme iron. Heme iron 
is derived from hemoglobin and myoglobin and found in animal sources of food like 
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liver, beef, turkey, and other kinds of meat. Non-heme iron refers to all non-animal 
sources of iron (plant sources, fortified food, and contaminant iron coming from dust, 
dirt, and soil). The two forms differ in their bioavailability. Heme iron is absorbed more 
effectively than non-heme iron and is considered the most bio-available form of iron 
(Bothwell et al 1979). During digestion, the pancreatic and gastrointestinal enzymes split 
the heme molecule from the globin molecule but the iron remains tightly bound within 
the porphyrin ring structure of the heme molecule and is taken up intact after binding to 
its receptors (Conrad et al 1967). Then the iron is released to the cytoplasm by the 
action of heme oxygenase (Raffin et al 1974). The average absorption of heme iron is 
about 25% (Hallberg et al 1979) whereas the absorption of non heme iron is often much 
less than that. The absorption of heme iron is regulated based on an individual’s iron 
status. During iron deficiency, heme iron absorption in the proximal intestine increases 
up to 40%, but decreases to about 10% during iron repletion (Hallberg et al 1997), an 
important regulatory mechanism in preventing iron overload in case of increased 
dietary intakes of iron.  
 
IRON REQUIREMENTS AND BIOAVAILABILITY 
Iron losses vary with age, sex, and disease status (hemorrhage, infection with 
hookworms and other parasites, or peptic ulcer). A typical male loses about 0.8-0.9 mg 
iron per day (Beard 2006) while females of reproductive age lose an average estimated 
additional 0.48 mg/day due to menstruation (WHO/FAO 2005b). However, the 
menstrual iron loss can be as high as 2.0 mg/day (Beard 2006). Infants, children, and 
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pregnant women have higher requirements for iron due to growth and development. 
Iron stores are exhausted during rapid growth, and if physiological requirements are not 
met by adequate iron intake, a nutritional iron deficiency will develop.  
Iron intake alone is not enough to ensure attaining adequate iron status for 
individuals. The bioavailability of dietary iron (how much is really absorbed) is very 
important.  Unfortunately, in addition to the low intake by children and women of foods 
rich in iron in many developing countries, most of the iron intake is in the form of non 
heme iron that comes from non animal sources. Due to poverty, people rely more on 
plant-based diets like grains and legumes which contain high amounts of energy but low 
amount of bioavailable iron.  The bioavailability of non-heme iron is affected by a 
number of inhibitors and facilitators of absorption. Absorption of non-heme iron is 
enhanced by ascorbic acid and animal proteins like meat, fish, and poultry (Cook and 
Monsen 1977, Davidsson et al 1998, Disler et al 1975a, Hallberg and Hulthen 2000) and 
greatly inhibited by phytate (grains, seeds, and beans), polyphenols (tannins in tea and 
coffee), organic acids (chlorogenic acid in coffee), and soy proteins (Cook et al 1981, 
Derman et al 1977, Disler et al 1975b, Gillooly et al 1983, Hallberg and Rossander 1982a, 
Hallberg and Rossander 1982b, Hallberg et al 1987, Hurrell et al 1992, Morck et al 1983). 
The highest iron bioavailability is associated with diets that are high in ascorbic acid and 
meat content, and low in phytate-rich cereals. Consuming no coffee or tea within 2 
hours of the main meals also enhances iron bioavailability (Morck et al 1983, WHO/FAO 
2005b).  
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Calcium has been found to interfere significantly with the absorption of both 
heme and non-heme iron although the precise mechanism is unknown (Gleerup et al 
1993, Gleerup et al 1995, Hallberg et al 1991, Hallberg et al 1992).  
Table 2.25 shows the bioavailability of iron from different type of diets that vary 
in their meat, phytate, and tannin content. The bioavailability is then expressed as 
amount of iron absorbed by a 55-kg woman with no iron stores, and then it is translated 
into the percentage absorbed for an iron intake of 15 mg/d.  
Table 2.25 
The potential bioavailability of iron in different diets types and estimated percentage 
absorbed for an iron intake of 15 mg/day 
 
 
 
 
Type of Diet 
 
 
 
Bioavailability 
(µg/kg/d} 
 
Absorption in 55-kg 
woman with no iron 
stores 
(mg/d) 
 
 
Bioavailability (%) for 
an iron intake of 15 
mg/d 
     
 Very high meat in two 
main meals daily and high 
ascorbic acid (theoretical) 
75.0 4.13 27.5 
 High meat/fish in two main 
meals daily 
66.7 3.67 24.5 
 Moderate meat/fish in two 
main meals daily 
53.2 2.93 19.5 
 Moderate meat/fish in two 
main meals daily; low 
phytate and calcium 
42.3 2.32 15.5 
 Low meat intake; high 
phytate, often one main 
meal 
25.0 1.38 9.2 
 Meat/fish negligible; high 
phytate; high tannin; and 
low ascorbic acid 
15.0 0.83 5.5 
Source: Adapted from (WHO/FAO 2005b) 
 
72 
In the Middle East, tea along with coffee is widely consumed with meals or 
immediately following meals. Tea is widely consumed by mothers, young girls, and even 
children. The high content of polyphenols in these beverages inhibits the absorption of 
non-heme iron in diet and greatly decreases its bioavailability. Iron absorption is 
decreased by 70-80% with consumption of 200 ml tea, and decreased by 60% with 
consumption of 150 ml coffee (Hallberg and Hulthen 2000).    
Iron intake and iron bioavailability were studied in a longitudinal study in 126 
iron-replete, non anemic 6-10 year old children in Morocco (Zimmermann et al 2005). 
The children consumed their regular cereal and legume-based diet for 15 months. The 
children’s diets had sufficient energy, protein and most importantly had high iron 
content (5.4 mg/1000 kcal). Based on the children’s iron intake, absorption of only 8% of 
their dietary iron would be sufficient to meet their requirements, but the absorption 
was estimated to be 2% only (0.22 mg/d). At the end of the study, 75% of children were 
iron deficient and about 33% had mild iron deficiency anemia. 
Iron status and tea consumption were reviewed in 16 studies that evaluated iron 
deficiency in relation to tea consumption (Temme and Van Hoydonck 2002). Six studies 
included infants and children, and another six included pre-menopausal women. 
Subjects in these 12 studies had a high prevalence of iron deficiency. The other 4 studies 
included men and elderly with low prevalence of iron deficiency. The review found that 
tea consumption was inversely associated with serum ferritin and/or hemoglobin in 
populations with marginal iron status but the association was not found in people with 
adequate iron stores.  
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Recently, the WHO published recommended nutrient intakes (RNIs) for iron 
based on the bioavailability of the usual diet consumed by the population (WHO/FAO 
2005b). For example, if the usually consumed diets of the population have an estimated 
bioavailability of 5.5% (form Table 2.25: diets that have a negligible content of 
meat/fish, high phytate, high tannin, and low ascorbic acid have a bioavailability of 
5.5%), then the RNI for iron for children at 4-6 years of age for example should increase 
up to 12.6 mg/day compared to 4.2 mg/day for diets with 15% bioavailability (Table 
2.26).   
Table 2.26 
 Recommended nutrient intakes (RNIs) for iron for different dietary iron bioavailability 
 
 
Group 
 
 
Mean body weight 
 (kg) 
Recommended nutrient intake 
(mg/day) for a dietary iron 
bioavailability of: 
15%  10%  5% 
Children (1-3 years) 13 3.9  5.8  11.6 
Children (4-6 years) 19 4.2  6.3  12.6 
Females (11-14) pre-menarch 46 9.3  14.0  28.0 
Females (11-14) 46 21.8  32.7  65.4 
Females (15-17) 56 20.7  31.0  62.0 
Women (18+ years) 62 19.6  29.4  58.8 
Postmenopausal women 62 7.5  11.3  22.6 
Lactating women 62 10.0  15.0  30.0 
Men (18+ years) 75 9.1  13.7  27.4 
Source: (WHO/FAO 2005b)  
 
Women of child bearing age along with teenage girls (i.e., menstruating women) 
have an increased iron requirement due to menstrual iron losses. On average, a 
menstruating woman looses approximately 0.56 mg/day over 28 days of the menstrual 
cycle (WHO/FAO 2005b). The volume of menstrual blood loss varies from woman to 
woman but it remains fairly constant for the same woman throughout her fertile life 
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(Hallberg et al 1966). Hallberg and Rossander-Hulten studied the dietary iron 
requirements in menstruating women taking into account three factors: the average 
basal iron loss (0.8 mg/day), the menstrual loss, and three different iron bioavailabilities 
based on three diet types ( 14% for Swedish diet, 16% for French diet, and 16.6% for US 
diet). A bioavailability of 15% was used to represent the bioavailability of the general 
Western-type diet. The study concluded that the dietary iron requirements for the 95th 
percentiles were 18.9 mg for menstruating women (18+ years old) and 21.4 mg for 
menstruating teenagers (Hallberg and Rossander-Hulten 1991).  
 
STAGES OF IRON DEFICIENCY 
Iron deficiency is “a state in which there is insufficient iron to maintain the 
normal physiological function of tissues such as blood, brain, and muscles” (WHO/CDC 
2004). It results from long-term negative iron balance (WHO/UNICEF/UNU 2001). The 
progression of iron deficiency occurs in three successive stages:  
• Iron deficiency (ID): characterized by exhaustion of iron stores 
(diminished ferritin and hemosiderin) but functional iron is not 
compromised. This stage is marked by a decrease in serum ferritin 
concentration.  
• Iron-deficient Erythropoieses (IDE): at this stage, the iron supply for 
eryhthropoiesis is reduced. This stage is marked by increases in serum 
transferrin receptors (TfR) and erythrocyte protoporphyrin but still 
anemia is not detected. 
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• Iron deficiency anemia (IDA): this is the final stage of iron deficiency 
which is characterized by low iron stores and sub-optimal hemoglobin 
concentration along with decreases in the following red cell indices: 
mean cell volume (MCV), mean cell hemoglobin (MCH), and mean cell 
hemoglobin concentration (MCHC).  
ASSESSMENT OF IRON DEFICIENCY 
The gold standard for the evaluation of iron status is the absence of stainable 
iron in the reticuloendothelial cells in the bone marrow (Bothwell et al 1979). However, 
this method is not practical for evaluation of iron status in field settings because it is 
expensive and invasive. The commonly used measures of iron status are mentioned in 
Table 2.27. Cook (2005) classifies the laboratory measures of iron deficiency into two 
major categories: screening and definitive measures (Cook 2005). The screening 
measures involve: hemoglobin; hematocrit; red cell indices; transferrin saturation; and 
erythrocyte zinc protoprphyrin. The definitive measures involves: ferritin, serum iron; 
transferrin receptor; and bone-marrow iron. The screening tests measure the iron 
supply to the circulating red blood cells (degree of hemoglobinization), while the 
definitive tests measure the depletion of iron stores and tissue iron deficiency.  
Each of these tests has its limitation in term of sensitivity and specificity (as 
discussed in Table 2.27. Therefore the use of a multivariable approach is preferred in 
population-based assessment when measurement of multiple indices is feasible 
(WHO/UNICEF/UNU 2001). A discussion on defining iron deficiency and iron deficiency 
anemia using multiple indices is presented later.  
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Table 2.27 
Description of iron deficiency and iron deficiency anemia indicators 
 
 
Explanation and comments 
 
Suggested cut-off values  
 
 
Hemoglobin (g/dl) and Hematocrit (PCV)% 
 
 
Hemoglobin (Hb): 
-Most widely used to assess iron deficiency 
anemia which is the final stage of iron 
deficiency, therefore it has a low sensitivity. 
Typically, 20-30% of body iron is lost before 
anemia develops (Cook 2005). Also, it has a low 
specificity. Measurement of Hb is indicative of 
anemia but not specifically iron deficiency 
anemia. Low Hb concentrations can result from 
deficiencies of vitamin A, B6, B12, and riboflavin, 
and folic acid (Fishman et al 2000, van den Broek 
and Letsky 2000). 
 
Hematocrit [Packed cell Volume (PCV)]: 
-Low sensitivity: it falls only in case of severe 
iron deficiency anemia 
-Low specificity: affected by same factors that 
influence Hb 
 
 
Hb and PCV cut-off values for iron deficiency 
anemia 
 
  Hb PCV 
Children  6-59 mo <11.0 <0.33 
 5-11 y <11.5 <0.34 
 12-14 y <12.0 
 
<0.36 
 
Women> 15 
y 
Non- 
pregnant 
<12.0 <0.36 
 Pregnant <11.0 
 
<0.33 
Men >15 y  <13.0 <0.39 
Source: (WHO/UNICEF/UNU 2001) 
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Table 2.27-continued 
Description of iron deficiency and iron deficiency anemia indicators 
 
 
Explanation and comments 
 
Suggested cut-off values  
 
 
Red Cell Indices: MCV, MCH, and MCHC 
-Mean corpuscular volume (MCV), mean corpuscular 
hemoglobin (MCH), mean corpuscular hemoglobin 
concentration (MCHC) are relatively late indicators of 
IDA. 
-In IDA, the reduction in MCV occurs in parallel with 
anemia, followed by a fall in MCH, then MCHC which 
is the least useful index.  
-Microcytic RBCs (small MCV) is a common sign of 
iron deficiency anemia. Macrocytic RBCs (high MCV) 
indicate megaloblastic anemia resulting from folate 
or vitamin B12 deficiency.   
 
Normal values for red cell indices for 
children and females 
Age (y) MCV MCH MCHC 
Children    
1-1.9 79 (67) 27.4 (22) 34.4 (32) 
2-4.9 81 (73) 28.1 (25) 34.5 (32) 
5-7.9 82 (74) 28.6 (25) 34.5 (32) 
Females    
12-14.9 86 (77) 29.4 (26) 34.1 (32) 
15-17.9 88 (78) 30.0 (26) 33.9 (32) 
>18.0 90 (81) 30.6 (26) 33.9 (32) 
Source: (WHO/UNICEF/UNU 2001)  
- Values are mean (-2SD). Units are: MCV (fl), MCH 
(pg), and MCHC (g/l). 
 
Erythrocyte Zinc Protoporphyrin (ZnPP) or Erythrocyte Protoporphyrin 
-When iron is insufficient in the bone marrow for 
heme biosynthesis, zinc is substituted for iron to 
form ZnPP instead of protoporphyrin IX. Therefore, 
high concentration of ZnPP in blood indicates a 
suboptimal supply of iron at the time of erythrocyte 
maturation (Gibson 2005). 
- Low specificity: can be elevated in infection or 
inflammation, lead poisoning, or hemolytic anemia.  
- In iron overload, normal iron levels, or mild iron 
deficiency without anemia, ZnPP remains normal. 
 
Moderate  and severe iron deficiency without 
anemia 
Age < 5 y Age >5y 
>70 µg/dl RBC >80 µg/dl RBC 
>2.6 µg/g Hb >3.0 µg/g Hb 
>61 mmol/mol heme >70 mmol/mol heme 
Source: (WHO/UNICEF/UNU 2001) 
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Table 2.27-continued 
Description of iron deficiency and iron deficiency anemia indicators 
 
Explanation and comments 
 
Suggested cut-off values  
 
Serum Iron, Transferrin (TIBC), and Transferrin Saturation 
 
-Both serum iron and transferrin saturation 
are subjected to wide diurnal variation.  
-The three variables are useful in determining   
nutritional iron deficiency where serum iron 
falls and TIBC increases causing a decrease in 
transferrin saturation [transferrin saturation= 
(Serum Iron/TIBC)100%] 
-Another limitation is that infections and 
chronic inflammatory conditions tend to lower 
transferrin saturation (due to decrease in both 
serum iron and TIBC).  
 
 
Transferrin saturation <16% 
 (WHO/UNICEF/UNU 2001) 
 
 
 
Serum Transferrin receptor (TfR) 
- TfR regulate the uptake of iron (TfR-transferrin iron complex) into cells especially erythroid 
precursors which are necessary for Hb synthesis (Skikne 2008).  
- Cells express TfRs on their surface in proportion to their iron requirements (Cook et al 1993). 
Therefore, TfR increase in response to iron deficiency or increased erythropoiesis.  
-TfR is a sensitive and reliable measure of functional iron deficiency (Skikne et al 1990). 
- A major advantage of measuring TfR is that (unlike ferritin) it is not affected by infection or 
inflammation (Skikne et al 1990) therefore, TfR can be used to distinguish anemia of chronic 
disease from iron deficiency anemia. When TfR is performed in conjunction with serum ferritin, 
the TfR will “be useful in establishing the true prevalence of iron deficiency anemia in population 
studies”(Cook et al 1993).  
-  Cut-off values vary according to the assay used. Currently there is no universally agreed 
reference value for TfR. 
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Table 2.27-continued 
Description of iron deficiency and iron deficiency anemia indicators 
 
Explanation and comments 
 
Suggested cut-off values  
 
 
Serum Ferritin  
- Ferritin is a very sensitive indicator of iron 
status. Serum or plasma ferritin concentration 
is the most useful measure for storage iron 
(Cook et al 1974). 
- In healthy adults, each 1µg/L of serum ferritin 
corresponds to 8-10 mg body iron, and it is 
equivalent to 120µg/L of storage iron per kg 
body weight in small adults or children (Finch 
et al 1986). 
- “serum ferritin is the only measure of iron 
status that can reflect a deficient, excess, or 
normal iron status”(Gibson 2005).  
-Ferritin is an acute-phase reactant protein. 
Therefore, it increases (independent of iron 
status) in response to acute/chronic infection 
or inflammation which makes it an unreliable 
indicator of iron status in population studies 
where there is high incidence of 
infection/inflammation.   
 
Serum ferritin Cut-off Points (µg/L) 
 
  
Children <5 y 
Children >5 y 
and Adults 
 
Depleted Iron 
Stores 
<12 <15 
 
Depleted Iron  
Stores + 
Infection 
<30 - 
 
Risk of Iron 
Overload 
 
- 
>200 
 (adult male) 
>150 
 (adult 
female) 
Source: (WHO/UNICEF/UNU 2001) 
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THE USE OF MULTIPLE INDICES TO ASSESS IRON STATUS 
Many challenges exist in assessing iron status of populations. First of all, 
although the prevalence of anemia has been used as an indicator to assess the 
prevalence of iron deficiency, iron deficiency could occur with or without anemia. In 
addition to dietary iron deficiency, anemia could be caused by: infectious diseases 
(malaria, hookworm infections), micronutrients deficiencies (folate, vitamin B12, and 
vitamin A), and inherited conditions like thalassaemia (WHO/CDC 2004). Therefore, a 
hemoglobin concentration below the recommended cut-offs may or may not reflect iron 
status. On the other hand, the absence of anemia doesn’t necessarily mean an adequate 
iron concentration. Iron deficiency might exist even when anemia is not present in the 
cases where iron deficiency is not severe enough or didn’t last long enough to cause 
anemia. The early stages of iron deficiency are characterized by low serum/plasma 
ferritin and elevated transferrin receptor concentrations.  
The second challenge is assessing iron status in the presence of infections. The 
pro-inflammatory cytokines: cytokine tumor necrosis factor alpha (TNFα) and 
interleukin 1-α (IL-1α) stimulate ferritin synthesis through transcription induction of the 
H chain of ferritin in the presence or absence of exogenous iron (Torti and Torti 2002). 
This means that in the presence of infection, it is difficult to interpret iron status based 
only on ferritin levels because ferritin might be high despite low iron stores.  
In the most recent report (2004) of the joint WHO/CDC technical consultation on 
the assessment of iron status at the population level, it was recommended that 
measurement of hemoglobin concentration is necessary to assess iron status of 
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populations even though anemia is not necessarily caused by iron deficiency, and that 
“measurement of serum ferritin and transferrin receptors provide the best approach to 
measuring iron status of populations” (WHO/CDC 2004). In areas where infection and 
inflammation are common, then serum ferritin alone is not a useful indicator of iron 
status, and therefore measurement of serum ferritin should be combined with the 
measurement of transferrin receptors to distinguish between iron deficiency and 
inflammation.  The WHO/CDC consultation suggests the following interpretation of 
serum ferritin and TfR in assessing iron status of populations (Table 2.28): 
 
Table 2.28 
Interpretation of low serum ferritin and high transferrin receptor concentrations in population 
surveys  
 
% serum ferritin values 
 < threshold 
(<12 µg/L in children, 
 <15 µg/L in Adults) 
% TfR values > threshold 
(Apply thresholds 
recommended by assay 
manufacturer) 
Interpretation 
< 20% a 
 
< 10% Iron deficiency is not prevalent 
< 20%  a 
 
≥ 10% 
 
Iron deficiency is prevalent; 
inflammation is prevalent 
≥ 20% b 
 
≥ 10% 
 
Iron deficiency is prevalent 
≥ 20% b 
 
< 10% Iron depletion is prevalent 
a <30% for pregnant women, b ≥30% for pregnant women, Source: (WHO/CDC 2004) 
 
To control for the high serum ferritin concentration resulting from infection or 
inflammation, the WHO/CDC report suggests the measurement of other acute phase 
proteins to help interpret ferritin data. These include: c-reactive protein (CRP), α-1-
antichymotrypsin (ACT), α-1- acid glycoprotein (AGP), serum amyloid A, fibrinogen, 
ceruloplasmin, complement factor-3 (C3), and haptoglobin. High values for an acute 
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phase protein indicates the presence of infection. With infection ferritin concentration is 
expected to be high despite low iron stores, and therefore individuals with such high 
values should be excluded from the analysis (if feasible) to define the population’s iron 
status.  
In a recent review on the interpretation of iron status indicators during infection 
(Northrop-Clewes 2008), the acute phase proteins are categorized into three groups: 
1. Acute phase proteins which increase by ½ fold like ceruloplasmin and C3. 
2. Acute phase proteins which increase by 2-5-fold, these include: 
haptoglobin, fibrinogen, AGP, and ACT.  
3. Acute phase proteins which increase as much as 1000-10,000-fold like 
CRP and serum amyloid A.  
Both CRP and amyloid A respond quickly to infection. CRP rises to concentrations 
> 5mg/L in the first 6 hours (Shine et al 1981) and peaks at 48-72 hours, but also returns 
to normal concentration (0.8 mg/L) quickly. While ACT rises quickly like CRP, it does stay 
at a higher concentration longer than CRP.  AGP shows a slow increase in response to 
infection/inflammation but it remains at a high concentration for longer period than 
both CRP and ACT (WHO/CDC 2004). “Ferritin was found to be the only biomarker of iron 
status that is consistently related to either CRP or AGP” (Beard et al 2006b).  Ferritin as 
an acute phase protein responds early to infection. An earlier study found that the 
increase in CRP concentrations at the initial phase of infection parallels those of ferritin, 
but in later stages of inflammation when CRP decreased, serum ferritin was maintained 
at a high level and gradually normalized over weeks (Baynes et al 1986). The WHO/CDC 
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consultation report stated that: “the most commonly measured acute phase protein is 
CRP, but there is evidence that AGP may better reflect the change in concentration of 
ferritin in serum and may be the useful acute phase protein to measure”(WHO/CDC 
2004) . 
Cogswell and colleagues (2009) compared two approaches used to identify iron 
deficiency (Cogswell et al 2009). The first one is a multivariable approach that is used by 
the National Health and Nutrition Examination Surveys (NHANES) which defines iron 
deficiency as: “having abnormal results for two or more of the following tests: serum 
ferritin concentration, erythrocyte protoporphyrin, or transferrin saturation” (US 
Department of Health and Human Services 2000). The second approach for the 
quantitative estimation of total body iron was proposed by Cook and colleagues (2003) 
using two indicators: transferrin receptor (TfR) and serum ferritin (SF) (Cook et al 2003). 
The logarithm of the ratio TfR/SF proposed in this model was found to be directly 
proportional (close to a linear relationship) to the amount of body iron expressed as 
mg/kg body weight as in the following formula:  
Body Iron (mg/kg) = - [log (TfR/Ferritin ratio) - 2.8229]/0.1207 
Positive values for body iron (> 0 mg/kg) indicates iron surplus in stores, and negative 
values (body iron <0 mg/kg) indicates tissue iron deficiency.   
The Centers for Disease Control and Prevention (CDC) has phased in this model 
on NHANES beginning 2003-2004 among preschool children and women of child bearing 
age (Cusick et al 2008). The battery of indicators measured in the NHANES to assess iron 
status had traditionally included ferritin, transferrin saturation, erythrocyte 
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protoporphyrin, and complete blood count. After phasing in the new model, transferrin 
receptor along with the traditional indicators were measured through the 2005-2006 
cycle, after which transferrin saturation and erythrocyte protoporphyrin were phased 
out (Cusick et al 2008).  The WHO presented the model proposed by Cook and 
colleagues (2003) for the quantitative estimation of total body iron in its joint WHO/CDC 
technical consultation report on the assessment of iron status at the population level 
and pointed out that despite the significant advance of this method on previous ones, 
there is a difficulty of validating the relationship between TfR/ferritin and body iron 
stores in children and young women by phlebotomy (WHO/CDC 2004).   
In the Cogswell study, iron status and inflammation were measured in 486 
children aged 1-2 years, 848 children aged 3-5 years, and 3742 non-pregnant females 
aged 12-49 years from NHANES 2003-2006. The study found that there was fair to good 
agreement between both approaches in identifying iron deficiency in children (aged 3-5 
years), and good agreement in females of child-bearing age. The important finding was 
that the second approach (the one based in TfR/ferritin ratio) found lower prevalence of 
iron deficiency, was less affected by inflammation, and better predicted anemia among 
females of child-bearing age.  
In addition to the use of TfR/ferritin ratio, the TfR-F index (TfR/ log ferritin) has 
been also studied and shown to be valuable in assessing iron status and in 
differentiating between anemia of chronic disease and iron deficiency anemia 
(Punnonen et al 1997, Weiss and Goodnough 2005). The diagnostic sensitivity and 
specificity of ferritin and TfR were maximized when the TfR-F index was used to identify 
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iron deficient patients and the index provided an area under the ROC curve (AUCROC ) 
value of 1.00 (Punnonen et al 1997). Other studies found that  TfR/log ferritin could 
sensitively detect iron deficiency, however, the use of log (TfR/ferritin) ratio had the 
highest sensitivity in determining the stages of iron deficiency (Lin et al 2008, Malope et 
al 2001).  With the lack of consensus on the use of TfR/ferritin ratio in defining iron 
status, there is a need for larger studies to validate the ratios of TfR/ferritin in detecting 
iron deficiency and establish definitive age-specific reference ranges that can be applied 
to population studies.    
 
ZINC 
OVERVIEW 
   The body content of zinc is estimated to range from 1.5-2.5 g, and this level is 
maintained with a daily absorption of approximately 5 mg of zinc in the small intestine 
(Cousins 2006). Approximately, thirty percent of total body zinc is in the skeletal 
muscles, and only 0.1% is in the form of plasma zinc (WHO/FAO 2005a). Almost 70% and 
20-40% of plasma zinc is bound to albumin and α2-macroglobulin, respectively, and less 
than 1% of plasma zinc is bound to cysteine and histidine. Blood zinc is found mostly in 
erythrocytes where more than 85% of zinc in red cells is found in carbonic anhydrase, 
and about 5% is present as Cu/Zn-superoxide dismutase (Cousins 2006). Zinc is involved 
in almost all metabolic pathways and plays a major role in DNA transcription, RNA 
translation, cellular division, and cellular activation. Further, it is required (as electron 
acceptor) for the catalytic function of more than 100 specific enzymes. These include 
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enzymes that belong to all enzyme classes (transferases, oxidoreductases, lysases, 
hydrolases, ligases, and isomerases) in addition to RNA polymerases (I, II, and III), 
alcohol dehydrogenase, carbonic anhydrase, and alkaline phosphatase (IZiNCG 2004). 
Plasma/serum zinc is maintained under tight homeostatic mechanisms that keeps 
normal levels of serum zinc  concentrations within the range of 12-15 mmol/L (78-98 
µg/dL) in healthy individuals (Gibson et al 2008).  
Zinc is a key trace element in the immune system. Zinc deficiency affects the 
development of both innate immunity (natural killer cells and neutrophils), and acquired 
immunity (T-lymphocyte functions, Th1-cytokine production, B-lymphocytes and 
antibody production). In addition, zinc deficiency has a crucial effect on macrophages 
where phagocytosis, intracellular killing, and cytokine production are compromised 
(Shankar and Prasad 1998). Benefits of oral zinc supplementation in the prevention 
and/or treatment of diarrhea in children were recently reviewed. Zinc supplements 
improve immune functions, increase resistance to infections, and reduce the severity, 
risk, and duration of diarrhea in malnourished children living in developing countries, 
and low and middle income countries (Fischer Walker and Black 2004, Scrimgeour and 
Lukaski 2008).  Zinc intervention studies that assessed the role of zinc in improving 
diminished cognitive ability and motor functioning suggest a relationship between zinc 
supplementation and motor development in infants, toddlers, and school aged children 
although more research is needed to confirm such relations (Black 2003).  
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ASSESSMENT OF ZINC DEFICIENCY 
Recently, the International Zinc Nutrition Consultative Group (IZiNCG) published 
its second technical document on zinc intervention strategies and summarized the new 
guidelines on the assessment of population zinc status (Brown et al 2009). The 
guidelines on the assessment of zinc status were reviewed and published following an 
interagency meeting on zinc status indicators by WHO, UNICEF, the International Atomic 
Energy Agency (IAEA), and IZiNCG (de Benoist et al 2007). These guidelines considered 
three main types of zinc assessment: biochemical, dietary, and functional methods. 
Ideally, these three indicators are combined together to set up the best estimate of zinc 
deficiency. A discussion on these three methods is presented below.   
Serum or plasma zinc concentration below the age/sex/time of the day/fasting 
status-specific cutoffs is considered the best available biochemical measure of zinc 
deficiency as recommended by the Joint WHO/UNICEF/IAEA/IZiNCG Interagency 
meeting on zinc status indicators (de Benoist et al 2007). Serum zinc is considered a 
good indicator of the population’s zinc status because it reflects the dietary intakes of 
zinc, both individual and population mean serum zinc responds consistently to zinc 
supplementation, and finally reference data are available for most age/sex groups. 
However, it should be noted that “serum zinc concentration may not be a reliable 
indicator of an individual’s zinc status. Nevertheless, the distribution of serum zinc 
concentrations among a representative sample of a population can be used to assess the 
risk of zinc deficiency in that population.” (IZiNCG 2007a).  
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Serum zinc concentrations suggested to define zinc deficiency are lower than 
normal (2.5th percentile) since zinc status varies by age, sex, time of the day, and fasting 
status. These values are presented in Table 2.29.  
Table 2.29  
Suggested lower serum zinc cutoffs for deficiency by age, sex, time of the day, and fasting 
status 
 
 
 
Time of the day and fasting 
status 
 
Suggested lower serum zinc cutoffs for deficiency (µg/dL)
* 
 
< 10 years 
 
> 10 years 
Males & females Non pregnant females Males 
 
Morning 
 
Fasting† 
 
Not available 
 
74 
 
70 
 Non-fasting 65 70 66 
Afternoon, non-fasting 57 61 59 
*
Divide by 6.54 to convert to µmol/L. 
 
†
fasting defined as no food or beverage consumption for at least 8 hours 
Source: (IZiNCG 2007a)  
 
If the prevalence of zinc deficiency according to the suggested lower cutoffs in 
the table is greater than 20%, public health intervention should be addressed to 
improve zinc status (Hess et al 2009). While serum or plasma zinc concentrations fall 
during severe infections or stress, “common, acute infections encountered in 
community settings do not have a major effect on the mean plasma zinc concentrations 
of children in low-income countries” (Brown 1998). 
The second approach for zinc status assessment is the dietary assessment which 
is done through the use of 24-hr recall or weighed dietary records to identify 
populations with sub-optimal zinc intake [zinc intake below the estimated average 
requirements (EAR)]. Risk of zinc deficiency increases when the prevalence of 
inadequate intakes is greater than 25% (de Benoist et al 2007). Zinc bioavailability is 
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highly variable with the type of food consumed. Protein found in meat, poultry, and fish 
enhances zinc absorption, and high levels of calcium, and high phytate: zinc ratios in the 
whole diet inhibit zinc absorption. The consumption of phytate-rich foods from plants 
greatly reduces the zinc bioavailability, therefore phytate: zinc molar ratio should be 
taken into account when determining dietary zinc bioavailability (IZiNCG 2007b).  
The recommended dietary intakes (RNIs) proposed by the WHO/FAO were 
established in 1996 based on the WHO estimates of average daily requirements for zinc 
with the addition of 50% or two standard deviations to ensure that the RNIs meet zinc 
requirements from diets differing in zinc bioavailability (WHO/FAO 2005a). Zinc adjusted 
RNIs based on zinc bioavailability are presented in Table 2.30. 
Table 2.30  
The recommended nutrient intake (RNIs) for zinc for different dietary zinc bioavailability 
 
 
 
Group 
 
 
 
Age (years) 
 
Mean body 
 weight 
 (kg) 
Recommended nutrient intake 
(mg/day) for a dietary zinc 
bioavailability of: 
50%   30%  15% 
Children  1-3  12 2.4  4.1  8.3 
 4-6  17 2.9  4.8  9.6 
 7-9  25 3.3  5.6  11.2 
Adolescents         
Females 10-18 47 4.3  7.2  14.4 
Males 10-18 49 5.1  8.6  17.1 
Adults         
Females 19-65 55 3.0  4.9  9.8 
 65+ 55 3.0  4.9  9.8 
Males 19-65 65 4.2  7.0  14.0 
 65+ 65 4.2  7.0  14.0 
Pregnant  women        
1st trimester  - 5.8  9.5  19.0 
2nd trimester  - 5.3  8.8  17.5 
3rd trimester  - 4.3  7.2  14.4 
Source: (WHO/FAO 2005a) 
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Finally, functional consequences of low zinc status could be used to suggest the 
need for zinc interventions or supplementation, although these consequences might not 
be related only to zinc deficiency. In other words, high incidence of infection or stunting 
among a population could be attributable to many other factors beside zinc deficiency. 
However, the meta-analysis by Brown and colleagues (2002) concluded that the severity 
of stunting predicted the response to zinc intervention, and growth responses were 
greater in children with low initial weight-for-age z scores and in those with low initial 
height-for-age z scores (Brown et al 2002). The IZiNCG suggests in its second report that 
the risk of zinc deficiency is of public health concern when the prevalence of low height-
for-age (The percentage of children under 5 years of age with height-for-age z-score less 
than −2.0 SD with respect to the reference population) is greater than 20%, and in that 
case nutrition intervention strategies should address zinc status (Hess et al 2009). 
Fischer Walker and Black supported this recommendation in their earlier review (Fischer 
Walker and Black 2007). The following functional indicators for assessing the risk of zinc 
deficiency were reviewed in 46 randomized controlled trials (RCTs) of zinc 
supplementation: infectious diseases, growth, and development outcomes. The review 
found that zinc supplementation decreases both the incidence and the prevalence of 
infectious diseases (diarrhea and pneumonia), and that zinc supplementation had a 
remarkable effect on linear growth especially among pre-school children who started 
the RCTs with low height-for-age irrespective of the children’s age. However, it was 
difficult to estimate the prevalence of zinc deficiency based on the incidence and 
prevalence of diarrhea and pneumonia. These results agree with Brown and colleagues 
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(2002) meta-analysis study mentioned earlier. Thus the prevalence of stunting among a 
population could be used as a functional indicator of population zinc status.  
In its first technical report, the International zinc consultative Group (IZiNCG) 
recommended the use of a composite index for the estimation of national risk of zinc 
deficiency based on two indicators: the prevalence of stunting among pre-school 
children and the percent of individuals at risk of inadequate dietary zinc intake based on 
national food balance sheets (IZiNCG 2004). However, in its second report, the IZiNCG 
stated that “the estimate of the extent of zinc deficiency should rely on the prevalence 
of stunting among children less than 5 years because not much data is available from 
nationally representative surveys on inadequate dietary zinc intake, and assessment of 
dietary zinc intake and serum zinc can be used to confirm the risk of zinc deficiency” 
(IZiNCG 2009). A prevalence of stunting >20% of a population is a public health concern 
for zinc (WHO 1995a). Countries in South and Southeast Asia, sub-Saharan Africa, and 
Central America have the highest prevalence rates of stunting (>30%) as shown in Figure 
2.8.  
Figure 2.8  
Prevalence of nutritional stunting in children under five years of age 
 
Source: (IZiNCG 2004) 
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The two indicators (stunting rates among children under 5 years of age, and the 
risk of inadequate zinc intake) were used to estimate the global burden of zinc 
deficiency based on data from 52 countries in 12 regions and sub-regions in the world 
(Fischer Walker et al 2009). Almost 453,207 of deaths were attributed to zinc deficiency 
(which is 4.4% of childhood deaths). Around 14.4% of diarrhea deaths, 10.4% of malaria 
deaths, and 6.7% of pneumonia deaths among children (6 months-5 years of age) were 
attributed to zinc deficiency.   
To sum up, in a review of evidence Gibson and colleagues (2008) have 
recommended three indicators of population zinc status: percentage of population with 
serum zinc below the cut-off points, percentage of stunted children (under 5 years of 
age), and the prevalence of inadequate zinc intakes i.e., below the estimated average 
requirements (Gibson et al 2008).  The use of serum zinc to assess population zinc status 
has been confirmed in several ways including: 1) in zinc interventions serum zinc 
successfully predicted functional responses to zinc supplementation 2) the strong 
relation between serum zinc and dietary intakes of zinc 3) the strong relationship 
between serum zinc at baseline and change in serum zinc after zinc intervention. When 
studying the usefulness of serum zinc in predicting functional responses to zinc 
supplementation, linear growth or height-for-age was considered the best functional 
outcome compared to infectious diseases (diarrhea, malaria, and pneumonia), and 
developmental outcomes. The use of other zinc indicators has been also discussed as 
potential zinc biomarkers such as: zinc concentration in hair, cells (erythrocytes, 
platelets, leucocytes, and neutrophils), metalloenzymes, and zinc-binding proteins (like 
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metallothionein), but still more research is needed to verify the accuracy and validity of 
such biomarkers.  
 
COGNITION, IRON, AND ZINC 
 
IRON AND COGNITION- POSSIBLE MECHANISMS 
 
Iron uptake in the brain occurs primarily through transferrin receptors found on 
brain capillary endothelial cells (Connor and Benkovic 1992, Fishman et al 1987). 
Transferrin is mainly found in oligodendrocytes in the brain and myelinating Schwann 
cells in the peripheral nervous system (Connor and Benkovic 1992). The brain responds 
to iron depletion and repletion through a homeostatic mechanism that is tightly 
regulated by the blood brain barrier. When an individual’s iron status is low the rate of 
iron intake in the brain increases, and when the iron status is high, iron uptake in the 
brain decreases (Taylor et al 1991), a very important regulatory mechanism given the 
high iron requirements by the brain along with the high susceptibility of the brain to 
oxidative damage. 
 Iron deposition in the brain differs by brain region and by stages of development 
(Pinero et al 2000, Youdim and Yehuda 2000), with the highest concentrations found in 
the globus pallidus, caudate nucleus, puamen, and substantia nigra (Beard 2003). These 
regions are high in iron content during adulthood but not during early stages of life 
(Beard 2001). This has been found in both rats (Connor and Menzies 1996) and humans 
where it was only by age of 12- 15 years that the substantia nigra became rich in iron 
(Aoki et al 1989). This means that brain sensitivity to iron deficiency is affected by the 
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different regional needs in the brain and different stages of neurodevelopment (Beard 
2001, Erikson et al 1997, Pinero et al 2000).  
 Iron is important for the proper myelination of the neurons (Kwik-Uribe et al 
2000, Youdim and Yehuda 2000, Yu et al 1986). A decrease in iron bioavailability due to 
low dietary intakes or availability or due to changes in iron storage capacity results in 
hypomyelination, a decrease in myelin proteins including proteolipids, and chronic 
changes in myelin composition (Ortiz et al 2004). Kwik-Uribe and coworkers (2000) 
studied the behavioral and biochemical effects of chronic iron deprivation during early 
development in mice, and also studied effect of postnatal consumption of Fe adequate 
diets on iron-deficient offspring. The mice fed the marginal iron diet showed significant 
differences in brain iron concentrations, dopamine metabolism, and myelin fatty acid 
composition compared to control mice. The postnatal consumption of iron adequate 
diets didn’t fully reverse all biochemical disturbances. The study found that chronic 
inadequate iron intakes during early development resulted in irreversible changes in 
brain biochemistry (Kwik-Uribe et al 2000).  
The distribution of iron in brain is associated with the metabolism of gamma-
aminobutyric acid (GABA) which modulates the activity of dopaminergic neurons. Some 
studies reported alteration in GABA metabolism as a result of iron deficiency (Li 1998, 
Shukla et al 1989). Hill (1988) pointed out that there is a great overlap between the iron 
distribution in the brain and the distribution of GABA, i.e., there is a similarity in the 
brain regions that are high in iron and brain regions that receive input from GABA nerve 
fibers (Hill 1988). These regions include: globus pallidus, substantia nigra, ventral 
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pallidus and the cerebellar nuclei. This is very important, because this overlap in the 
localization of iron and GABA occurs in the brain regions that regulate the cognitive 
(learning and memory), behavioral, and emotional functions (Youdim and Yehuda 2000).  
Iron is a co-factor for the synthesis of neurotransmitters including tyrosine 
hydroxylase (norepinephrine, and dopamine), tryptophan hydroxylase (serotonin), and 
also is a co-factor for xanthine oxidase, and ribonucleotide reductase: the rate limiting 
step in DNA synthesis (Youdim and Green 1978, Youdim et al 1989). There is an overlap 
in the distribution of dopamine and iron in the brain which occurs mainly in the striatum 
which is the major input area of the basal ganglia system. The striatum is believed to 
have the highest concentration of both dopamine and iron (Beard and Connor 2003). 
The striatum which is rich in dopamine receptors and dopaminergic fibers is best known 
for its involvement in higher order cognitive and emotional processes, reward-related 
processes and  motor functioning (Lozoff and Georgieff 2006). Studies have consistently 
shown that the dopamine system is sensitive to changes in iron status (Burhans et al 
2005, Erikson et al 2000, Morse et al 1999, Unger et al 2008). Lower dopamine 
transporter density has been found in iron-deficient brain regions (Erikson et al 1997, 
Pinero et al 2000), and dietary iron deficiency was found to be significantly correlated 
with decrease in dopamine (D2) receptor density in the brain regions that are iron 
deficient (Erikson et al 2001). Other studies reported reductions in dopamine D1 and D2 
receptors and monoamine transporters in iron deficient rats (Beard et al 2006a, Felt et 
al 2006). The changes in monoamine transporters and the neurochemical/behavioral 
abnormalities were persistent despite early repletion of iron status (Felt et al 2006, 
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Lozoff et al 2006a). In fact, Beard and Connor (2003) noted that delayed development as 
a consequence of iron deficiency during infancy persists despite iron repletion, whereas 
these consequences appear to be reversible if iron deficiency occurs during preschool 
and older childhood (Beard and Connor 2003).  
 
IRON AND COGNITION-LOOKING FOR EVIDENCE 
Grantham-McGregor and Ani (2001) looked for evidence of a causal relationship 
between iron deficiency and children’s cognition and behavior through a review of more 
than 26 intervention studies and 10 longitudinal studies (Grantham-McGregor and Ani 
2001). They found an association between iron deficiency anemia and poor cognitive 
and motor development. The longitudinal studies consistently showed that children 
who were anemic during infancy continued to have poor cognition and poor school 
performance at an older age (middle childhood). However, the review indicated that 
poor socioeconomic status prevents causal inferences from being made. Iannotti and 
colleagues (2006) reviewed 26 randomized controlled trials of oral iron supplementation 
in young children (0-59 months of age) living in developing countries, and found that 
iron deficient or anemic children had reduced cognitive and motor development, 
particularly if it was for longer duration (Iannotti et al 2006). 
Sachdev  and colleagues  (2005) evaluated 17 randomized controlled trials with 
interventions that included oral or parenteral iron supplementation, fortified formula 
milk or cereals and examined psychomotor development, cognition, mental 
development, or school performance as an outcome measure in children (Sachdev et al 
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2005). An association was found between iron deficiency anemia and poor motor 
development in children. However, the review showed conflicting data regarding the 
role of iron supplementation in improving motor and cognitive functions in children. The 
meta-analysis showed a modest effect of iron supplementation on mental development 
among children above 7 years of age, but no convincing evidence was found for the 
effect of iron intervention on mental or motor development in children below 27 
months of age.  
Lozoff et al (2006) reviewed follow-up studies from around the world regarding 
long-term effect of iron deficiency on cognition, neurophysiological functions, motor 
functioning, and social-emotional functions in infants, pre-school children, and 
adolescents (Lozoff et al 2006b). All studies showed nearly consistent results: children 
who had iron deficiency during infancy continued to perform less well than children who 
had adequate iron status during infancy. Lozoff (2007) stated that: “there is compelling 
evidence that 6-24 month-old infants with iron deficiency anemia are at risk for poorer 
cognitive, motor, social-emotional, and neurophysiological development in the short 
term. Iron-deficiency anemia in this age period is also consistently associated with 
poorer long term outcomes”.(Lozoff 2007) 
Adequate iron status during “critical periods” of development is necessary for 
“normal” development (Beard 2003). The question remains about what is the age that is 
considered the “critical period” of development for iron effects on the brain. 
Additionally, the time of onset of iron deficiency, the severity and duration of iron 
deficiency, and the overlap with other nutritional deficiencies are important 
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determinants of long-term consequences on cognitive, behavioral and developmental 
outcomes. 
 
IRON DEFICIENCY- COGNITIVE AND DEVELOPMENTAL OUTCOMES IN PRESCHOOL CHILDREN 
Research suggests poor cognitive, motor, or social functioning in iron-deficient 
infants and young children up to 24 months of age (Aukett et al 1986, Black et al 2004a, 
Friel et al 2003, Heywood et al 1989, Idjradinata and Pollitt 1993, Lozoff et al 1987, Oski 
and Honig 1978, Oski et al 1983, Walter et al 1983, Walter et al 1989, Williams et al 
1999). Longitudinal studies also showed that infants with chronic iron deficiency fail to 
catch up to the children with good iron status in development tests despite correction 
of iron status (Algarin et al 2003, Corapci et al 2006, Dommergues et al 1989, Hurtado et 
al 1999, Lozoff et al 1991, Lozoff et al 2000, Lozoff et al 2006b, Palti et al 1985, Shafir et 
al 2006, Walter 2003). However, research on the developmental outcomes and motor 
and cognitive functioning among iron deficient pre-school children is limited. The few 
available studies showed impaired motor, cognitive, and developmental outcomes 
among iron deficient pre-school children (Lozoff et al 2007, Metallinos-Katsaras et al 
2004, Pollitt et al 1983, Pollitt et al 1986, Soewondo et al 1989, Stoltzfus et al 2001).  
Pollitt examined various psychological tests in mildly iron-deficient children aged 
3-6 years at baseline and after 3 months of oral iron therapy (Pollitt et al 1983). 
Psychological tests included: the Stanford-Binet Intelligence Scale, measures of 
attention (discrimination learning), conceptual learning (oddity learning), and short term 
recall. The study found that iron deficient children had lower scores on tests of 
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discrimination learning and memory than the control group, and that iron 
supplementation improved attention in iron deficient children. Pollitt (1986) conducted 
another study in Guatemala that assessed the performance of 25 preschool children 
with iron deficiency anemia, and 25 iron-replete children aged 3-6 years on a series of 
cognitive tests (attention, memory, and learning tasks) before and after 3 months of 
oral iron therapy (Pollitt et al 1986). The study found that iron deficient children with or 
without anemia performed poorly on problem-solving situations and those with iron 
deficiency anemia showed more deficits in attention and higher order cognitive 
functions than non anemic children. The study also concluded that iron-deficient 
children are not likely to improve their performance on measures of cognitive functions 
following iron repletion therapy.  
A double-blind clinical trial assessed the effect of iron supplementation on 
cognitive functions among 176 Indonesian children aged 3-6 years (Soewondo et al 
1989).  Half the children received iron supplementation for 8 weeks while the other half 
received placebo. Significant changes were found from pre to post intervention in the 
iron-deficient anemic children in cognitive processes related to verbal intelligence, 
visual attention, and concept learning. The study concluded that iron deficiency anemia 
but not iron deficiency was related to low scores on various cognitive tests. 
The effect of iron supplementation on development of language and motor skills 
was assessed in 614 pre-school children aged 6-59 months in Zanzibar (Stoltzfus et al 
2001). Although iron supplementation improved motor and language development, the 
effect on motor development was limited to children who were severely anemic 
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(Hb<9.0g/dL at baseline). The effect of two months supplementation of 15 mg iron on 
attention and conceptual thinking was examined in 49 children at 3-4 years of age in 
Greece (Metallinos-Katsaras et al 2004). Twenty-one children were anemic at baseline 
(Hb <11.2 g/dL, TS<16%, and ferritin <12 mcg/L. Twenty-eight children had good iron 
status (baseline Hb>12.0 g/dl, and either TS >20% or serum ferritin >12 mcg/L. Iron 
supplementation resulted in improvement in selective attention but not oddity learning 
tasks among anemic children. The effect of iron supplementation among children with 
good iron status was not significant. 
Affect, social looking toward adults, and behavior as a function of iron status in 
pre-school children (aged 47-68 months) with or without iron deficiency anemia were 
recently evaluated in a cross sectional study in India (Lozoff et al 2007). Seventy-four 
children had iron deficiency anemia and 164 were non-anemic. Children with iron 
deficiency anemia showed a greater wariness and hesitancy as evidenced by less social 
looking toward their mothers, taking longer time to touch a stimulus toy, and being 
slower to smile than non anemic children.  
Two follow-up studies assessed various development tests and intellectual 
functioning among Costa Rican pre-school children who had either chronic, severe iron 
deficiency or good iron status at infancy. All infants with iron deficiency were treated in 
infancy and none had iron deficiency after treatment. The first study tested 163 children 
at 5 years of age on motor and mental functioning (Lozoff et al 1991). All children had 
excellent hematologic status and growth at five years of age. The tests showed that 
children with moderate iron deficiency anemia as infants (n=30) had poorer 
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performance on perceptual speed, performance IQ, visual matching, visual motor 
integration, and gross and fine motor performance even after controlling for maternal 
IQ and home socioeconomic status.  The second study compared child affect and 
behavior, and quality of mother-child interaction of 40 children at five years of age who 
formerly had  chronic and severe iron deficiency (as infants) to 102 children with good 
iron status at infancy (Corapci et al 2006). Children with chronic iron deficiency at 
infancy showed lower levels of physical activity, positive affect, and verbalization at 5 
years of age. Mother-child interaction (eye contact, shared positive affect, turn taking) 
was lower in children with chronic iron deficiency compared to children with good iron 
status at infancy.  
In summary, almost all reviews of the current literature on the effects of iron 
deficiency on children’s cognition and behavior (Beard and Connor 2003, Grantham-
McGregor and Ani 2001, McCann and Ames 2007, Thomas et al 2009), and reviews on 
the role of iron supplementation in improving development and cognition outcomes 
(Iannotti et al 2006, Sachdev et al 2005), have supported an association between iron 
deficiency anemia and cognitive and behavioral performance. Yet, a direct and 
unequivocal causal connection has not been clearly established.  
 
ZINC AND COGNITION- POSSIBLE MECHANISMS 
 
The exact biological mechanisms by which zinc deficiency alters brain functions 
and relates to cognition and behavior are not yet clear, but research has shown that zinc 
is essential for neurogenesis, neuronal migration, and synaptogenesis (Bhatnagar and 
Taneja 2001). Zinc acts as a neuromodulator in synaptic transmission (Colvin et al 2003, 
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Frederickson and Bush 2001, Kay and Toth 2008). Zinc is highly concentrated in the 
synaptic vesicles of particular neurons called “zinc-containing” neurons which are 
subsets of glutamatergic or “gluzinergic” neurons (Frederickson et al 2000, Hesse 1979, 
Howell et al 1984, Smart et al 2004), and these neurons are found almost exclusively in 
the cerebral cortex and limbic structures of the forebrain (Bitanihirwe and Cunningham 
2009, Brown and Dyck 2004, Frederickson et al 2000). Because of the abundance and 
exclusive presence of “gluzinergic” neurons in the mammalian cerebral cortex, it has 
been suggested that zinc might have a critical role in cortical communication 
(Frederickson et al 2000), cognitive and emotional functioning (Bitanihirwe and 
Cunningham 2009), as these zinc containing neurons contribute to the synaptic plasticity 
underlying learning and memory (Brown and Dyck 2004).  
In addition to that, there is increasing evidence that zinc deficiency alters the 
expression of specific subunits of the neurotrophins and N-methyl-D-aspartate (NMDA) 
receptors for glutamate, and thus controlling glutamate as a neurotransmitter in the 
central nervous system. The NMDA receptors are involved in neuronal differentiation, 
neuronal migration, and synaptic plasticity in hippocampus (a brain region that is 
involved in learning and memory), especially during early periods of development where 
synaptic plasticity is crucial (Chowanadisai et al 2005, Levenson 2006, Smart et al 2004). 
Zinc deficiency can alter the developmental regulation of NMDA receptors and cause 
changes that persist long after the correction of zinc status, and this indicates the 
importance of having adequate dietary zinc intakes during fetal and neonatal 
development (Levenson 2006) 
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Zinc deficiency has been studied in animals. Rats and monkey models have been 
used to study the effect of zinc restriction or deprivation during different stages of the 
life cycle. Rats have been used in studies that involve the prenatal and infancy periods 
since they have a short period (2 weeks) between weaning and puberty, whereas rhesus 
monkeys have been used to study zinc deficiency during infancy, childhood and 
adolescence since they have relatively a longer period between weaning and puberty 
that reaches 3 years (Bhatnagar and Taneja 2001). Research on animals has shown that 
zinc deficiency is associated with reduced motor activity, decrease in performance on 
tasks of visual attention and short-term memory, impaired spatial learning and 
knowledge retention, and increased emotional response to stress (Bhatnagar and 
Taneja 2001, Black 2003, Golub et al 1995, Golub et al 2000, Tahmasebi Boroujeni et al 
2009). Zinc deprivation in animals has been associated with impairments in learning and 
memory that are poorly reversible later in life (Sandstead 2003).  
 
ZINC AND COGNITION-LOOKING FOR EVIDENCE 
Relatively few studies have assessed the impact of zinc deficiency on cognition 
and behavior in humans. There are some observational studies but most of the research 
has involved zinc supplementation trials in pregnant women, infants, and school-age 
children with mixed results.   
Merialdi and colleagues (1999) assessed the impact of improvement of maternal 
zinc status during pregnancy on fetal neurobehavioral development in Peru (Merialdi et 
al 1999). Pregnant women were randomly assigned to receive a daily supplement of 60 
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mg iron and 250 mcg folate, with or without 15 mg zinc (for 10-24 week of gestation, 
and 1 week post partum). Fifty-five fetuses were electronically monitored at 32 and 36 
weeks of gestation where fetal heart and movement patterns were observed. Increased 
fetal heart range, minimal fetal heart variability, increased number of accelerations, and 
more vigorous fetal movements were observed in the fetuses of mothers who received 
zinc supplementation.  
Zinc nutriture of 50 women living in a periurban Egyptian village was assessed 
over the last 6 months of pregnancy and the first 6 months of lactation (Kirksey et al 
1991, Kirksey et al 1994). Estimated zinc intake was approximately 2mg/day from diets 
high in phytate and fiber. Performance on Bayley’s Motor Development Scale at 6 
months of age was negatively related to maternal intakes of zinc, phytate, and fiber.  
A randomized controlled study has assessed developmental outcomes in 52 
infants with very low birth weight (Friel et al 1993). Infants were randomly allocated to 
either 11 mg zinc/L of formula or 6.7 mg zinc /L for 6 months. Higher loco-motor 
development score on Griffiths mental development sub scales in infants using the 
formula with higher zinc content was reported. A randomized, double blind, placebo-
controlled study has assessed the impact of daily supplementation of zinc (10 mg) for 7 
months on activity patterns of 85 Guatemalan infants recruited at 6-9 months of age 
(Bentley et al 1997). Zinc supplemented infants were significantly more frequently 
observed sitting up or playing than lying, and less likely to be observed crying or 
whining. 
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To investigate the impact of zinc supplementation on observed activity levels 
among 93 children (aged 12-23 months), a randomized controlled trial was conducted in 
a low socioeconomic urban population in New Delhi (Sazawal et al 1996). Zinc (10 
mg/day) was supplemented for at least one month along with selected vitamins. 
Children in the zinc group spent 72% more time performing higher movement activities. 
A greater effect was observed in boys.  
In northeast Brazil, a double blind part-randomized efficacy trial was conducted 
to assess the impact of zinc supplementation on mental and psychomotor development 
of 205 term infants weighing 1500-2499 gm born to low income families (Ashworth et al 
1998). Low birth weight infants were randomly allocated to receive 1 mg zinc (n=68) or 
placebo (n=66), and another group received 5 mg zinc (n=71). The supplementation 
started at birth and lasted for 8 weeks. Bayley Scales of Infant Development were used 
to assess mental and psychomotor development at 6 and 12 months of age and no 
difference was found in the scores of the three groups. However, at 12 months of age, 
child behavior was rated on 5 scales (responsiveness to tester, emotional tone, activity 
level, cooperation with the test procedure, and amount of vocalization). Children who 
received five mg of zinc supplement had significantly higher rating on behavior, 
particularly responsiveness. 
The effect of zinc supplementation on neurodevelopment during infancy was 
assessed in Chile (Castillo-Duran et al 2001). Term infants (n=150) were randomly 
assigned to receive 5 mg zinc or placebo daily for 12 months. Solid food and iron were 
added at 5 months of age.  Assessment of psychomotor development, mental 
106 
development, behavior rating, emotional regulation, and motor quality showed no 
difference between the two groups at 6 months of age. However, at 12 months of age, 
scores on motor quality were found to be significantly different with higher mean motor 
quality for the zinc supplemented group.  
An interesting study assessed the impact of weekly supplements of iron (20 mg+ 
1mg riboflavin), zinc (20 mg+ 1mg riboflavin), iron + zinc (20mg iron+20mg zinc+ 1 mg 
riboflavin), or micronutrient mix (MM) [twice the recommended dietary allowance of 16 
vitamins and minerals in addition to 20 mg iron, 20 mg zinc, and 1 mg riboflavin] to 221 
infants at age of 6 months to age of 12 months in Bangladesh (Black et al 2004a). Bayley 
Scales of Infant Development II and the Home Observation Measurement of 
Environment (HOME) scale were administered to children at 6 months of age (pre-
intervention) and 12 months of age (post intervention). Maternal education, HOME 
score, months breastfed, anemia, growth by 6 months, and change in growth from 6 to 
12 months were controlled. The study showed that although psychomotor development 
index scores (PDI) had decreased from 6 months to 12 months for all groups, it 
decreased less for the “iron+ zinc”  and MM groups compared to the control group (1 
mg riboflavin). That means that supplementation with iron and zinc together or with 
MM containing iron and zinc had protected the infants from the decline in the motor 
development. Moreover, the effect size for the (iron + zinc) group was similar to that for 
the MM group, which indicates that there was no additional benefit of the added 
vitamins and minerals on the children’s motor development (Black et al 2004a). The 
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study concluded that there are beneficial effects of weekly combined iron and zinc 
supplementation on motor development and orientation-engagement.        
The effect of zinc supplementation and psychosocial stimulation on the 
psychomotor development of undernourished children was studied in a randomized 
controlled trial among 114 Jamaican children aged 9-30 months (Gardner et al 2005). 
Children were randomly assigned into four groups: stimulation alone (weekly home 
visits for 30 minutes demonstrating maternal-child interactions), zinc supplementation 
alone (10 mg), both stimulation and zinc supplementation, and control (neither 
stimulation nor zinc supplementation). Griffith’s mental development scales were used 
to assess development, and these involved: locomotors (large muscle activities such as 
walking or jumping), hand and eye coordination, hearing and speech, and performance 
on shape recognition, block construction, and block patterns. Zinc supplementation 
improved development only in children who received stimulation. Hand and eye 
coordination was improved in all children who received zinc supplementation, but the 
improvement was greater in those who received both stimulation and zinc 
supplementation.     
Despite the mentioned studies that have shown the beneficial effects of zinc 
supplementation on child development, there are some conflicting results regarding the 
impact of zinc supplementation on infant and child mental development and behavior. 
 Gibson and colleagues (1989) found no zinc treatment effect on attention span 
in a double-blind, pair-matched study that involved schoolboys at 5-7 years of age in 
Ontario, Canada  (Gibson et al 1989). Study participants were randomly assigned to 
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receive either 10 mg zinc or placebo daily for one year. Four subsets were used to 
measure attention span, these include: sentence imitation, word sequence, oral 
directions, and design reproduction. No difference was found in average attention span 
scores between treatment groups at baseline, 6 months, and 12 months of the study.  
A double-blind zinc intervention study of 162 Guatemalan children (mean age 
81.5 months) didn’t find any significant effect for zinc supplement on cognition (Cavan 
et al 1993). Children were assigned to either zinc supplement group (10 mg zinc + 
micronutrients mix per day) or placebo group (micronutrients mix without zinc) for 12 
months. No treatment effect was found for the total cognitive scores or for the three 
subsets administered (letter sequence, oral directions, and design reproduction).  
A randomized, double-blind, controlled trial assessed the impact of 5 mg zinc 
supplementation for a period of 5 months on the mental development index (MDI) 
subscale of the Bayley Scales of Infant Development (Hamadani et al 2001). Three 
hundred one infants aged one month were randomly assigned to receive either zinc 
supplement or placebo, and developmental levels were assessed at 7 and 13 months of 
age in 212 infants. Unexpectedly, the zinc-supplemented group had slightly but 
significantly lower scores on the mental development index of the Bayley Scales than 
the placebo group, even after controlling for nutritional status and social background.   
A follow-up study found no treatment effect of zinc supplementation during 
pregnancy on mental development and behavior of infants at 13 months of age 
(Hamadani et al 2002). Pregnant Bangladeshi women (n=559) were randomly allocated 
to receive either 30 mg zinc or placebo at 4 months of gestation each day until delivery. 
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Bayley Scales of Infant Development II and behavior rating were administered to infants 
at 13 months of age. Infants in the placebo group had higher scores on mental 
development index and psychomotor development index compared to zinc-
supplemented group even after controlling for differences between the two groups.   
Another study also found no effect of zinc supplementation on the mental or 
psychomotor development index in children aged 12-18 months (Taneja et al 2005). In a 
double-blind, randomized, placebo-controlled trial, infants received 10 mg zinc or 
placebo daily for 4 months. Bayley Scales of Infant Development II were administered at 
enrollment and at the end of the study. There was no difference in psychomotor index 
scores and adjusted mean mental scores in the treatment and the control groups.    
A relatively long follow-up study found no effect of zinc supplementation of 
women in later stages of pregnancy on the neurological development of their children 
at five years of age (Tamura et al 2003). In a double-blind trial pregnant women received 
either 25 mg zinc or placebo daily during the second half of pregnancy. Three hundred 
fifty five children (mean age= 5.3 years) took six tests that included: the differential 
ability scales, visual sequential memory, auditory sequential memory, knox cube, gross 
motor scale, and grooved pegboard tests. Again, no difference in scores was found 
between children whose mothers received zinc supplementation and those children 
whose mothers received the placebo.   
Lind and colleagues (2004) compared the effect of combined iron and zinc 
supplementation with effects of iron and zinc as single micronutrients on psychomotor 
development in 680 Indonesian infants at 6-12 months of age (Lind et al 2004).  Infants 
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were randomly assigned into four groups that received daily supplementation of: 10 mg 
iron, 10 mg zinc, 10 mg iron and 10 mg zinc, or placebo. Results of the study showed 
that single supplementation with iron only improved psychomotor development, but 
neither single supplementation with zinc nor the combined supplementation of iron and 
zinc had a significant effect on psychomotor development.  
Another study that found no effect of zinc supplementation on development and 
behavior of infants involved a nine months supplementation trial of 5 mg zinc on small 
for gestational age (SGA) infants in New Delhi (Black et al 2004b). Two hundred infants 
were randomized to receive daily supplements of micronutrients mix with or without 
zinc from one to nine months of age. Bayley Scales of Infant Development II were used 
to measure infants’ development and behavior at 6 and 10 months. Zinc 
supplementation had no effect on infants’ development or behavior at either 6 or 10 
months.   
In summary, research suggests a beneficial effect of zinc supplementation on 
infants and child mental development and behavior. However, some studies that 
involved zinc supplementation trials in pregnant women, infants, and school-age 
children have shown conflicting results.   
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CHAPTER III 
 
 
METHODOLOGY 
 
STUDY DESIGN AND RECRUITMENTS OF PARTICIPANTS  
A convenience sample of 93 women and their children aged 4–5 years from 
urban/suburban areas in Northern Jordan was recruited for the study. Participants were 
approached by direct contact with the help of local community centers. Potential 
participants included mothers of ages between 18-45 years who had children of age 4-5 
years. Mothers were called by the local community centers and a brief explanation of 
the study was given on the phone, after which mothers who were interested in 
participation were scheduled to come with their children to the community center 
where they were given a detailed explanation of every aspect of the study. After 
completion of the consent form for the mothers and the assent form for children, 
mothers were screened for pregnancy and mothers and children were screened for 
illness and date of birth. Any child or mother with high temperature, acute illness 
(illness in the same day or in the previous three days), or serious health problem was 
excluded from the study. Pregnant women were also excluded from participation.  
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Mothers reported date of birth for themselves, and date of birth for children was 
determined based on governmental birth certificates. In the community center, 
anthropometric measurements were collected for mothers and children, a 
questionnaire was administered individually to the mothers, and cognitive tests were 
administered to children. After that, participants were transferred to a local clinical 
laboratory where non-fasting venous blood samples were drawn from each participant. 
All samples were taken between June and July 2007. Hematological tests that require 
fresh blood were done immediately, and results were reported to participants. Serum 
and plasma samples were transferred into trace element-free tubes which were then 
frozen at -20 °C, shipped in dry ice to the laboratories of the Nutritional Sciences 
Department at Oklahoma State University in the USA and stored at -20°C until analyzed. 
 
ETHICAL REVIEW 
All procedures of the study were reviewed and approved by the Oklahoma State 
University Institutional Review Board (IRB Application No. HE0731). An informed written 
consent was obtained from the mothers, and verbal assent was obtained from the 
children using the content in the assent form.  
 
 RESEARCH ASSISTANTS 
 Four university graduates research assistants were trained on anthropometric 
measurements, questionnaire administration to mothers, and cognitive test 
administration to children. Two of the research assistants held masters degrees, one in 
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education and one in sociology. Two research assistants had bachelors degrees, one in 
pharmacy and one in chemistry. The research assistants received training to ensure high 
quality and standardized performance in the field work.  
 
ANTHROPOMETRIC MEASUREMENTS 
The anthropometric measurements collected from participants were weight and 
height for mothers and children, in addition to mid upper arm circumference (MUAC) 
for children. Height and MUAC were reported to the nearest millimeter, and weight was 
reported to the nearest 100 gram. To ensure standardization in anthropometric 
measurements, height and MUAC measurements were taken by the same individual for 
all participants, and weight was taken by the same individual for all participants. All 
measurements were taken in duplicate and averages of the duplicates were reported. 
When there was a difference between two measurements, a third measurement was 
taken for verification. Body mass index (BMI) was calculated for mothers as body weight 
(kg)/height (m2). For chapter four, anthropometric data for children were expressed as 
z-scores based on the CDC/WHO 1978 reference using Epi Info, v. 3.4.3 (Centers for 
Disease Control, USA). For chapters five and six, anthropometric data for children were 
expressed as z-scores based on the WHO (World Health Organization) 2007 reference 
using AnthroPlus, version 1.0.2 (WHO 2009). 
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THE QUESTIONNAIRE 
The questionnaire was validated by a group of academic experts in research, 
statistics and dietetics who reviewed the questions to ensure face and content validity. 
Second, a focus group discussion with local women was carried out and some items of 
the questionnaire were modified to eliminate ambiguity. The questionnaire was filled 
for each mother by the researcher or a research assistant based on one to one interview 
that lasted from 40-60 minutes for each participant. The questionnaire was bilingual, 
i.e., the questions and potential answers (multiple choices) were written in both English 
and Arabic. Although the research assistants were fluent in English, to avoid any 
spontaneous and unsystematic translation that might result in bias, they were asked 
and trained to administer the questions as they were written in Arabic.   
 The questionnaire consisted of four sections, and each section consisted of two 
parts; one part concerned the mother and the other part concerned her child, and 
mother’s responses for her self and her child were reported. The questionnaire 
consisted of the following sections: 
Section 1: General health status description for the mother and the child and family 
health histories.  
Section 2: Socioeconomic and demographic characteristics. The questions 
concerning the mothers in this section involved:  age, marital status, parental education 
and occupation, average household income (defined as total monthly family income 
after rent deduction), number of children, and number of pregnancies. Questioning 
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concerning the child involved: child’s gender, date of birth, child order in his/her 
siblings, and type of family the child lives in (nuclear or joint family).  
Section 3: Life style. Questions concerning the mothers in this section involved: 
hours spent daily in housework, hours spent on field/gardening work, sports 
performance (if yes, where and for how long), daily exposure to sun light, and dress 
style. Questions concerning the child in this section involved: time spent on watching 
TV, time spent in kindergarten (KG) if the child goes to KG, time spent in active play, and 
daily exposure to sunlight.  
Section 4: Nutrition and dietary intakes. Questions concerning mothers and children 
in the section involved: type and amount of bread consumed, type of flour used to make 
baked goods, consumption of various food categories like: milk; milk derivatives; tea; 
fruits; vegetables; chicken; meat; liver; sardines; and fish, smoking, and the use of 
supplements. For dietary questions that involved amount consumed, participants were 
shown sample measures to ensure consistency and accuracy in reporting. These 
involved: 150 ml cup to represent cup of tea, 250 ml cup to represent cup of milk, 
shaken milk, or yogurt, dish containing 250 gm labna (similar to cream cheese), a piece 
of white cheese that weighed 250 gm, and a piece of bread that weighed 40 gm.  
 
BLOOD DRAWING 
Non fasting venous blood samples were obtained from mothers and children in a 
clinical laboratory in the center of Irbid city in Northern Jordan. Blood was drawn using 
trace-element free evacuated blood collection tubes (Sarstedt, Newton, NC). One 
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aliquot was immediately used before centrifuging for the determination of complete 
blood count (CBC). Blood samples were refrigerated and allowed to clot for 30 minutes. 
Samples then were centrifuged at 3000 rpm for 10 minutes. Separated serum and 
plasma were aliquoted into trace-element free vials. Around 2 ml serum and 2 ml 
plasma were obtained from each mother and child. All steps followed the protocol 
recommended by the International Zinc Nutrition Consultative Group for the 
assessment of population zinc status (IZiNCG 2007a).    
 
ASSESSMENT OF VITAMIN D 
Serum 25(OH)D and intact serum parathyroid hormone (PTH) were measured 
using enzyme-linked immunoabsorbent assay (ELISA) kits (IDS, Fountain Hills, AZ, USA). 
The assay defined expected values for 25(OH) D were: 47.7-144 nmol/L. Normal range 
for PTH was 0.8-3.9 pmol/L as defined by the assay. For 25 (OH) D and PTH, standards 
and serum samples were analyzed in duplicate, and values for the manufacturer’s 
controls fell within the certified ranges. Coefficient of variation (CV) for the low and high 
controls for 25(OH) D were 15.4% and 9.0%, respectively. For PTH the CV for the low 
and high controls were 18.7% and 8.4%, respectively.  
 
ASSESSMENT OF ANEMIA 
Hemoglobin concentration less than 12 mg/dl was used to define anemia in 
mothers. For children, Hb <11 mg/dl was used to define anemia in children less than 60 
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months of age, and Hb < 11.5 mg/dl was used to define anemia in children aged 60 
months or older(WHO/UNICEF/UNU 2001).  
 
ASSESSMENT OF IRON INDICATORS 
Plasma ferritin, transferrin receptor (TfR), and α-1-acid glycoprotein (AGP) were 
determined in 93 mothers and their children. Plasma ferritin was measured using 
immunoradiometric assay (Ramco Laboratories, Inc. Stafford, Texas); transferrin 
receptor was measured using enzyme immunoassay (Ramco Laboratories, Inc. Stafford, 
TX); α-1-acid glycoprotein was assayed using radial immunodiffusion (Kent laboratories, 
Redmond, Washington). For ferritin, AGP, and TfR, standards and serum samples were 
analyzed in duplicate, and values for the manufacturer’s controls fell within the certified 
ranges. A coefficient of variation (CV) for the low, medium, and high controls for ferritin 
was 1.5%, 2.0%, and 1.9%, respectively. For TfR, the CV for the medium and high 
controls was 15.1% and 15.9%, respectively. For AGP the CV for the low, medium, and 
high controls was 4.1%, 9.8%, and 6.1% respectively. 
For plasma ferritin cut-off points of 15 µg/L and 12 µg/L were used to define iron 
deficiency in absence of inflammation in mothers and children (WHO/UNICEF/UNU 
2001), respectively. An AGP concentration ≥1.2 was used to indicate the presence of 
inflammation (Paracha et al 2000, Wieringa et al 2002).  
Quantitative estimation of body iron (mg/kg) was based on the model proposed 
by Cook and colleagues (Cook et al 2003) using the following formula: 
Body Iron (mg/kg) = - [log10 (TfR/Ferritin ratio) - 2.8229]/0.1207 
118 
Positive values for body iron (> 0 mg/kg) indicate iron surplus in stores, and negative 
values (body iron <0 mg/kg) indicate tissue iron deficiency.  
Plasma ferritin, TfR, and the ratio of TfR to plasma ferritin TfR/ferritin (TfR in mg/L 
and ferritin in µg/L) were used to assess iron deficiency in mothers and children. 
Sensitivity, specificity, and area under the curves were calculated using the receiver 
operator characteristics (ROC) curves to assess the performance and define the cut-off 
points of TfR, TfR/Ft and TfR/Log10 ferritin in the diagnosis of iron deficiency and the 
differentiation between anemia of chronic disease (ACD) and iron deficiency anemia 
(IDA)  (Lin et al 2008, Malope et al 2001, Punnonen et al 1997). 
Sensitivity (SN) was defined as proportion of people with disease who test 
positive:  
SN= TP/ (TP+FN) 
 
And specificity (SP) was defined as proportion of people without a disease who test 
negative 
SP = TN/ (TN+FP) 
 
Where: TP is true positive, FN is false negative, TN is true negative, and FP is false 
positive. 
 
The ROC curve was obtained by plotting sensitivity on the x-axis against 1-
specificty on the y-axis for every possible cut-off value for the diagnostic test. Ideally, a 
perfect diagnostic test will yield 100% sensitivity and 100% specificity with an area 
under the curve (AUCROC) of one. An area of 0.5 is a poor indicator and represents a test 
result that was obtained by random chance. Usually AUCROC will fall between 0.5 and 1.0 
and the closer the AUCROC is to one the better the discriminant ability of the diagnostic 
test. Based on AUCROC, tests can be non informative (AUCROC =0.5), less accurate (AUCROC 
between 0.5 and 0.7), moderately accurate (AUCROC between 0.7 and 0.9), highly 
119 
accurate (AUCROC between 0.9 and 1.0), and perfectly accurate (AUCROC =1.0) (Swets 
1988).  
The optimal sensitivity and specificity were defined as the minimal value of: (1-
SN)2 + (1-SP)2. The likelihood ratio for a positive test (LR+) was defined as: SN/(1-SP) and 
was defined as the probability of individual with disease to test positive divided by the 
probability of an individual without a disease to test positive. The likelihood ratio for a 
negative test (LR-) was defined as: (1-SN)/SP and was defined as the probability of 
individual with disease to test negative divided by the probability of an individual 
without disease to test negative.   
 
ASSESSMENT OF ZINC STATUS 
Plasma zinc was determined using inductively coupled plasma mass 
spectrometry (ICPMS) (Elan 9000, Perkin Elmer, Norwalk, CT). All plasma samples were 
diluted (1:20) with 0.1% nitric acid (GFS Chemicals, Powell, OH). Gallium (10 µg/L) was 
used as the internal standard (Perkin Elmer Pure Atomic Absorption Standard, Norwalk, 
CT). A sample check (concentration of 50 µg/L) was measured repetitively (once after 10 
participants’ samples), and the mean, standard deviation, and CV were 52.0 µg/L, 0.76, 
and 1.5%, respectively. Plasma zinc concentration below the age/sex/time of the 
day/fasting status-specific cutoffs is considered the best available biochemical measure 
of zinc deficiency as recommended by the Joint WHO/UNICEF/IAEA/IZiNCG Interagency 
meeting on zinc status indicators (de Benoist et al 2007). A cut-off point of 70 µg/dL for 
mothers and 65 µg/dL for children was used to define deficiency (IZiNCG 2007a). 
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COGNITIVE TESTS 
Cognitive function was assessed in children using components of the Peabody 
Picture Vocabulary Test-IV (PPVT-IV) - Form A and of the Kaufman Assessment Battery 
for Children (K-ABC-II).  The PPVT-IV test measures the receptive vocabulary of children 
and adults (Dunn and Dunn 2007). Each PPVT item consists of two parts: the stimulus 
word and a display of four pictures, one of which describes the stimulus word. The PPVT 
set consists of 150 picture pages along with 150 stimulus words. Two school teachers 
and two mothers in Jordan helped in the translation of the stimulus words to the Arabic 
language, and identifying the pictures that might be unfamiliar to children in Jordan due 
to cultural differences. Then, the test was evaluated by having it administered to 
children around 4-5 years of age (other than study participants), and based on children 
responses, the test was revised again, some words were changed, and the test was re-
administered to another group of children. After that the researcher along with the 
group of school teachers and mothers agreed on the Arabic translation for the stimulus 
words used in the test and these words were written down in Arabic on the response 
forms. Very few questions were manipulated to suit the children’s culture, for example: 
children were asked to point at the drawer instead of the fence (item 30), the mouse 
instead of the squirrel (item 35), the clown instead of the knight (item 64), and the 
piano instead of the harp (item 92). To ensure consistency, the test was administered to 
the children by the same person. Children were asked to point to the picture that best 
described the stimulus word, and their responses were written on the response form. 
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Raw scores were calculated by subtracting the total number of errors from the number 
of the ceiling item.  Then raw scores were transformed into the corresponding standard 
scores for each age group.  
The Kaufman Assessment Battery for Children (K-ABC-II) is a measure of the 
processing and cognitive abilities of children and adolescents aged three through 
eighteen (Kaufman and Kaufman 2004). The children were tested on two of the five 
scales of KABC-II: sequential and simultaneous processing.  The core subtests on the 
sequential K-ABC-II scale included: number recall (memory span) and word order 
(memory span, and working memory). The core subtests on the simultaneous K-ABC-II 
scale included: conceptual thinking (visualization and induction), face recognition (visual 
memory), triangles (spatial relations, and visualization), and pattern reasoning 
(induction, and visualization). In addition, the hand movement (memory span and visual 
memory) which is a supplementary test was also administered to children. In addition, 
the non verbal index of the K-ABC-II (NVI) was measured and was used to assess 
processing and cognitive abilities of children using both core and supplementary 
subtests that can be communicated with gestures and responded to without speaking.  
The PPVT and K-ABC-II subtests were administered to all children n the same 
order: PPVT, followed by conceptual thinking, followed by face recognition, followed by 
number recall, followed by triangles, followed by word order, followed by pattern 
reasoning, and finally hand movements. Children took the tests under similar settings, 
and each test was administered by the same examiner for all children. The following 
table shows a description of the K-ABC subtests: 
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Table 3.1 
Description of the K-ABC-II subtests 
 
 
subtest 
Description 
 
Conceptual thinking 
 
 
The child views a set of 4 or 5 pictures and identifies the one picture that doesn’t 
belong with the others.  
Face recognition 
 
The child attends closely to photographs of one or two faces that are exposed 
briefly and then selects the correct face or faces, shown in different pose, from a 
group photograph.  
Number recall 
 
The child repeats a series of numbers in the same sequence as the examiner said 
them, with series ranging from 2 to 9 numbers. The numbers are single digits. 
(All numbers used in the number recall subtest are of one syllable. However, 
numbers used in the test were the Arabic numbers which are pronounced in two 
or more syllables. To ensure consistency, all numbers used in the subtest were 
numbers with 2 syllables only. These include the numbers 1, 2, 5, 6, 7, 9, and 10 
in Arabic. 
Triangles 
 
The child assembles several identical foam triangles (blue on one side, yellow on 
the other) to match a picture of an abstract design; for easier items, the child 
assembles a set of colorful plastic shapes to match a model constructed by the 
examiner.  
Word order 
 
The child touched a series of silhouettes of common objects in the same order as 
the examiner said the names of the objects.  
Pattern reasoning  
 
The child is shown a series of stimuli that form a logical linear pattern, but one 
stimulus is missing; the child completes the pattern by selecting the correct 
stimulus from an array of 4-6 options at the bottom of the page. Most stimuli are 
abstract, geometric shapes, but some easy items use meaningful pictures.  
Hand movement  The child copies the examiner’s precise sequence of taps on the table with the 
fist, palm, or side of the hand.  
Source: adapted from (Kaufman and Kaufman 2004) 
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CONVERSION OF K-ABC RAW SCORES INTO STANDARD SCORES 
Raw scores for the seven subtests (conceptual thinking, face recognition, 
number recall, triangles, word order, pattern reasoning, and hand movement) were 
reported, and then transformed into the corresponding scaled scores for each age 
group. Then the sum of the scaled scores for the three K-ABC scales was calculated as 
the following: 
For children < 5years of age, (n=39, age (min-max) = 53-59 months): 
• Nonverbal index K-ABC-II = conceptual thinking + face recognition + triangles + 
hand movement 
• Simultaneous K-ABC-II = conceptual thinking + face recognition + triangles 
• Sequential K-ABC-II = number recall + word order 
For children ≥ 5 years of age, (n=50, age (min-max) = 60-71 months): 
• Nonverbal index K-ABC-II= conceptual thinking + face recognition + triangles + 
hand movement + pattern reasoning 
• Simultaneous K-ABC-II for children ≥ 5 years of age = conceptual thinking + 
triangles + pattern reasoning 
• Sequential K-ABC-II = number recall + word order 
For children ≥ 6 years of age, (n=4, age (min-max) = 72-73 months): 
• Nonverbal index K-ABC-II = conceptual thinking + triangles + hand movement + 
pattern reasoning + story completion (scaled scores for those four children were 
not added for this scale since children were not tested on story completion).   
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• Simultaneous K-ABC-II = conceptual thinking + triangles + pattern reasoning + 
Rover (scaled scores for those four children were not added up for this scale 
since children were not tested on Rover).  
• Sequential K-ABC-II = number recall + word order 
 
STATISTICAL ANALYSIS 
For vitamin D and PTH analysis, variables were checked for normality, and 
natural logarithm (ln) transformations were performed for skewed variables which 
included: mothers’ 25(OH)D and PTH, and children’s PTH. Means ± standard deviations 
or percentages were used to express results unless otherwise stated. Analysis of 
variance was used to compare subgroups of the participants, and a p-value of ≤ 0.05 
was significant. The relationships between serum 25(OH) D and serum PTH in both 
mothers and children were evaluated with linear and non-linear regression models 
using GraphPad Prism, v. 5, (GraphPad Software, La Jolla, CA). Other statistical analyses 
were conducted using the Statistical Package for the Social Sciences, v.15.0 (SPSS Inc., 
Chicago, IL, USA).  
For iron indicators and zinc analysis, variables that had skewed distribution 
(ferritin, TfR, TfR/Ferritin, AGP and Hb) were transformed to logarithms and geometric 
means ± 1SD were reported for those variables. Statistical analyses were conducted 
using the Statistical Package for the Social Sciences (SPSS/PASW), version 18.0 (SPSS Inc, 
Chicago, IL, USA). Analysis of variance was used to compare subgroups of the 
participants. Stepwise multiple regression analysis was performed to determine the 
125 
variance contributed by different socioeconomic variables identified in correlation 
analysis for the prediction of cognitive scores.  
 
 
 
 
126 
CHAPTER IV 
 
ASSESSMENT OF SERUM 25(OH) D IN WOMEN OF CHILDBEARING AGE AND THEIR 
PRESCHOOL CHILDREN IN NORTHERN JORDAN DURING SUMMER 
 
 
ABSTRACT 
 
Objective: To assess vitamin D status in women and their children at 4-5 years of age in 
northern Jordan during summer. 
Design: A cross-sectional study; 93 mother-child dyads volunteered through local 
community centers between June-July 2007. Anthropometric measurements were 
performed and information on socioeconomic status, health issues, lifestyle factors, and 
nutritional intake were obtained from mothers by questionnaire.  
Main measures: Serum 25(OH) D and serum PTH 
Results: Mean age (SD) was 34.0 (6.0) years for mothers and 60.7 (5.4) months for 
children. Maternal body mass index (BMI) was 29.6 (5.6) with 77% of women having 
BMI ≥ 25 kg/m2. Mean concentration of 25(OH)D was 25.6 (9.6) nmol/L in mothers; Only 
two women (2.2%) had 25(OH)D concentrations less than 12.5 nmol/L, but 48.9% of 
women were below 25.0 nmol/L, and 97.8% had serum 25(OH)D less than 50 nmol/L. 
No woman had values above 75 nmol/L. Children had higher (p<.0001) 25(OH) D than
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 their mothers with a mean of 55.8 nmol/L. The children also had lower (p<.0001) mean 
serum PTH than their mothers (1.47 vs. 3.12 pmol/L, respectively). Only three children 
had serum 25(OH) D less than 25 nmol/L, but 39% (n=34) had 25(OH)D less than 50.0 
nmol/L. Older women and those with five or more  pregnancies had significantly 
reduced mean 25(OH)D. Children living in families with lower incomes had significantly 
higher mean serum 25(OH)D as did children consuming fortified milk compared to non-
fortified milk.  
Conclusion: Despite the abundant sunlight during summer, vitamin D status is a concern 
for mothers and children in Jordan.  
Key words: vitamin D deficiency; 25(OH)D; parathyroid hormone; women of child-bearing 
age; Jordan 
 
INTRODUCTION 
There is a growing body of research suggesting that vitamin D deficiency is 
widespread among women in the Middle Eastern countries, and while considerable 
research has been done to determine the prevalence of vitamin D deficiency among 
adolescent females (Moussavi et al 2005, Olmez et al 2006, Siddiqui and Kamfar 2007), 
women of child bearing age  (Dawodu et al 1998, Fonseca et al 1984, Gannage-Yared et 
al 2000, Ghannam et al 1999, Mishal 2001), veiled/non veiled women (Alagol et al 2000, 
Allali et al 2008, El-Sonbaty and Abdul-Ghaffar 1996, Islam et al 2006, Meddeb et al 
2005),  postmenopausal women (Rassouli et al 2001), and women with osteoporosis 
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(Basaran et al 2007, Lips et al 2006). Limited research has been done to determine 
vitamin D status among children in Middle Eastern countries.  
A few studies  reported inadequate vitamin D status among: infants and their 
mothers in United Arab Emirates (Dawodu et al 2001, Dawodu et al 2003), Turkey 
(Hatun et al 2005), Kuwait (Molla et al 2005) , and Saudi Arabia (Taha et al 1984); infants 
and pre-school children (aged 4-72 months) in Saudi Arabia (Bahijri 2001); and school 
children (aged 10-16 years) in Lebanon (El-Hajj Fuleihan et al 2001).  
With the abundant sunlight in the region, one would assume that populations of 
these countries would be secured from being vitamin D deficient, but the research on 
vitamin D status of Middle Eastern women has shown the opposite. On average 5-10 
minutes of direct sunlight exposure of the arms and legs (half the minimal erythema 
dose) will produce about 3000 IU of vitamin D3 (Holick 2007); however, amount of body 
surface area that is actually exposed to sunlight depends on clothing style, use of 
sunscreen, and lifestyle.  
To our knowledge no study has assessed the vitamin D status of both women 
and their pre-school children in the region. This study assessed serum 25(OH)D and 
parathyroid hormone in women  and their children at 4-5 years of age in Jordan, and 
investigated  the variables that might influence vitamin D status in the study population. 
 
METHODS 
A convenience sample of 93 women and their children at 4-5 years of age from 
urban/suburban areas in northern Jordan (31°N) was recruited for the study.  
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Participants were approached by direct contact with the help of local community 
centers. Exclusion criteria were acute illness or pregnancy in mothers. The study was 
approved by Oklahoma State University Institutional Review Board, and informed 
written consent was obtained from the mothers. Four university graduate research 
assistants in Jordan were trained and assisted in taking anthropometric measurements 
and in administration of the questionnaire.  
Weight (kg) and height (cm) were measured for each mother and child, and 
middle upper arm circumference (cm) was measured for children. A questionnaire 
covering health status, demographic characteristics, income (defined as total monthly 
family income after rent deduction), life style, and nutrition of mother and child was 
administered individually to mothers.   The questionnaire was validated by a group of 
academic experts in research, statistics, and dietetics who reviewed the questions to 
ensure face and content validity. Secondly a focus group discussion with local women 
was carried out and some items of the questionnaire were modified to eliminate 
ambiguity.  
After collection of anthropometric measurements and questionnaire data in the 
field, participants were transferred to a local clinical laboratory where venous blood 
samples were drawn from each participant. All samples were taken between June and 
July, 2007. Serum samples were frozen at -20°C, shipped in dry ice to our laboratories at 
Oklahoma State University in the USA, and stored at -20°C until analysis.  Serum 
25(OH)D and intact serum PTH were measured using enzyme-linked immunoabsorbent 
assay (ELISA) kits (IDS, Fountain Hills, AZ, USA).  
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Body mass index (BMI) was calculated for mothers as body weight (kg)/height 
(m2).  Anthropometric data for children were expressed as z-scores based on the 
CDC/WHO 1978 reference using Epi Info, v. 3.4.3 (Centers for Disease Control, USA). The 
relationships between serum 25(OH) D and serum PTH in both mothers and children 
were evaluated with linear and non-linear regression models using GraphPad Prism, v. 5, 
(GraphPad Software, La Jolla, CA). Other statistical analyses were conducted using the 
Statistical Package for the Social Sciences, v.15.0 (SPSS Inc., Chicago, IL, USA). Variables 
were checked for normality, and natural logarithm (ln) transformations were performed 
for skewed variables which included: mothers’ 25(OH) D and PTH, and children’s PTH. 
Means ± standard deviations or percentages were used to express results unless 
otherwise stated. Analysis of variance was used to compare subgroups of the 
participants, and a p-value of ≤ 0.05 was significant.  
 
RESULTS 
Study group characteristics 
The characteristics of the participants are summarized in Table 4.1. The mean 
age of the women was 33.9 y and their children (51 boys and 42 girls) had a mean age of 
60.7 mo. The children’s middle upper arm circumference (MUAC) ranged from 14.0-19.5 
cm, four children only (4.3%) were below -2 standard deviations for weight-for-age (-2z), 
and two children (2.2%) were below -2 for the height-for-age z-score. 
The women had high BMIs with a mean of 29.6, and 77% of women were 
overweight with a BMI ≥ 25 kg/m2. Seventy-four women (79.6%) were currently 
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married, and 17 women (18.3%) were widows; widows had a significantly higher BMI (p 
< .05) than other women (32.5 vs. 28.9 kg/m2, respectively). The mean number of 
children per woman was 4.1. Eighteen percent of women had completed 8 years or less 
of school, but most had completed high school. Ninety-one percent didn’t have a job, 
and the monthly income for each family (gross income-housing) was equivalent to 325 
USD.  
The women reported 5.3 sun exposure hours per week, and 70% of women said 
that they never tended to avoid sun exposure.  However, most women (86%) were 
wearing clothing that showed only their hands and faces, 10 women (10.8%) were 
wearing full- covering clothing, and only 3 women were wearing western dress style. 
 
Food consumption patterns of mothers and children 
Seventy percent of women and 87% of children reported milk consumption, but 
consumption was only 4.1 cups per week for women and 5.6 cups per week for children. 
Additionally, 23% of mothers and 11% of children reported consumption of milk 
derivatives like yogurt and cheese but not milk (Table 4.2). The majority of mothers 
(73.8%) and children (82.7%) who drank milk consumed the commercially processed 
milk, while 26.2% of women and 17.3% of children consumed raw (unpasteurized) milk. 
Most of the commercially processed milk is in the powder form and is fortified with 
vitamin D.  
Fish consumption was relatively rare; more than 75% of both the mothers and 
the children reported that they never or rarely consumed fish. Approximately half of 
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women and children had never or rarely consumed liver. None of the children had used 
multivitamin supplements. Only 7 women reported taking supplements, and their 
25(OH)D of 30.4 nmol/L was not significantly different from the 25.2 nmol/L for those 
women not using multivitamin supplements. 
 
Serum 25(OH) D and PTH concentrations 
Serum 25(OH) D, the major circulating metabolite of vitamin D, was used to 
assess vitamin D status (Holick 2006b, Lips 2004). Serum 25(OH) D  reflects the total  
vitamin D from the two sources, synthesis from sun light exposure and dietary intake 
(Holick 2006b).  
Mean concentration of 25(OH) D was 25.6 nmol/L in women (Table 4.3). Forty-
five women (48.9%) were below 25.0 nmol/L, and 90 women (97.8%) has serum 
25(OH)D less than 50 nmol/L. Mothers’ mean PTH was 3.12 pmol/L with 27.2 % above 
3.9 pmol/L, the upper range of normal for the analysis. Children had a higher mean 
25(OH)D than their mothers with a mean concentration of 55.8 nmol/L (p < .0001) 
(Figure 4.1). The children also had a lower mean serum PTH (1.47 pmol/L) than their 
mothers (p < .0001). Only three children (3.4%) had serum 25(OH) D less than 25 
nmol/L, and more than 61% (n=53) had serum 25(OH) D higher than 50.0 nmol/L.  
In mothers, the negative relationship between serum 25(OH) D and serum PTH 
did not reach significance in the linear regression model (p= .086). In the nonlinear 
regression model, serum PTH didn’t reach a plateau as all serum 25(OH) D observations 
were below 80 nmol/L.  
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In children the relationship between serum 25(OH) D and PTH was studied using 
a linear regression analysis; for 1 unit increase in serum 25(OH) D concentrations on the 
ln-scale, serum PTH concentrations on the ln-scale decreased by 0.226 units (p<0.000). 
In addition to that, a non-linear regression model was fitted between serum 25(OH)D 
and serum PTH; based on the non-linear weighted least squares regression analysis, the 
plateau for serum PTH was reached at 1.36 pmol/L in children [ PTH (pmol/L) = 1.363 + 
0.987 exp (-0.0435 * 25(OH) D nmol/L), and the asymptote for the curve was reached in 
the 25(OH) D range of 69.9- 80 nmol/L. 
 
Effect of age, number of pregnancies, BMI, dress style, and income on mean 25(OH) D 
 Women less than 29 years of age had mean 25(OH) D of 30.5 nmol/L compared 
to a mean in all women older than 29 years of 24.3 nmol/L (p<0.05). Women who had 
five or more pregnancies had lower (p <0.05) mean serum 25(OH) D (22.3 nmol/L) 
compared to women reporting less than 5 pregnancies (27.9 nmol/L). Women who had 
five or more pregnancies had a 63.2% prevalence of serum 25(OH)D less than 25.0 
nmol/L compared to 38.9% prevalence among women who had less than 5 pregnancies. 
There was no significant difference in mean 25(OH) D concentration between women in 
normal, over weight, and obese BMI categories. Likewise dress style had no significant 
effect on mean serum 25(OH) D concentrations in women although the number of 
women in western dress was very small (Table 4.4). 
Serum 25(OH) D concentration in children was negatively correlated with income 
(r= - 0.230, p < .05) but this was not so in mothers. Children living in families with 
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income less than $212 per month had a significantly higher mean serum 25(OH) D than 
children living in families with income more than $212 per month (61.6 vs. 52.6 nmol/L, 
respectively), while mothers with monthly income less than $212 had a significantly 
higher mean serum PTH than mothers living with monthly income less than $212 (3.6 vs. 
2.9 pmol/L, respectively).  
 
Milk type consumed relation to serum 25(OH) D and serum PTH 
In children there was a significant difference in serum 25(OH) D concentrations 
and serum PTH according to milk type consumed by the children, whereas this 
difference was not significant among mothers. Children who consumed the unfortified 
fresh milk had lower (p< .05) mean serum 25(OH)D (43.0 nmol/L) and higher mean 
serum PTH (2.0 pmol/L) compared to those children who consumed the fortified milk 
who had a mean serum 25(OH)D concentration of 56.0 nmol/L and mean serum PTH of 
1.4 pmol/L (Table 4.5).   
 
DISCUSSION 
The results showed high prevalence of serum 25(OH) D less than 25.0 and 50.0 
nmol/L among women of child-bearing age in Jordan during summer. Mean serum 
25(OH)D concentrations in mothers were much lower than those of their 4-5 years old 
children, although 39.1% of children still had 25(OH)D concentrations less than 50.0 
nmol/L.  In Jordan one would assume that the abundant sun light during summer would 
be sufficient to produce adequate levels of 25(OH) D among the population. Although 
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70% of women said they did not avoid sun exposure, the daily sun exposure hours 
reported by mothers were less than 1 hr/day. In addition to that, 74% of women (n=69) 
reported that they avoid sun exposure during the time from 11:00 am to 3:00 pm. Only 
8 women had jobs, whereas more than 50% of children were attending pre-schools 
where most of them walk home at noon. The differences in time and frequencies of sun 
exposure hours between mothers and their children might be a factor contributing to 
the higher mean concentrations of 25(OH) D in children compared to their mothers.  
Dietary vitamin D sources were limited; more than 75% of the mothers and 80% 
of children reported that they never or rarely consumed fresh fish or sardines, and only 
7.5% of mothers used multivitamin supplements. While 70% of women and 87% of 
children did consume milk, a considerable percentage of mothers and their children 
consumed the raw unfortified milk. The data illustrate the significant differences in 
mean serum 25(OH) D and PTH concentrations between children consuming the raw 
unfortified milk and those consuming the fortified milk.  
The higher 25(OH) D in young women and in women in women with less than 
five pregnancies may be explained by  younger women having a more outgoing lifestyle 
and those with fewer pregnancies being  less housebound. A study in Lebanon found 
that a high degree of parity (≥ 4) negatively impacted vitamin D status (Gannage-Yared 
et al 2000).  
Several studies in the Middle East and North Africa found a significant impact of 
dress style on serum 25(OH) D status among women (Alagol et al 2000, Allali et al 2008, 
Dawodu et al 1998, El-Sonbaty and Abdul-Ghaffar 1996, Gannage-Yared et al 2000, 
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Meddeb et al 2005), but in some studies dress was not significant (Islam et al 2006, 
Mishal 2001). In our study 86% of the women wore clothing that covered the whole 
body except for hands and face, and only 3% wore western clothing, so a clothing style 
comparison could not be made statistically.  
Mothers had high BMI value, which perhaps could be explained by their 
sedentary lifestyle, and high number of pregnancies (42% of women had 5 or more 
pregnancies).  Although literature suggests that obesity is related to low serum 25(OH) 
D among individuals (Holick 2003, Liel et al 1988, Need et al 1993, Parikh et al 2004), 
and percentage body fat is inversely proportional to serum 25(OH) D in healthy women 
(Arunabh et al 2003), due to decrease in bioavailability of vitamin D with obesity 
(Wortsman et al 2000), in this study BMI has no significant impact on mean serum 
25(OH) D among women.    
In this study children living in families with lower income had higher mean serum 
25(OH) D.  Perhaps this may be explained partially by these children spending more of 
their day outside the house because of the poor housing environment, which supports 
the important role of sun exposure for vitamin D status.    
The fact that children had higher mean serum 25(OH) D concentrations than 
their mothers should not mask the fact that these children still had low concentrations 
of serum 25(OH) D, especially since the study was conducted in the middle of summer. 
There is not yet a consensus on what would be normal 25(OH) D values for children. 
However, a very recent study by (Looker et al 2008) reported on US NHANES data.  The 
sample included 895 children aged 1-5 years, and mean ± SEM was 76.43 ± 1.58 nmol/L. 
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In our study, the relationship between serum 25(OH) D and serum PTH in children 
showed that PTH started to increase at 25(OH)D concentrations lower than 69.9 nmol/L; 
based on this value almost 78.5% of children  may have had inadequate vitamin D 
status. Children in our study had a mean serum 25(OH)D (55.8 nmol/L) during summer 
that was lower than  reported for pre-school children of similar age (4.8 years) in Greece 
during the fall (Nicolaidou et al 2006) where the immigrant children from Eastern 
Europe had a mean 25(OH)D concentration of 69.7 nmol/L, and the Greek children had a 
mean 25(OH)D of 83.8 nmol/L.   
To our knowledge this was the first study to assess 25(OH)D in mothers of child 
bearing age and their children at 4-5 years of age in the region. The study was 
conducted during summer, and values of 25(OH) D are expected to be even lower 
during winter based on the literature (Chapuy et al 1996, Goswami et al 2000, Pal et al 
2003, Pasco et al 2004). Natural foods rich in vitamin D are not commonly consumed by 
the larger population, and there are no governmental regulations that mandate vitamin 
D fortification for the processed milk and milk products produced in Jordan. 
Unfortunately until now, there are no recommended dietary guidelines concerning 
vitamin D intake in the Middle East and North Africa region (MENA), despite the high 
prevalence of vitamin D deficiency. Recently, the MENA consensus on osteoporosis 
recommended the daily intake of 400 IU of vitamin D for women 50-70 years old, and 
600 IU for women older than 70 years (Maalouf et al 2007), but there remain no 
guidelines for younger women and for children. Despite the abundant sunlight during 
summer, vitamin D status is a concern for young mothers and children in Jordan. 
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Nutrition education programs should be implemented to inform women about the 
consumption of vitamin D fortified milk products as well as the importance of sufficient 
exposure to sunlight to attain optimal vitamin D status for themselves and their 
children. There is a need to assess vitamin D status at the national level so that 
strategies for vitamin D fortification and supplementation are developed and 
implemented.    
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Figure 4.1 
Relation between serum 25(OH) D and serum PTH in mothers and children in Jordan 
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Table 4.1 
 Characteristics of the study participants 
 N mean (SD) Median Percentile 
    25
th 75th 
Mothers      
Age (years) 93 33.9 (5.9) 35.0 29.0 38.0 
BMI (kg/m2) 93 29.6 (5.6) 29.0 25.2 33.5 
Number of  pregnancies 93 4.8 (2.5) 4.0 3.0 6.0 
Number of children 93 4.1 (1.9) 4.0 3.0 5.0 
Income (USD/month)* 92 325 (272) 254 174 353 
Years of schooling 92 10.7 (2.3) 12.0 9.0 12.0 
Time spent in garden or field 
work (hr/wk) 
15 2.6 (2.4) 2.0 1.0 3.0 
Sun exposure (hr/wk) 93 5.3 (4.6) 3.5 1.8 7.0 
      
Children      
Age (months) 93 60.7 (5.4) 61.0 55.0 65.0 
Weight- for-age (z) 93 -0.0 (1.1) 0.1 -0.6 0.6 
Height–for-age (z) 93 0.5 (1.2) 0.6 -0.3 1.4 
Child MUAC** (cm) 93 16.7 (1.2) 16.7 16.0 17.5 
*Income is defined as total monthly family income after rent deduction in US $. 
**MAUC: Middle upper arm circumference. 
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Table 4.2 
Food consumption patterns by mothers and children 
   
Mothers 
(%) 
  
Children 
(%) 
Milk and milk products*      
• No  7.5  2.2 
• Yes:   Fluid milk, powdered milk, 
and milk products 
70.0  87.0 
  Milk products only but not 
fluid or powdered milk 
22.5  10.8 
     
Milk type consumed**     
• Raw milk  26.2  17.3 
• Commercial milk:  Powdered (vitamin D 
fortified) 
63.1  72.8 
  Liquid (not all vitamin D 
fortified) 
10.8  9.9 
     
Liver consumption     
• Never or rarely  43.4  51.6 
• Once a month or 
more 
 
56.6  48.4 
     
Multivitamin use     
• No  92.5  100 
• Yes  7.5  0 
* Milk products included: cheese, yogurt, labneh (sour cream).  
**Milk type consumed by the 65 mothers and 81 children who consume milk 
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Table 4.3 
 Serum 25(OH)D distribution in mothers and children and means of serum PTH in these 
categories   
Serum 25(OH)D Category 
(nmol/L) 
 
%N 
 
PTH (pmol/L) 
Mean (SD) 
 
Mothers 
  
Mean = 25.6 (9.6)nmol/L   
<12.5 2.2 2.59 (0.27) 
12.5-24.9 46.7 3.35 (1.40) 
25-49.9 48.9 2.97 (1.28) 
50-75 2.2 2.16 (0.64) 
>75 0 - 
Total (n=92) 100 3.12 (1.32) 
 
Children 
  
Mean = 55.8 (19.8)nmol/L   
<12.5 0 - 
12.5-24.9 3.4 1.89 (1.25) 
25-49.9 35.6 1.64 (0.87) 
50-75 46.0 1.31 (0.58) 
>75 14.9 1.52 (0.52) 
Total (n=87) 100 1.48 (0.72) 
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Table 4.4 
Differences in mean serum 25(OH) D in mothers by  age, BMI, dress style, and number of 
pregnancies 
Variable  
 
N 
25(OH)D (nmol/L) 
Mean 
Prevalence of  
25 (OH)D  
<25 nmol/L 
 
Age (years) 
 
< 29 
 
19 
 
30.5a 
 
47.4 % (n=9) 
 ≥ 29 74 24.3
b 48.6% (n=36) 
     
BMI (kg/m2) <18.5 1 28.1 0% (n=0) 
 18.5-24.99 20 24.6 55.0% (n=11) 
 25.0-29.99 33 26.8 30.3% (n=10) 
 ≥ 30.0 48 24.9 50.0 % (n=24) 
     
Dress Style Full covering 10 28.4 50.0% (n=5) 
 Showing only 
face & hands 
79 24.9 50.6% (n=40) 
 Western style 3 31.9 0% (n=0) 
     
Number of  
Pregnancies 
<5 54 27.9 a 38.9% (n=21) 
≥ 5 38 22.3 b 63.2% (n=24) 
     
Note: Variables with different superscripts were significantly different, p< 0.05 
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Table 4.5 
Milk type consumed and mean serum 25(OH) D and PTH in mothers and children 
   Milk type 
consumed 
 25(OH) D (nmol/L)   PTH (pmol/L) 
  n Mean (SD)  n Mean (SD) 
 
Mothers 
 
unfortified 
 
17 
 
26.6 (14.5) 
  
16 
 
3.1 (1.4) 
 fortified  41 26.0 (7.4)  41 3.0 (1.1) 
       
Children unfortified 14 43.0 (12.8) a  13 2.0 (1.1) a 
 fortified  53 56.0 (19.8) b  58 1.4 (0.6) b 
Note: Variables with different superscripts were significantly different, p< 0.05 
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CHAPTER V 
 
ASSESSMENT OF IRON AND ZINC STATUS OF WOMEN OF CHILDBEARING AGE AND 
THEIR CHILDREN IN JORDAN  
 
 
ABSTRACT 
Prevalence of iron and zinc deficiency among women and their preschool children was 
assessed in Jordan in July 2007. Hemoglobin and plasma ferritin, zinc, transferrin 
receptors and α-1-acid glycoprotein (AGP) were determined in 93 mothers and their 
children. Measurements of hemoglobin, ferritin, and zinc showed 29% of mothers and 
10% of children to be deficient by at least two parameters, and 24% of mothers and 3% 
of children were deficient by three parameters. Thirty-eight women (41%) and 24 
children (26%) were anemic. Mothers with ferritin <15 μg/L were 54%, and 16% of 
children had ferritin <12 μg/L; half of children were below 22 μg/L. Mothers body iron 
(mean ± SD) was estimated to be significantly lower (0.5 ± 4.9) mg/kg than their children 
(3.5 ± 3.8) mg/kg; 45% of mothers had an iron deficit of 4.0 mg/kg body weight while 
18% of children had an iron deficit of 0.71 mg/kg body weight. More than 50% of 
mothers and 30% of children had AGP≥1.2 g/L. Plasma zinc was 67.2 ± 11.4 μg/dL in 
mothers and 64.6 ± 9.4 μg/dL in children. More than half of women (58%) and children 
(56%) were below IZiNCG cutoffs for zinc deficiency. Zinc was correlated for mothers 
and children (r=0.33, p<.005). The performance of three parameters: TfR, TfR/ferritin, 
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and TfR/Log10 ferritin in detecting iron deficiency among mothers and children was 
evaluated using receiver operator characteristics (ROC) curves. TfR/ferritin and 
TfR/Log10ferritin appeared to have better diagnostic efficiency in detecting iron 
deficiency than the use of TfR alone. In summary, co-existing micronutrient deficiencies 
were widespread among mothers and children in northern Jordan. 
 
INTRODUCTION 
Iron deficiency  
Anemia and iron deficiency are among the most common nutritional disorders 
affecting children and women in both industrialized and developing countries. In the 
Middle East, about 47% of pre-school children (0.8 million) have hemoglobin (Hb) levels 
below 11 g/dl and almost 40 million women of child bearing age (non-pregnant) have 
Hb levels below 12 g/dL (WHO 2008). According to the WHO classification of public 
health significance of anemia in populations based on prevalence estimated from 
hemoglobin or hematocrit (WHO/UNICEF/UNU 2001), the prevalence of anemia in the 
Eastern Mediterranean region is considered a severe public health problem among pre-
school children (>40%) and moderate among women of child-bearing age (20%-40%). 
In Jordan, it is estimated that more than 200,000 children under the age of five 
years and almost 30% of non-pregnant women of reproductive age are anemic (WHO 
2008). In 2003, the Ministry of Health estimated the prevalence of anemia, iron 
deficiency, and iron deficiency anemia to be 32%, 40%, and 22%, respectively among 
non-pregnant women of reproductive age, and 20%, 26%, and 10%, respectively among 
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pre-school children (Ministry of Health 2003). Some studies found a prevalence of 
anemia that reaches 41% among pregnant women (Albsoul-Younes et al 2004), and 40% 
among women of reproductive age (Mawajdeh et al 2003). Ferritin is the most useful 
measure for storage iron in absence of inflammation (Cook et al 1974). However, in 
populations with high incidence of inflammation it becomes an unreliable indicator of 
iron status and serum transferrin receptor (TfR) has shown promise in identifying iron 
status without being influenced by acute or chronic inflammation (Skikne et al 1990). In 
addition to the use of TfR, both TfR/ferritin and TfR/Log ferritin had been demonstrated 
to be valuable in assessing iron status (Lin et al 2008, Malope et al 2001, Punnonen et al 
1997, Vazquez Lopez at al 2006). 
 
Zinc deficiency   
The World Health Organization (WHO) identified the factors contributing most to 
burden of disease in developing countries; zinc deficiency was ranked as the 5th factor 
followed by iron deficiency as the 6th (WHO 2002). Worldwide, 16% of lower respiratory 
tract infections, 10% of diarrheal disease, and 18% of malaria, are attributed to zinc 
deficiency (WHO 2002). Globally about half of the human population is at risk of low 
zinc intake (Brown and Wuehler 2000). The first cases of zinc deficiency in humans were 
reported in the Middle East region in the 1960s, specifically in Iran and Egypt (Prasad et 
al 1961, Prasad et al 1963), and zinc deficiency was highly correlated with severe 
anemia, growth retardation, and delay in sexual maturation. The prevalence of zinc 
deficiency in the Middle East North Africa (MENA) region is estimated to reach 46%, a 
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percentage that makes the region ranked third after South Asia (79%) and Sub-Saharan 
Africa (50%) (Caulfield et al 2006). The prevalence of zinc deficiency in the MENA region 
was estimated by examining the availability of zinc in the local diet in the following 
countries: Afghanistan, Algeria, Djibouti, Egypt, Iraq, Morocco, Pakistan, Somalia, Sudan, 
and Yemen (Caulfield and Black 2004). Diets in the MENA region are characterized by 
low zinc bioavailability contributed to by diets high in phytate that inhibits zinc 
absorption. Currently, there are no estimates of the national prevalence and distribution 
of zinc deficiency in Jordan, and there is a serious lack of awareness of the importance 
of zinc in human nutrition not only in Jordan but also in the MENA region.  
This study aims to assess the prevalence of iron deficiency and zinc deficiency in 
mothers and their preschool children living in northern Jordan. A second aim of this 
study is to evaluate the diagnostic efficiency and assess the sensitivity and specificity of 
serum TfR and different TfR/ferritin ratios in identifying iron deficiency in women of 
child-bearing age and preschool children in Jordan.  
 
METHODS 
A convenience sample of 93 women and their children aged 4–5 years from 
urban/suburban areas in Northern Jordan was recruited for the study. Participants were 
approached by direct contact with the help of local community centers. Exclusion 
criteria were acute illness or pregnancy in mothers. The study was approved by the 
Oklahoma State University Institutional Review Board, and an informed written consent 
was obtained from the mothers. Four university graduate research assistants in Jordan 
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were trained and assisted in taking anthropometric measurements and in 
administration of the questionnaire and the cognitive tests.  
Weight (kg) and height (cm) were measured for each mother and child, and 
middle upper arm circumference (MUAC) (cm) was measured for children. Height and 
MUAC were reported to the nearest millimeter, and weight was reported to the nearest 
100 gram. A questionnaire covering health status, demographic characteristics, income 
(defined as total monthly family income after rent deduction), lifestyle and dietary 
intakes of mother and child was administered individually to mothers. The 
questionnaire was validated by a group of academic experts in research, statistics and 
dietetics who reviewed the questions to ensure face and content validity. Second, a 
focus group discussion with local women was carried out and some items of the 
questionnaire were modified to eliminate ambiguity. 
After collection of anthropometric measurements and questionnaire data in the 
field, participants were transferred to a local clinical laboratory where non-fasting 
venous blood samples were drawn from each participant. All samples were taken 
between June and July 2007. Serum and plasma samples were transferred into trace 
element-free tubes which were then frozen at -20 °C, shipped in dry ice to our 
laboratories at Oklahoma State University in the USA and stored at -20 °C until analysis. 
In addition to hemoglobin (Hb), the following were measured: plasma ferritin (Ft) using 
immunoradiometric assay (Ramco Laboratories, Inc. Stafford, TX); transferrin receptor 
(TfR) using enzyme linked immunoassay (Ramco Laboratories, Inc. Stafford, TX); α-1-acid 
154 
glycoprotein (AGP) using radial immunodiffusion (Kent Laboratories, Redmond, WA); 
and plasma zinc (Zn) using inductively coupled plasma mass spectrometry (ICPMS).  
For serum ferritin (Ft), AGP, and TfR, standards and serum samples were 
analyzed in duplicate, and values for the manufacturer’s controls fell within the certified 
ranges. Coefficients of variation (CV) for the low, medium, and high controls for AGP 
were 4.1%, 9.8%, and 6.1%, respectively. For serum ferritin, the CV for the low, medium, 
and high controls were 1.5%, 2.0%, and 1.9%, respectively. For TfR, the CV for the 
medium and high controls was 15.1% and 15.9%, respectively. For plasma zinc, a sample 
check (concentration of 50 µg/L) was measured repetitively (once after 10 participants’ 
samples), and the mean, standard deviation, and CV were 52.0 µg/L, 0.76, and 1.5%, 
respectively.  
Plasma zinc concentration below the age/sex/time of the day/fasting status-
specific cutoffs is considered the best available biochemical measure of zinc deficiency 
as recommended by the Joint WHO/UNICEF/IAEA/IZiNCG Interagency meeting on zinc 
status indicators (de Benoist et al 2007). A cut-off point of 70 µg/dL for mothers and 65 
µg/dL for children was used to define deficiency (IZiNCG 2007a). 
Hemoglobin concentration less than 12 g/dl was used to define anemia in 
mothers. In children, Hb <11 g/dl was used to define anemia in children less than 60 
months of age (n= 39), and Hb < 11.5 g/dl was used to define anemia in children aged 60 
months or older (n=54) (WHO/UNICEF/UNU 2001).  
Quantitative estimation of body iron (mg/kg) was based on the model proposed 
by Cook and colleagues (2003) using the following formula: 
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 Body Iron (mg/kg) = - [log (TfR/Ferritin ratio) - 2.8229]/0.1207 
 Positive values for body iron (> 0 mg/kg) indicate iron surplus in stores, and negative 
values (body iron <0 mg/kg) indicate tissue iron deficiency (Cook et al 2003).  
Serum ferritin, TfR, and the ratio of TfR to serum ferritin TfR: Ft (TfR in mg/L and 
Ft in µg/L) were used to assess iron deficiency in mothers and children. For serum 
ferritin, cut-offs of 15 µg/L for mothers and 12 µg/L for children were used to define 
iron deficiency in absence of inflammation (WHO/UNICEF/UNU 2001). An AGP 
concentration ≥1.2 g/L was used to indicate the presence of inflammation (Paracha et al 
2000, Wieringa et al 2002).  
Sensitivity, specificity, and area under the curves were calculated using the 
receiver operator characteristics (ROC) curves to assess the performance and define the 
cut-off points of TfR, TfR/Ft and TfR/Log Ft in the diagnosis of iron deficiency and the 
differentiation between anemia of chronic disease (ACD) and iron deficiency anemia 
(IDA) (Lin et al 2008, Malope et al 2001, Punnonen et al 1997). Sensitivity (SN) was 
defined as proportion of people with disease who test positive: SN= TP/ (TP+FN). 
Specificity (SP) was defined as proportion of people without the disease who test 
negative SP = TN/ (TN+FP), where: TP is true positive, FN is false negative, TN is true 
negative, and FP is false positive. 
The ROC curve was obtained by plotting sensitivity on the x-axis against 1 minus 
specificity on the y-axis for every possible cut-off value for the diagnostic test. Ideally, a 
perfect diagnostic test will yield 100% sensitivity and 100% specificity with an area 
under the curve (AUCROC) of one. An area of 0.5 is a poor indicator and represents a test 
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result that was obtained by random chance. Usually AUCROC will fall between 0.5 and 1.0 
and the closer the AUCROC is to 1 the better the discriminant ability of the diagnostic 
test. Based on AUCROC, tests can be non informative (AUCROC =0.5), less accurate (AUCROC 
between 0.5 and 0.7), moderately accurate (AUCROC between 0.7 and 0.9), highly 
accurate (AUCROC between 0.9 and 1.0), and perfectly accurate (AUCROC =1.0) (Swets 
1988).  
The optimal sensitivity and specificity were defined as the minimal value of (1-
SN)2 + (1-SP)2. The likelihood ratio for a positive test (LR+) was defined as: SN/(1-SP). The 
likelihood ratio for a negative test (LR-) was defined as: (1-SN)/SP and was defined as 
the probability of an individual with disease to test negative divided by the probability 
of an individual without a disease to test negative.   
Body mass index (BMI) was calculated for mothers as body weight (kg)/height 
(m2). Anthropometric data for children were expressed as z-scores based on the WHO 
(World Health Organization) 2007 reference using AnthroPlus, version 1.0.2 (WHO 
2009). Variables that have skewed distribution were transformed to logarithms and 
geometric means ± 1SD were reported for those variables. Variables with skewed 
distribution included: ferritin, TfR, and TfR/ferritin in mothers and children, and AGP and 
Hb in children. Statistical analyses were conducted using the Statistical Package for the 
Social Sciences (SPSS/PASW), version 18.0 (SPSS Inc, Chicago, IL, USA). Analysis of 
variance was used to compare subgroups of the participants.  
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RESULTS 
The characteristics of the participants are summarized in Table 5.1. The mean 
age of the women was 33.9 years and their children (51 boys and 42 girls) had a mean 
age of 60.7 months. The children's mid-upper arm circumference ranged from 14.0 to 
19.5 cm; only four children (4.3%) had less than -2 SD for weight-for-age (-2 z), whereas 
two children (2.2%) had <-2 for the height-for-age z-scores. 
Women had high BMIs with a mean of 29.6 kg/m2, and 77% of women were 
classified as overweight or obese with a BMI ≥25 kg/m2. In total, 74 women (79.6%) 
were married and 17 women (18.3%) were widows; widows had a significantly higher 
BMI (P<0.05) than did other women (32.5 vs 28.9 kg/m2, respectively). The mean 
number of children per woman was 4.1. A total of 18% of women had completed 8 
years or less of school, but most had completed high school. In total, 91% of the 
participants were not working outside the home, and the monthly income for each 
family (gross income-housing) was equivalent to 325 US$. Mothers of 48 children 
reported that their children went to kindergarten.  
 
Hemoglobin 
The biochemical indices are presented in Table 5.2. Thirty-eight women (41%) 
were anemic with a mean ± SD Hb concentration of 12.2 ± 1.0 g/dL. In children, the 
prevalence of anemia was higher in the older children (age ≥ 60 months) than the 
younger ones (age <60 months). Twenty children aged >59 months (37%) had Hb <11.5 
g/dL, whereas around 10% (n=4) of children aged ≤ 59 months had Hb <11 gm/dl. In 
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mothers, hemoglobin concentration had a significant negative correlation with TfR (r=-
0.32, p<.005), and a significant positive correlation with plasma ferritin and zinc (r=0.51, 
p<.000 and r=0.30, p<.005 respectively), and with estimated body iron (r=0.52, p<.000). 
In children Hb correlated negatively with TfR (r=-.21, p<.05). 
 
Plasma ferritin, TfR, and body iron 
Plasma ferritin concentrations ranged from 0.6 µg/L to 122.0 µg/L in mothers, 
and from 1.6 µg/L to 160.2 µg/L in children. More than half of the women (54%, n=50) 
were below the defined cut-off points for ferritin deficiency (15 µg/L), and 
approximately 75% (n=70) were below 32 µg/L (Table 5.2). Sixteen percent of children 
had ferritin below 12 µg/L, and half were below 22 µg/L. In mothers, as expected, 
plasma ferritin negatively and significantly correlated with TfR (r=-0.38, p<.000). But 
interestingly, in children, plasma ferritin and TfR were not significantly correlated (Table 
5.3). Mothers had significantly lower mean serum ferritin and higher TfR (13.1 ± 3.1 
µg/L, and 7.6 ± 1.5 mg/L, respectively) than their children (21.9 ± 2.0 µg/L, and 5.9 ± 1.4 
mg/L, respectively). Forty-one women (44%) and 13 children (14%) had TfR above the 
normal range of TfR (2.9-8.3 mg/L) as defined by the assay.   
Mothers had significantly lower mean body iron compared to their children (p 
<.000) as noted in the cumulative frequency plot (Figure 5.1). The mean ± SD body iron 
for mothers was 0.5 ± 4.9 mg/kg, and 45% of mothers (n=42) had an iron deficit of 4.0 
mg/kg body weight. Children had a mean body iron of 3.5 ± 3.8 mg/kg and 18% of 
children (n=17) had an iron deficit of 0.71 mg/kg body weight.   
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Zinc  
Mean ± SD of plasma zinc was 67.2 ± 11.4 in mothers and 64.6 ± 9.4 in children 
with no significant difference between mothers and children. Fifty-four women and 53 
children were below the defined cut-off points for zinc deficiency (Table 5.2). Seventy-
five percent of both mothers and children had plasma zinc below 73.1 µg/dL and 70.1 
µg/dL, respectively. Mothers’ zinc correlated positively with children’s zinc (r=0.33, 
p<.005), and only in mothers, zinc had a positive correlation with Hb (r=0.30, p<.005).  
 
AGP, ferritin, and BMI 
Inflammation was prevalent among study participants. More than half of the 
mothers (n=50), and 30% of children (n=28) had AGP≥1.2 g/L. Mothers had significantly 
higher mean AGP (p<.000) than their children, with a mean AGP of 1.2 ± 0.4 g/L, and 1.0 
± 1.5 g/L in mothers and children, respectively. In children, AGP was positively 
correlated with ferritin (r= 0.35, p<.005). In mothers, BMI was significantly correlated 
with AGP (r=.22, p<.05), ferritin (r=0.21, p<.05), number of pregnancies (r=0.33, p<.000), 
and age (r= 0.42, p<.000). In all mothers with inflammation (AGP≥1.2 g/L), only eight 
mothers had WBC count >10,000mm3, and only two of the eight mothers were anemic. 
However, in children, only six children of those with high AGP had WBC count 
>10,000mm3, and none were anemic.  
When mothers were grouped according to BMI into 3 groups (BMI <25.0 kg/m2, 
n= 21, BMI=25.0-29.99 kg/m2, n= 34, and BMI ≥30.0 kg/m2, n=38), there was no 
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significant difference between the three BMI groups on all biochemical indices (ferritin, 
TfR, AGP, Iron, Hb, and zinc). However, when overweight women (BMI=25.0-29.99 
kg/m2, n=34) and obese women (BMI≥30 kg/m2, n= 38) were combined in one group 
(BMI≥25 kg/m2, n=72), and tested against women with normal BMI, AGP was 
significantly higher in the combined group (overweight and obese) compared to women 
with normal BMI, Table 5.4.  Although there was no significant difference between the 
two groups on all other indices, mean ferritin was higher in the overweight and obese 
mothers (13.8 ± 3.2 µg/L) compared to the mothers with normal weight (10.9 ± 2.8 
µg/L). At the same time mean TfR was almost the same in the two groups (7.3 ± 1.7 
mg/L) and (7.7 ± 1.5 mg/L) in mothers with BMI <25 kg/m2, and the combined 
overweight and obese mothers, respectively.   
 
Prevalence of anemia, iron deficiency, and iron deficiency anemia among mothers 
As presented above, there was a widespread prevalence of anemia, 
inflammation, and low iron stores among mothers. Figure 5.2 provides the method that 
was followed to identify mothers with iron deficiency anemia (IDA), anemia of chronic 
disease (ACD), iron deficiency (ID), and women with normal indices. At the same time 
the performance of the three parameters (TfR, TfR/ferritin, and TfR/Log10ferritin) in 
detecting iron deficiency among these groups was evaluated using receiver operator 
characteristics (ROC) curves. 
 Mothers were grouped first into 2 categories: anemic mothers (Hb<12 mg/dL, 
n=38) and non-anemic mothers (Hb≥12 mg/dL, n= 55). Non-anemic mothers were 
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further grouped into two groups based on the presence or absence of inflammation. 
Those non-anemic mothers without inflammation (AGP<1.2 g/L), ferritin ≥ 15 µg/L, and 
with no abnormal findings in the complete blood count (WBC and RBC count, PCV, MCV, 
MCH, and MCHC) were considered the control group (n=18). The control group had the 
following measures (mean ± SD): ferritin: 32.3 ± 1.8 µg/L; TfR, 5.9 ± 1.5 mg/L; 
TfR/Ferritin, 0.2 ± 1.6; TfR/Log10ferritin, 4.0 ± 1.3; AGP, 0.9 ± 0.2 g/L; and Hb, 13.1 ± 0.6 
mg/dL.  
The iron deficient group of the non-anemic mothers was determined based on 
having ferritin < 15 µg/L in presence or absence of inflammation. Thirteen mothers with 
AGP ≥ 1.2 g/L and nine mothers with AGP <1.2 g/L also had ferritin < 15 µg/L. These two 
groups were combined together as non-anemic iron deficient mothers (n=22). 
Before determining the prevalence of iron deficiency among the remaining 15 
non-anemic mothers who had high AGP and adequate ferritin, the performance of three 
parameters (TfR, TfR/ferritin, and TfR/Log10ferritin) in detecting iron deficiency was 
evaluated using receiver operator characteristics (ROC) curves among the control group 
and the iron deficient group. As shown in Figure 5.3, the area under the curve (AUCROC) 
was highest for TfR/Ferritin (AUCROC =0.985, p=.000), followed by TfR/Log10ferritin 
(AUCROC =0.856, p=.000), and the least was for TfR (AUCROC =0.727, p=.016). The 
sensitivity of TfR >6.7 mg/L, TfR/Ferritin >0.37, and TfR/Log10ferritin >5.5 in the 
diagnosis of iron deficiency was 72.7%, 95.5% and 81.8%, respectively. The specificity 
was 76.5%, 94.1%, and 82.4% for TfR, TfR/Ferritin, and TfR/Log10ferritin, respectively. 
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 The TfR/Ferritin showed the highest efficiency in determining iron deficiency 
with AUCROC =0.985 and 95% CI= 0.977-1.00.  
The optimal TfR/Ferritin cut-off point was determined at 0.37, at this point the 
ROC curve reached the closest distance (0.006) to the upper left-hand corner (0, 1) of 
the graph. The likelihood ratio for a positive test (LR+) for this point was 16.2, a high 
value (LR+ >10 significantly increases the probability of a disease) which means that a 
mother with iron deficiency is about 16 times more likely to be “ruled in” as having iron 
deficiency using the TfR/ferritin cut-off point of 0.37 than a mother who is not iron 
deficient. The same cut-off point had also a very low LR- value <0.1 which “rules out” 
that the mother is iron deficient. In other words, LR- represents the probability of an 
iron deficient mother to test negative (falsely identified as iron-sufficient) divided by the 
probability of an iron-sufficient mother to have a negative test (correctly identified as 
iron-sufficient). At TfR/ferritin cut-off point of 0.37, a mother with iron deficiency has a 
probability of .05 or about 1/20 of those without iron deficiency to be detected as not 
having iron deficiency. In other words, an iron-sufficient mother is 20 times more likely 
to be detected as iron–sufficient compared to an iron-deficient mother using a 
TfR/ferritin cut-off point of 0.37 to define deficiency.  
The optimal cut-off point of TfR/Ferritin= 0.37 was used to identify iron 
deficiency in the remaining non-anemic mothers with inflammation (n=15). Only one 
mother was identified as being iron deficient (TfR/ferritin<.37) while the rest were iron 
sufficient despite inflammation. An independent sample t-test was used to see if there 
was any significant difference between the control group (n=18) and the group of 
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mothers who were identified as iron sufficient in presence of inflammation (n=14), and 
there was no significant difference in all biochemical indices (ferritin, TfR, TfR/ferritin, 
iron, and Hb) except of course for AGP which was higher in the group of mothers who 
were iron sufficient with inflammation. Non-anemic mothers who were identified as 
iron sufficient were grouped together (n=14+17=31) and were named group 1 (G1): 
iron-sufficient and not anemic. Non-anemic mothers who were identified as iron 
deficient were grouped together (n= 22+1=23), and were named G2 (iron deficient and 
not anemic).  
Among anemic mothers, the performance of three parameters (TfR, TfR/ferritin, 
and TfR/Log10ferritin) in differentiating between iron deficiency anemia (IDA) and 
anemia of chronic disease (ACD) was evaluated using the receiver operator 
characteristics (ROC) curves (excluding those women with both ferritin≥ 15 µg/L and 
AGP≥ 1.2 g/L). As shown in Figure 5.4, the three indicators were significant in identifying 
iron deficiency among anemic mothers with TfR/ferritin having the highest AUCROC 
(.985, p=.000), followed by TfR/Log10ferritin (AUC
ROC=.935, p=.000), and then TfR with 
AUCROC=.812, p=.005). The sensitivity of TfR >7.3 µg/ml, TfR/Ferritin >0.42, and 
TfR/Log10ferritin >5.8 in the differentiation between IDA and ACD was 82.8%, 96.6% and 
89.7%, respectively. The specificity was 77.8%, 100%, and 88.9% for TfR, TfR/Ferritin, 
and TfR/Log10ferritin, respectively. Both TfR/ferritin and TfR/Log10ferritin showed high 
efficiency in differentiating between IDA and ACD, but TfR/ferritin had the highest 
AUCROC and the highest specificity and sensitivity were reached at a cut-off point of 0.42. 
At this cut-point, the TfR/ferritin had a likelihood ratio for a negative test (LR-) of 0.03, 
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which means that a mother who is not iron deficient is about 33 times more likely to be 
detected as iron-sufficient than an iron deficient mother using a TfR/ferritin cut-off 
point of 0.42.     
Based on a TfR/ferritin cut-off point of 0.42, anemic mothers with a TfR/ferritin ≥ 
0.42 were classified as mothers with iron deficiency anemia (IDA), n=28, and were 
named group 3 (G3), and anemic mothers with TfR/ferritin < 0.42 were classified as 
mothers with anemia of chronic disease (ACD), n=10, and were named group 4 (G4). 
Significant differences in means for all biochemical indices of the four mothers groups 
are described in Table 5.5.  
 
Prevalence of anemia, iron deficiency, and iron deficiency anemia among children 
A similar way of analysis (that was used with mothers) was followed to identify 
iron status of children. As described (Figure 5.5), sixty-nine children were non-anemic. 
Those non-anemic children with ferritin ≥ 12 µg/L, AGP <1.2 g/L, and with no abnormal 
findings in the TfR and the complete blood count were considered the control group 
(n=36). The control group had the following measures (mean ± SD): ferritin: 22.3 ± 1.5 
µg/L; TfR: 4.8 ± 1.4 mg/L; TfR/Ferritin: 0.2 ± 1.8; TfR/Log10ferritin: 3.8 ± 1.4; AGP: 0.8 ± 
0.2 g/L; Hb: 12.1 ± 0.6 mg/dL; and zinc: 65.5 ± 9.2 µg/dL. Of the non-anemic children 
only eight children had low ferritin (<12 µg/L). 
The performance of three parameters (TfR, TfR/ferritin, and TfR/Log10ferritin) in 
detecting iron deficiency was evaluated using receiver operator characteristics (ROC) 
curves among the control group and the iron deficient group. As shown in Figure 5.6, 
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the area under the curve (AUCROC) was highest for TfR/Ferritin (AUCROC =0.986, 
95%CI=0.947-1.0, p=.000). The TfR/ Log10ferritin  was also significant (p<.005) with 
AUCROC (95%CI)= 0.907(0.750-1.0), while transferrin receptor was not significant with 
AUCROC (95%CI)= 0.667(0.453-0.880). The sensitivity of TfR/Ferritin >0.45, and 
TfR/Log10ferritin >5.9 in the diagnosis of iron deficiency was 100% and 75.0%, 
respectively. The specificity was 91.7% and 94.4% for TfR/Ferritin, and TfR/Log10ferritin, 
respectively.  
The optimal TfR/Ferritin cut-off point of 0.45 had the closest distance (0.007) to 
the upper left-hand corner (0, 1) of the ROC graph. The likelihood ratio for a positive 
test (LR+) for this point was 12.0, a high value (LR+ >10) which means that an iron-
deficient child is about 12 times more likely to be “ruled in” as having iron deficiency 
using the TfR/ferritin cut-off point of 0.45 than a child who is not iron deficient. Since 
sensitivity determined at this cut-off point equals one, LR- also will be zero (LR-= 1-
sesntivity/specificity). A sensitivity of one or LR- of zero means that there is no 
probability of a child with iron deficiency to be identified as iron sufficient using 
TfR/ferritin>0.45 as a cut-off point to define deficiency. Based on this, non-anemic 
children were grouped into group 1: iron sufficient and not anemic (n=55), and group 2: 
iron deficient but not anemic (n=13).    
Among anemic children, the performance of three parameters (TfR, TfR/ferritin, 
and TfR/Log10ferritin) in differentiating between iron deficiency anemia (IDA) and 
anemia of chronic disease (ACD) was evaluated using the receiver operator 
characteristics (ROC) curves (excluding those children with both ferritin≥ 12 µg/L and 
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AGP≥ 1.2 g/L). As shown in Figure 5.7, only TfR/ferritin and TfR/ Log10ferritin indicators 
were significant in identifying iron deficiency among anemic children with TfR/ferritin 
having the highest area under the curve (AUCROC,95%CI)= (.986, .942-1.0, p=.001), 
followed by TfR/Log10ferritin (AUC
ROC, 95%CI)= (.833,.782-.912, p=.025), while 
transferrin receptor was not significant with AUCROC (95%CI) = 0.556(0.227-0.884). The 
TfR/ferritin showed the highest efficiency in differentiating between IDA and ACD 
among anemic children, with the highest AUC ROC and highest sensitivity and specificity 
(1.00 and 91.7, respectively) at a cut-off point of 0.43. At this cut-point, the TfR/ferritin 
had a high likelihood ratio for a positive test (LR+) =12.0, which means that a child with 
iron deficiency is about 12 times more likely to be “ruled in” as having iron deficiency 
using the TfR/ferritin cut-off point of 0.43 than a child who is not iron deficient. The 
same cut-off point had LR- = 0. Based on the TfR/ferritin cut-off point of 0.43, anemic 
children were grouped into two groups: group 3 (G3): children with iron deficiency 
anemia (IDA), n=9; and group 4 (G4): children with anemia of chronic disease (ACD), 
n=15. Significant differences in means for all biochemical indices of the four groups of 
children are described in Table 5.6.  
 
Iron Indices and Food consumption patterns of mothers and children  
Meat and liver consumption 
Approximately half of the women and children had never or rarely consumed 
liver. Sixty percent of women (n=56) and 54% of children (n=50) reported eating meat at 
least twice a week. No significant differences were found on all biochemical indices for 
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mothers based on amount of liver or meat consumed. In children, no significant 
differences were found on all biochemical indices based on meat consumption, while 
liver consumption correlated positively with iron (mg/kg), r=.24, p<.05. A significant 
difference on iron status was found based on how often the child consumes liver. Those 
children who consumed liver at least twice a month had higher estimated means ± SD 
for body iron (4.9 ± 5.4 mg/kg) compared to those children who consumed liver once a 
month or less (iron= 2.9 ± 2.7 mg/kg) as shown in Table 5.7.  
 
Bread consumption 
Eighty-three women reported consumption of bread that was made from 
fortified flour (fortified with iron and folic acid), only six women reported consumption 
of bread that was made from whole grain (unfortified), and four women consumed both 
bread types. Despite having no significant difference among these three groups for 
ferritin, TfR, TfR/ferritin, zinc, and iron (comparison is difficult due to the small sample 
size of mothers consuming whole grain and both flour types), mothers consuming the 
fortified flour had higher mean ferritin, iron, and zinc concentrations and lower TfR and 
TfR/ferritin than mothers consuming bread made from unfortified flour and mothers 
consuming bread made from both flour types (Table 5.8). For children, almost all 
children (94%) were consuming bread that was made from fortified flour, one child was 
consuming bread made from whole grain (unfortified), and four children were 
consuming bread made from both flour types.  
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Mineral supplements 
None of the children had taken mineral supplements. Of the 93 women studied, 
only 16 women reported taking supplements and most of these supplement were either 
iron alone or multivitamin/mineral supplements that contained iron. Although there 
was a trend for higher mean plasma ferritin and lower TfR in women taking 
supplements compared to those not taking supplements, the differences were small and 
not statistically significant (Table 5.9).  
 
Tea consumption  
Eighty-three percent of women (n=77) reported consumption of tea with a mean 
± SD of 21.8 ± 16.3 cups per week. Consumption among mothers ranged between 0.5-
70.0 cups per week, while consumption for children ranged between 2-35 cups per 
week for 67 children with mean ± SD of 11.1 ± 8.2 cups per week. Whether tea was 
consumed with/without meals was also reported for mothers and children. Thirty-one 
mothers reported consumption of tea with meals, 17 women reported tea consumption 
between meals, and 28 women reported consumption of tea both with meals and 
between meals.  
Interestingly, among mothers iron indices didn’t differ by the amount of tea 
consumed but it did differ by whether the tea was consumed with or without meals.  As 
shown in Table 5.10, means ± SD of ferritin and iron were significantly lower, and means 
± SD of TfR/ferritin and TfR/Log10Ferritin were significantly higher in mothers consuming 
tea strictly with meals (n=31) compared to the group of mothers who consume tea 
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between and with meals (n=28). In addition, TfR was significantly higher in the groups of 
mothers who consume tea strictly with meals (8.8 ± 1.5 mg/L) compared to those who 
don’t consume tea (6.4 ± 1.6 mg/L).  
 
Women’s Marital Status 
There was a trend for lower means of plasma ferritin, Hb, and zinc in the 
combined subgroup of widowed (n=17) and separated women (n=2) than in the 
subgroup of currently married women (n=74). However the differences were not 
statistically significant (Table 5.11). Perhaps the trend could be explained by the lower 
discretionary income of widowed/separated women compared to the currently married 
women. In fact, widowed/separated women had significantly (p<.005) lower mean 
monthly discretionary income ($160) compared to currently married women who have 
mean monthly discretionary income of $373. 
 
DISCUSSION 
The data suggest that there are widespread co-existing micronutrient 
deficiencies among mothers and to a lesser extent among children based on low values 
for hemoglobin, ferritin, and zinc. Among mothers, fifty-four percent had ferritin< 15 
µg/L, 58% had zinc< 70 µg/dL, 41% had Hb< 12 g/dL, 34% had both low ferritin and low 
zinc, at least 29% had two or more co-existing micronutrient deficiencies, and about 
24% were deficient on the three parameters: Hb, ferritin, and zinc. These results 
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indicate that micronutrient deficiencies are still a major public health problem for 
women living in suburban areas of Jordan.  
Among children, zinc deficiency was very prevalent with 52 children (56%) below 
65 µg/dL. Sixteen percent of children (n=15) had ferritin < 12 µg/L, twenty-six percent 
(n=24) were anemic, ten percent of children had both low ferritin and low zinc, 14% 
were both anemic and had low zinc, and only three children were deficient on all three 
parameters (Hb, ferritin, and zinc). The high prevalence of zinc deficiency among 
children is striking given that the percentage of stunting among those children is very 
low. Only two children (2.2%) had <-2 for the height-for-age z-scores. This means that 
the absence of stunting should not be perceived as sufficient evidence for adequate zinc 
levels among children. The IZiNCG suggests in its second report that the risk of zinc 
deficiency is of a public health concern when the prevalence of low height-for-age (The 
percentage of children under 5 years of age with height-for-age z-score less than −2.0 
SD with respect to the reference population) is greater than 20%, and in this case 
nutrition intervention strategies should address zinc status (Hess et al 2009). In our case, 
stunting was almost absent among study participants but still zinc deficiency is of a high 
concern. In fact, this emphasized the need to use the three indicators: prevalence of 
stunting among children under five, biochemical assessment (serum/plasma zinc< cut 
off points), and the prevalence of inadequate zinc intakes (Gibson et al 2008, Hess et al 
2009, IZiNCG 2007a) to ideally reflect zinc status of children.  
Another important finding in this study is the high prevalence of inflammation 
among study participants and especially among women. Nearly half of the mothers 
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(n=46), and 28% of children (n=26) had AGP>1.2 g/L, despite the fact that when mothers 
and children were recruited for the study any potential participant with any sign of 
infection and/or inflammation was excluded, and none of the participants had any sign 
of infection at time of blood collection. Any participant with high temperature, having a 
disease at time of blood collection or three days earlier was immediately excluded from 
participation. Ten women and 15 children were classified as having anemia of chronic 
disease (ACD). Anemia of chronic disease is the second most prevalent type of anemia 
after iron deficiency anemia, it is caused by chronic activation of the immune system 
(Agarwal and Prchal 2009), and it has the characteristic of an adaptive immune response 
(Zarychanski and Houston 2008). AGP was not correlated with ferritin or iron in 
mothers, while in children AGP positively correlated with ferritin (r=0.35, p<.000). 
Perhaps one potential explanation is that among mothers there was a high prevalence 
of inflammation, high prevalence of overweight and obesity, and a high prevalence of 
iron deficiency, so even though ferritin, as an acute phase protein, would be expected to 
increase in presence of inflammation, it also might decrease due to the high prevalence 
of obesity (which is also an inflammatory state that will decrease iron absorption as 
discussed below). In children, with the absence of obesity, high levels of AGP correlated 
positively with ferritin without the presence of any opposing factor that would decrease 
ferritin status. One limitation of this study is that C-reactive protein was not measured, 
and it is possible that a combination of the two measures (AGP and CRP) would have 
given a better estimation on the prevalence of inflammation in the study population.   
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The high prevalence of inflammation in mothers could be explained by the fact 
that those mothers had a high prevalence of overweight (37%, n=34) and obesity (40%, 
n=37). Literature suggests a link between excess body fat and an increase in pro-
inflammatory cytokines, particularly TNF-α (Greenberg and Obin 2006, Hotamisligil et al 
1995). The adipose tissue secreted cytokines can drive a state of chronic low-grade 
inflammation that plays an important role in obesity related disorders (Bekri et al 2006, 
Nathan 2008).  In fact, the data in this study showed that overweight and obese women 
had significantly higher AGP (mean ± SD= 1.3 ± 0.4 g/L) compared to mothers with 
normal weight (mean ± SD= 1.1 ± 0.4 g/L). 
Many studies have shown that there is a great overlap between overweight 
and/or obesity and iron deficiency among adults (Yanoff et al 2007), children (Nead et al 
2004, Zimmermann et al 2008) and women (Bentley and Griffiths 2003, Eckhardt et al 
2008, Tussing-Humphreys et al 2009). In addition to the fact that overweight individuals 
might have higher iron requirements, hepcidin has been proposed as a potential 
mediator between increased adiposity and iron deficiency (Miraglia Del Giudice et al 
2009, Schulze et al 2008). Hepcidin has been shown to be expressed in the adipose 
tissue (in addition to the liver). Adipose tissue in obese patients showed increased 
expression of C-reactive protein and interleukin 6 which in turn were shown to promote 
hepcidin expression (Bekri et al 2006). In addition to that, it has been found that leptin 
(production of which increases in overweight and obese people) up-regulates hepatic 
tissue expression of hepcidin (Chung et al 2007). The hepcidin secreted from both 
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adipose tissue and liver acts as a negative regulator of intestinal iron absorption and 
reduces dietary iron absorption (Laftah et al 2004).   
The data in our study have shown a significantly higher inflammatory state in 
obese and overweight mothers compared to mothers with normal weight, but no 
significant difference was found in ferritin, TfR, TfR/ferritin, and iron between the two 
groups. Mean ferritin levels tended to be higher in the obese and overweight mothers 
(13.8 ± 3.2 µg/L) compared to the mothers with normal weight (10.6 ± 2.8 µg/L) 
although the difference was not significant. Transferrin receptor was very close in both 
groups. The percentage of women with deficit body iron estimates was also very close, 
i.e. 45% in mothers with normal weight, and 44% in mothers who are overweight or 
obese, respectively. Further analysis is needed to understand and explore the relation 
between the high levels of AGP, the high incidence of obesity, and the low iron status of 
mothers in this study.  
The ratio of TfR/ferritin has been used to quantitatively estimate total body iron 
(Cook et al 2003). This approach has been used by several investigators (Beard et al 
2006b, Cook et al 2005, Iannotti et al 2005, Zimmermann et al 2005), and the Centers 
for Disease Control and Prevention (CDC) has phased in this approach in NHANES 
beginning in the years 2003-2004 (Cusick et al 2008). In this study, the mean ± SD body 
iron for mothers was 0.5 ± 4.9 mg/kg, and 45% of mothers (n=42) had an average iron 
deficit of 4.0 mg/kg body weight. Children had a mean body iron of 3.5 ± 3.8 mg/kg and 
18% of children (n=17) had an average iron deficit of 0.71 mg/kg body weight.   
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In settings where there is no co-existing inflammation/infection, serum ferritin 
remains a useful indicator of iron status. However, in case of high prevalence of 
infection/inflammation, the use of serum ferritin alone is not sufficient to detect iron 
deficiency. In these settings, TfR is most valuable in assessing iron status since it has the 
distinct advantage over ferritin of not being affected by the acute phase response (Cook 
et al 1993). The ratio of TfR/ferritin had been demonstrated to be valuable in assessing 
iron deficiency. This ratio takes advantage of the increase in TfR and the decrease in 
ferritin in the case of iron deficiency (Punnonen et al 1997). Some studies found that 
TfR/Log10 ferritin had the highest efficiency in determining the extent of iron deficiency. 
For example, Punnonen et al (1997) found that while TfR/ferritin improved the 
diagnostic sensitivity and specificity in detecting iron deficiency compared to TfR or 
ferritin alone, the TfR/Log ferritin index provided an outstanding indicator of iron 
depletion (Punnonen et al 1997). Malope et al (2001) found that while TfR/Log ferritin 
could sensitively reflect iron deficiency, the use of Log (TfR/ferritn) ratio had the highest 
sensitivity in determining stages of iron deficiency (Malope et al 2001). Lin et al (2008) 
similarly showed that although both Log (TfR/ferritin) and TfR/Log ferritin could 
sensitively reflect stages of iron deficiency, the use of Log (TfR/ferritin) provided the 
highest sensitivity in determining iron deficiency (Lin et al 2008). Another study 
recommended both TfR/ferritin and LogTfR/ferritin for the discrimination of iron 
deficiency in the absence of anemia (Vazquez Lopez et al 2006). On the other hand, 
there are some studies that didn’t find any improvement in accuracy in detecting iron 
175 
deficiency by the use of TfR/Log ferritin over ferritin (Lewis et al 2007), TfR alone 
(Markovic et al 2005), or both ferritin and TfR (Lee et al 2002).   
This study has shown that both TfR/ferritin and TfR/Log10ferritin could sensitively 
detect iron deficiency and could serve as reliable indices for determining the extent of 
iron deficiency in women of child-bearing age and preschool children. TfR/ferritin had 
higher diagnostic efficiency with the highest area under the curve (which reached 99%) 
and the highest sensitivity and specificity at the determined cut-off point in both 
mothers and children. This study didn’t aim to specify cut-off points for TfR/ferritin or 
TfR/Log ferritin to identify iron deficiency, instead it aimed to examine whether the use 
of TfR/ferritin or TfR/Log ferritin can improve the diagnosis of iron deficiency, especially 
in presence of high rates of inflammation. In fact, the different studies that examined 
the use of TfR/ferritin or TfR/log ferritin had determined the highest efficiency of either 
or both ratios at different cut off points. This is may be due to two reasons: first, until 
now there are no universally agreed reference values for TfR, and cut-off values vary 
according to the assay used. Secondly, the ROC analysis is complex with no single 
analytic approach that can be applied for all studies. The area under the curve of a 
diagnostic test produced from a group of participants doesn’t have a fixed value, and if 
the same diagnostic test was repeated on a different group of participants with similar 
characteristics, the AUC produced might be different (Hanley and McNeil 1983). 
Therefore, the performance of the diagnostic test should be judged within the context 
of the study. A second important aspect for a valid use of ROC curves in biomedical 
analysis is to have an accurate reference standard. In the case of defining iron deficiency 
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the use of the gold standard (the absence of stainable iron in the reticuloendothelial 
cells in the bone marrow) to define the reference groups is not always feasible, and only 
few studies have used stained bone marrow aspirates to determine iron deficient and 
iron sufficient groups. A third factor related to ROC curves is determining the optimal 
cut-off point of a diagnostic test. A perfect diagnostic test would have 100% sensitivity 
and 100% specificity with an area under the curve of one. Unfortunately, this is not 
usually the case. The researcher determines the optimal cut-off point based on a trade-
off between sensitivity and specificity over a continuous range of points.  
Given the impracticality of using the gold standard for the evaluation of iron 
status in the field setting, the study relied on normal values for ferritin, Hb, TfR, and 
blood indices in absence of inflammation to establish the control group. In fact, the 
Centers for Disease Control and Prevention (CDC) has traditionally relied upon the use 
of ferritin, transferrin saturation, erythrocyte protoporphyrin, and complete blood count 
in assessing iron status in NHANES. However, when the CDC phased in the use of the 
TfR/ferritin ratio based (Cook et al 2003) model beginning in 2003-2004, it also phased 
out the use of transferrin saturation and erythrocyte protoporphyrin after the 2005-
2006 cycle (Cusick et al 2008).  
There is a need for larger studies to further evaluate the TfR/ferritin and reach 
consensus on definitive age- specific cut-off values or reference ranges that can be 
applied to population studies.  
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Figure 5.1 
The cumulative frequency of body iron in mothers and children  
 
 
 
Body iron (mg/kg) for mothers and children calculated using cook and colleagues (2003) 
approach based on the following equation: Body Iron (mg/kg) = [log (TfR/ferritin ratio)- 
2.8229]/0.1207. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
183 
Figure 5.2 
Schematic diagram of mothers’ groups based on Hb, AGP, and iron status  
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Figure 5.3  
ROC curves for TfR, TfR/ferritin, and TfR/Log10 ferritin identifying iron deficiency in non-
anemic mothers 
 
 
 
 
 
 AUCROC (SE) Sig Sensitivity Specificity LR+ LR- 
TfR .727 (.09) .016 72.7 76.5 3.1 .36 
TfR/ferritin .985 (.01) .000 95.5 94.1 16.2 .05 
TfR/Log10ferritin .856 (.06) .000 81.8 82.4 4.6 .22 
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Figure 5.4  
ROC curves for TfR, TfR/ferritin, and TfR/log10 ferritin identifying iron deficiency in anemic 
mothers 
 
 
 
 
 AUC (SE) Sig sensitivity specificity LR+ LR- 
TfR .812 (.08) .005 82.8 77.8 3.7 .22 
TfR/Ferritin .985 (.02) .000 96.6 100 - .03 
TfR/Log10ferritin .935 (.04) .000 89.7 88.9 8.1 .12 
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Figure 5.5 
Schematic diagram of children’ groups based on Hb, AGP, and iron status  
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Figure 5.6  
ROC curves for TfR, TfR/Ferritin, and TfR/Log10ferritin identifying iron deficiency in non-
anemic children 
 
 
 
 
 
 AUC (SE) Sig sensitivity specificity LR+ LR- 
TfR .667 (.11) .196 75.0 61.1 1.9 .41 
TfR/Ferritin .986 (.02) .000 100 91.7 12.0 - 
TfR/Log10ferritin .907 (.06) .002 75.0 94.4 13.4 .26 
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Figure 5.7  
ROC curves for TfR, TfR/Ferritin, and TfR/log10ferritin identifying iron deficiency in anemic 
children 
 
 
 
 AUC (SE) Sig sensitivity specificity LR+ LR- 
TfR .556 (.17) .708 66.7 75.0 2.7 .44 
TfR/Ferritin .986 (.02) .001 100 91.7 12.0 - 
TfR/Log10ferritin .833 (.10) .025 83.3 75.0 3.3 .22 
 
 
 
 
 
 
 
 
 
 
189 
Table 5.1 
 Characteristics of the study participants 
 
 N Mean ± SD Median Percentile 
    25
th
  75th  
Mothers      
Age (years) 93 33.9 ±5.9 35.0 29.0 38.0 
BMI (kg/m2) 93 29.6 ±5.6 29.0 25.2 33.5 
Number of  pregnancies 93 4.8 ±2.5 4.0 3.0 6.0 
Number of children 93 4.1 ±1.9 4.0 3.0 5.0 
Income (USD/month)* 92 325 ±272 254 174 353 
Years of schooling 92 10.7 ±2.3 12.0 9.0 12.0 
      
Children      
Age (months) 93 60.7 ±5.4 61.0 55.0 65.0 
Weight- for-age (z) 93 -0.0 ±1.1 0.1 -0.6 0.6 
Height–for-age (z) 93 0.5 ±1.20 0.6 -0.3 1.4 
Child MUAC** (cm) 93 16.7 ±1.2 16.7 16.0 17.5 
*Income is defined as total monthly family income after rent deduction in US $. 
**MAUC: Mid-upper arm circumference. 
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Table 5.2 
Means, SD, and percentiles of various biochemical indices in mothers and children 
 
  Ferritin 
 (µg/L) 
 TfR 
 (mg/L) 
 Zinc 
 (mg/L) 
 AGP  
(g/L) 
TfR/ 
Ferritin 
 Hb 
 (g/dL) 
            
 
M
o
th
e
rs
 
Mean 13.1  7.6  67.2  1.2 0.6  12.2 
S.D. 3.1  1.5  11.4  0.4 3.9  0.99 
P25 5.6  5.6  57.8  1.0 0.2  11.6 
P50 14.0  7.8  67.8  1.2 0.4  12.2 
P75 31.8  10.3  73.1  1.5 1.5  13.0 
Prevalence 
(%) 
<15 µg/L 
= 53.8 
 ≥8.5mg/L 
=44.4 
 
 <70mg/L 
=58.1 
 ≥1.2 g/L  
=53.8 
  <12 g/dL = 40.9 
            
 
C
h
il
d
re
n
 
Mean 21.9  5.92  64.6  1.0 0.3  11.7 
S.D. 2.0  1.4  9.4  1.5 2.1  1.1 
P25 14.6  4.8  58.1  0.8 0.2  11.3 
P50 21.9  6.2  63.2  1.0 0.3  11.6 
P75 31.3  7.3  70.1  1.3 0.4  12.2 
Prevalence 
(%) 
<12 µg/L 
=16.1 
 
 ≥8.5mg/L 
=14.0 
 
 <65mg/L  
=55.9 
 ≥1.2 g/L 
=30.0 
 
  <11 g/dL= 
 10.3 (age≤ 59m) 
<11.5 g/dL= 
 37.0 (age> 59m) 
Mean comparison 
(mothers√children) 
p <.005  p <.000  N.S.  p <.000 p <.000  p <0.005 
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Table 5.3 
Correlations between biochemical indices in mothers and children  
 
  Children (n=93)  Mothers (n=93) 
  Ft TfR AGP Zn Hb  Ft TfR AGP Zn 
C
h
il
d
re
n
 
Ft           
TfR .10          
AGP .35† .17         
Zn .08 -.02 -.17        
Hb .12 -.21‡ -.02 .14       
            
M
o
th
e
rs
 
Ft .14 .06 -.12 .03 -.01      
TfR .04 .38† .26† -.02 .01  -.38*    
AGP -.04 .02 .-.01 .04 .12  .004 .15   
Zn .15 -.07 -.12 .33† .07  .14 -.04 .13  
Hb .06 -.16 -.03 -.02 -.06  .51* -.32† .01 .30† 
*Sig. at P<.000, †Sig. at p<.005, and, ‡ Sig. at p<.05 
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Table 5.4 
Various biochemical indices in mothers according to BMI 
 
 BMI <25.0 kg/m2 
(n=21) 
Mean ± SD 
BMI≥25.0  kg/m2 
(n=72) 
Mean ± SD 
   
BMI (kg/m2) 23.0 ± 1.1
b
 31.6 ± 1.2
 a
 
Ferritin (µg/L) 10.9 ± 2.8 13.8 ± 3.2 
TfR (mg/L) 7.3 ± 1.7 7.7 ± 1.5 
TfR/Ferritin 0.7 ± 4.1 0.6 ± 3.9 
Zinc (mg/L) 68.6 ± 11.4 67.0 ± 11.4 
AGP (g/L) 1.1 ± 0.4c 1.3 ± 0.4d 
Hb (g/dL) 12.2 ± 0.9 12.2 ± 1.0 
a,b Sig. at p<.000 ; c,d Sig. at p<.05 
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Table 5.5 
Differences in biochemical indices among mothers’ iron status groups  
 
           
  G1:  
iron 
sufficient, 
not anemic 
(n=32) 
 G2:  
iron 
deficient, 
not anemic 
(ID) 
 (n=23) 
 G3:  
iron 
deficiency 
anemia 
(IDA) 
 (n=28) 
 G4:  
anemia of 
chronic 
disease 
(ACD) 
(n=10) 
  
  Mean ± SD  Mean ± SD  Mean ±SD  Mean ±SD   
 
Ferritin (µg/L) 
 
 
34.3 ±1.7 
 
 
7.8 ± 2.2 
 
 
4.5 ±2.2 
 
 
37.1 ±1.8 
  
G1 ѵ G2, p<.000 
G1 ѵ G3, p<.000 
G2 ѵ G4, p<.000 
G3 ѵ G4, p<.000 
TfR (mg/L)  6.2 ± 1.5  8.1 ± 1.5  9.8 ± 1.4  6.0 ±1.5 
 G1 ѵ G3, p<.000 
G3 ѵ G4, p<.01 
TfR/Ft  0.2 ± 1.6  1.0 ± 2.6  2.2 ± 2.5  0.2 ± 2.2 
  
G1 ѵ G2, p<.000 
G1 ѵ G3, p<.000 
G2 ѵ G4, p<.000 
G3 ѵ G4, p<.000 
 
TfR/Log10Ferritin 
 
4.3 ± 1.4  8.3 ± 12.8  16.4 ± 2.2  3.9 ±1.6 
 G1 ѵ G3, p<.01 
 
 
AGP (g/L) 
 
 
1.2 ± 0.4  1.3 ± 0.4  1.2 ± 0.4  1.3 ± 0.4 
 
 
 
Zinc (mg/L) 
 
 
70.0 ± 11.5  67.3 ± 10.7  63.5 ± 8.5  68.5 ±17.8 
 
 
Hb (g/dL)  13.1 ±0.6  12.6 ±0.5  11.2 ±0.6  11.5 ± 0.3 
 G1 ѵ G3, p<.000 
G1 ѵ G4, p<.000 
G2 ѵ G3, p<.000 
G2 ѵ G4, p<.000 
 
BMI (kg/m2) 
 
 29.0 ± 1.2  28.6 ± 1.2  28.9 ± 1.2  31.0 ± 1.2   
Iron (mg/kg) 
 
Iron 
 Surplus 
 4.7 ± 1.7 
 
 
Iron Deficit 
1.6 ± 3.4 
 
 
Iron Deficit 
4.2 ± 3.3 
 
Iron 
Surplus 
 5.1 ± 2.8 
 G1 ѵ G2, p<.000 
G1 ѵ G3, p<.000 
G2 ѵ G3, p<.05 
G2 ѵ G4, p<.000 
G3 ѵ G4, p<.000 
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Table 5.6 
Differences in biochemical indices among children’s iron status groups  
 
           
  G1:  
Iron 
sufficient, 
not anemic 
 
(n=55) 
 G2:  
Iron 
deficient, 
not anemic 
(ID) 
 (n=13) 
 G3:  
Iron 
deficiency 
anemia 
(IDA) 
 (n=9) 
 G4:  
anemia of 
chronic 
disease 
(ACD) 
(n=15) 
  
  Mean ± SD  Mean ± SD  Mean ± SD  Mean ± SD   
 
 
Ferritin (µg/L) 
 
 
27.2 ± 1.7 
 
 
11.3 ± 2.3 
 
 
10.0 ± 1.2 
 
 
24.7 ± 1.4 
  
G1 ѵ G2, p<.000 
G1 ѵ G3, p<.000 
G2 ѵ G4, p<.05 
G3 ѵ G4, p<.05 
 
TfR (mg/L) 
 5.3 ± 1.4  7.5 ± 1.5  7.2 ± 1.4  6.4 ± 1.4  G1 ѵ G2, p<.05 
TfR/Ft  0.2 ± 1.8  0.7 ± 1.8  0.7 ± 1.4  0.3 ± 1.5 
  
G1 ѵ G2, p<.000 
G1 ѵ G3, p<.000 
G2 ѵ G4, p<.000 
G3 ѵ G4, p<.005 
 
TfR/Log10Ferritin 
 
3.9 ± 1.3  8.6 ±4.7  7.5 ±2.2  4.8 ±1.4 
 G1 ѵ G2, p<.000 
G1 ѵ G3, p<.000 
G2 ѵ G4, p<.000 
G3 ѵ G4, p<.05 
 
 
AGP (g/L) 
 
1.0 ± 1.6  1.0 ± 1.4  1.1 ± 1.3  1.0 ± 1.4 
 
 
 
Zinc (mg/L) 
 
65.2 ± 9.0  63.3 ± 8.6  64.4 ± 11  63.9 ± 12 
 
 
Hb (g/dL)  12.1 ± 1.1  12.0 ± 1.0  10.7 ± 1.1  11.0 ± 1.0 
 G1 ѵ G3, p<.000 
G1 ѵ G4, p<.000 
G2 ѵ G3, p<.000 
G2 ѵ G4, p<.000 
Iron (mg/kg) 
 
Iron 
Surplus 
4.9 ± 3.8 
 
 
Iron 
Surplus 
.0008 ± 2.1 
 
 
 
Iron Deficit 
0.29 ± 1.3 
 
Iron 
Surplus 
3.4 ±1.3 
 
 
G1 ѵ G2, p<.000 
G1 ѵ G3, p<.005 
G2 ѵ G4, p<.000 
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Table 5.7 
Differences in means ± SD of iron indices according to liver consumption among children 
  Eat liver at least twice a 
month 
(n=27) 
 
Mean ±SD 
 Eat liver once a month 
or less 
 (n=66) 
 
Mean ±SD 
Ferritin (µg/L)  25.5 ± 2.1   20.5 ± 2.1  
TfR (mg/L)  5.6 ± 1.5  6.1 ± 1.4 
TfR/Ft  0.2 ± 2.2   0.3 ± 2.1  
TfR/Log10Ferritin  4.4 ± 1.7
 
  5.4 ± 3.1 
AGP (g/L)  1.0 ± 1.6  1.0 ± 1.5 
Zinc (mg/L)  65.2 ± 10.3  64.3 ± 9.1 
Hb (g/dL)  11.6 ± 1.1  11.8 ± 1.1 
Iron (mg/kg)  4.9 ± 5.4 a  2.9 ± 2.7 b 
a,b sig at p<.05 
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Table 5.8 
Means ± SD of iron indices in mothers consuming bread made from different flour types  
  Unfortified 
whole grain 
(n=6) 
 
Mean ± SD 
 Fortified 
white flour 
(n=83) 
 
Mean ± SD 
 Both flour 
types 
(n=4) 
 
Mean ± SD 
Ferritin (µg/L)  6.4 ±2.9  14.0 ±3.1  9.0 ±3.1 
TfR (mg/L)  8.7 ±1.4  7.5 ±1.5  9.2 ±1.9 
TfR/Ft  1.4 ±3.2  0.5 ±3.9  1.0 ±5.2 
AGP (g/L)  1.2 ±0.4  1.3 ± 0.4  1.1 ±0.5 
Zinc (mg/L)  64.6 ±13.8  67.6 ±11.5  63.7 ±8.4 
Hb (g/dL)  11.0 ±1.0
b  12.3 ±0.9
a  12.3 ±1.0 
Iron (mg/kg)  -2.6 ±4.2  0.8 ±4.8  -1.5 ±6.0 
a,b sig at p<.005 
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Table 5.9 
Means ± SD of iron indices in mothers using and not using supplements  
  Mothers taking 
 supplements 
(n=16) 
 
Mean ± SD 
 Mothers not taking  
supplements 
(n=77) 
 
Mean ± SD 
Ferritin (µg/L)  15.4 ± 2.8  12.6 ± 3.2 
TfR (mg/L)  7.2 ± 1.5  7.7 ± 1.5 
TfR/Ft  0.4 ± 3.4  0.6 ± 4.0 
TfR/Log10Ferritin  8.9 ± 8.6  10.8 ± 20.3 
AGP (g/L)  1.2 ± 0.5  1.3 ± 0.4 
Zinc (mg/L)  65.6 ± 13.3  67.5 ± 11.1 
Hb (g/dL)  11.8 ± 1.0  12.3 ± 1.0 
Iron (mg/kg)  1.3 ± 4.4  0.3 ± 5.0 
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Table 5.10 
Differences in means ± SD of iron indices according to tea consumption among mothers 
 
  Strictly with 
meals 
(n=31) 
 
Mean ± SD 
 Between 
meals   
(n=17) 
 
Mean ± SD 
 Both: between 
and with meals 
(n=28) 
 
Mean ± SD 
 Don’t drink 
tea 
(n=17) 
 
Mean ± SD 
Ferritin (µg/L)  9.5 ± 2.9
b 
  13.8 ± 3.8
 
  17.6 ± 3.1
a 
  13.4 ± 2.8
 
 
TfR (mg/L)  8.8 ± 1.5
 a  7.6 ± 1.5  7.0 ± 1.5  6.4 ± 1.6
 b 
TfR/Ft  0.9 ± 3.8
a
  0.6 ± 4.6
 
  0.4 ± 3.5
 b 
  0.5 ± 3.6
 
 
TfR/Log10Ferritin  17.5 ±27.7
 a 
  7.4 ± 16.9
 
  6.2 ± 8.9
 b 
  7.8 ± 6.0 
AGP (g/L)  1.3 ± 0.4  1.3 ± 0.3  1.3 ± 0.4  1.1 ± 0.4 
Zinc (mg/L)  66.4 ± 9.6  69.7 ± 13.3  66.1 ± 11.1  68.3 ± 13.2 
Hb (g/dL)  11.9 ± 0.9  12.4 ± 1.1  12.4 ± 0.9  12.3 ± 1.1 
Iron (mg/kg)  -1.2 ± 4.8
 b 
  0.7 ± 5.5
 
  1.8 ± 4.5
 a 
  1.2 ± 4.6
 
 
Tea consumed (cups)  14.6 ± 9.4  16.6 ± 18.7  32.5 ± 15.4  - 
a,b sig at p<.05 
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Table 5.11  
Differences in means ± SD of iron indices among currently married women and 
widowed/separated women   
  Currently married 
women 
(n=74) 
 
Mean ± SD 
 Widowed and 
separated women 
(n=19) 
 
Mean ± SD 
Ferritin (µg/L)  14.5 ± 3.1  8.8 ± 3.0 
TfR (mg/L)  7.3 ± 1.5
 b  9.1 ± 1.5
 a 
TfR/Ft  0.5
 
± 3.9
b
  1.0 ± 3.4
a
 
TfR/Log10Ferritin  10.3 ± 20  11.4 ± 13.9 
AGP (g/L)  1.2 ± 0.4  1.3 ± 0.4 
Zinc (mg/L)  67.7 ± 11.9  65.4 ± 9.4 
Hb (g/dL)  12.3 ± 1.0  11.9 ± 0.8 
Iron (mg/kg)  1.0 ± 4.9
a
  -1.6 ± 4.4
 b
 
a,b sig at p<.05 
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CHAPTER VI 
 
ASSESSMENT OF IRON AND ZINC INDICATORS AND COGNITIVE FUNCTIONS OF 
PRESCHOOL CHILDREN IN JORDAN 
  
ABSTRACT 
 
The association between iron and zinc deficiency and children’s performance on 
cognitive tests was assessed in Jordan in July 2007. Hb and plasma ferritin, transferrin 
receptor (TfR), zinc, α-1- acid glycoprotein (AGP) were determined in 93 preschool 
children. In addition, tests to assess the non verbal cognitive functions (PPVT-IV and K-
ABC-II) were administered to the children, and their relation to the children’s iron 
status, nutritional status and socioeconomic status of the children and their mothers 
were analyzed. Mean age ± SD for children was 60.7 ± 5.4 months. Mean concentrations 
of plasma ferritin, TfR, AGP, and Hb were 21.9 ± 2.0 µg/L; 5.9 ± 1.4 mg/L; 1.0 ± 1.5 g/L; 
and 11.7 ± 1.1 g/dL, respectively. Number (%) of children who had ferritin 
concentrations <12 µg/L and TfR concentrations ≥ 8.5 µ/mL were 15 (16.1%) and 13 
(14%), respectively, and 28 children had AGP> 1.2 g/L. Mean plasma zinc was 64.6 ± 9.4 
µg/dL, 53 children (56%) had plasma zinc < 65.0 µg/dL, and 75% had plasma zinc <70.1 
µg/dl. The analysis of results of cognitive tests performed by children showed no 
significant difference between girls and boys on all dimensions of the tests. Neither 
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ferritin nor zinc predicted child performance on the tests, except for the number recall 
subtest. Children who had plasma zinc ≥57.0 µg/dL had significantly higher scores on the 
number recall subtest (9.9 ± 2.3) compared to children who had plasma zinc< 57.0 µg/dL 
(8.5 ± 2.4). Children’s scores on all cognitive tests were not different among groups of 
children with different iron status, but socioeconomic variables predicted many of the 
cognitive tests. Stepwise multiple regression showed that father’s education predicted 
children performance on the PPVT-IV, mother’s education and family income predicted 
children’s performance on the nonverbal index of the K-ABC-II, mother’s education and 
father’s education predicted children performance on the simultaneous scale of K-ABC-
II, only mother’s education predicted children’s performance  on triangles, hours 
children spent watching TV predicted  their performance on word order, and finally 
kindergarten attendance predicted children’s performance on hand movement. 
A possible explanation for the lack of an association between iron deficiency and 
cognitive measures is that children didn’t have severe iron deficiency. More research is 
needed to assess short-term and long-term developmental outcomes in Jordanian 
preschool children with low iron and zinc status. 
 
INTRODUCTION 
Research suggests poor cognitive, motor, or social functioning in iron deficient 
infants and young children up to 24 months of age (Aukett et al 1986, Black et al 2004a, 
Friel et al 2003, Heywood et al 1989, Idjradinata and Pollitt 1993, Lozoff et al 1987, Oski 
et al 1983, Walter et al 1983, Walter et al 1989, Williams et al 1999). Longitudinal 
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studies also showed that infants with chronic iron deficiency failed to catch up to the 
children with good iron status in developmental tests overtime despite correction of 
iron status (Algarin et al 2003, Corapci et al 2006, Dommergues et al 1989, Hurtado et al 
1999, Lozoff et al 1991, Lozoff et al 2000, Lozoff et al 2006b, Palti et al 1985, Shafir et al 
2006, Walter 2003). However, research on the developmental outcomes and motor and 
cognitive functioning among iron-deficient preschool children is limited. The few 
available studies showed impaired motor, cognitive, and developmental outcomes 
among iron deficient pre-school children (Lozoff et al 2007, Metallinos-Katsaras et al 
2004, Pollitt et al 1983, Pollitt et al 1986, Soewondo et al 1989, Stoltzfus et al 2001).  
Animal studies have shown that zinc deficiency is associated with reduced motor 
activity, decrease in performance on tasks of visual attention and short-term memory, 
impaired spatial learning and knowledge retention, and increased emotional response 
to stress (Bhatnagar and Taneja 2001, Black 2003, Golub et al 1995, Golub et al 2000, 
Tahmasebi Boroujeni et al 2009). Zinc deprivation in animals has been associated with 
impairments in learning and memory that are poorly reversible later in life(Sandstead 
2003).  
Few research studies have been conducted to assess the impact of zinc 
deficiency on cognition and behavior in humans. There are some observational studies 
but most of the research has involved zinc supplementation trials in infants and school-
age children with mixed results. Many zinc intervention studies that assessed the role of 
zinc in improving diminished cognitive ability and motor functioning have suggested a 
relationship between zinc supplementation and motor development in infants, toddlers, 
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and school aged children (Ashworth et al 1998, Bentley et al 1997, Black et al 2004a, 
Castillo-Duran et al 2001, Friel et al 1993, Gardner et al 2005, Kirksey et al 1991, Kirksey 
et al 1994, Merialdi et al 1999, Sazawal et al 1996), although more research is needed to 
confirm such relations (Black 2003). On the other hand, other studies found no impact 
of zinc supplementation on infant and child mental development and behavior (Black et 
al 2004b, Cavan et al 1993, Gibson et al 1989, Hamadani et al 2001, Hamadani et al 
2002, Lind et al 2004, Tamura et al 2003, Taneja et al 2005). 
No previous study has investigated the relation between nutritional status and 
cognition of preschool children in Jordan. This study aimed to assess the association 
between children’s performance on tests of non-verbal cognitive functions and their 
iron and zinc indicators.  
 
METHODS 
A convenience sample of 93 women and their children aged 4–5 years from 
urban/suburban areas in Northern Jordan was recruited for the study. Participants were 
approached by direct contact with the help of local community centers. An exclusion 
criterion was acute illness. The study was approved by the Oklahoma State University 
Institutional Review Board, and an informed written consent was obtained from the 
mothers. Four university graduate research assistants in Jordan were trained and 
assisted in taking anthropometric measurements, administration of the questionnaire, 
and in the administration of cognitive tests.  
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Weight (kg), height (cm), and mid-upper arm circumference (cm) were measured 
for children. A questionnaire covering health status, demographic characteristics, 
income (defined as total monthly family income after rent deduction), lifestyle and 
dietary intakes of children was administered individually to mothers. The questionnaire 
was validated by a group of academic experts in research, statistics and dietetics who 
reviewed the questions to ensure face and content validity. Second, a focus group 
discussion with local women was carried out and some items of the questionnaire were 
modified to eliminate ambiguity. 
After collection of anthropometric measurements and questionnaire data in the 
field, participants were transferred to a local clinical laboratory where non-fasting 
venous blood samples were drawn from each participant. All samples were taken 
between June and July 2007. Hemoglobin concentration was measured immediately, 
and serum and plasma samples were transferred into trace element-free tubes which 
were then frozen at -20 °C, shipped in dry ice to our laboratories at Oklahoma State 
University in the USA and stored at -20 °C until analysis. In addition to Hemoglobin (Hb), 
the following were measured in 93 mothers and their children: plasma ferritin (Ft) was 
measured using immunoradiometric assay (Ramco Laboratories, Inc. Stafford, Texas); 
transferrin receptor (TfR) was measured using enzyme immunoassay (Ramco 
Laboratories, Inc. Stafford, TX); α-1-acid glycoprotein (AGP) was assayed using radial 
immunodifusion (Kent Laboratories, Redmond, WA); and plasma zinc (Zn) was measured 
using inductively coupled plasma mass spectrometry (ICPMS).  
205 
For plasma ferritin, AGP, and TfR, standards and serum samples were analyzed in 
duplicate, and values for the manufacturer’s controls fell within the certified ranges. 
Coefficients of variation (CV) for the low, medium, and high controls for AGP were 4.1%, 
9.8%, and 6.1%, respectively. For plasma ferritin, the CV for the low, medium, and high 
controls were 1.5%, 2.0%, and 1.9%, respectively. For TfR, the CV for the medium and 
high controls was 15.1% and 15.9%, respectively. For plasma zinc, a sample check 
(concentration of 50 µg/L) was measured repetitively (once after 10 participants’ 
samples), and the mean, standard deviation, and CV were 52.0 µg/L, 0.76, and 1.5%, 
respectively.  
Hemoglobin concentration less than <11 mg/dl was used to define anemia in 
children less than 60 months of age (n= 39), and Hb < 11.5 mg/dl was used to define 
anemia in children aged 60 months or older (n=54) (WHO/UNICEF/UNU 2001). A cut-off 
point of 65 µg/dL was used to define zinc deficiency in children (IZiNCG 2007a). 
Quantitative estimation of body iron (mg/kg) was based on the model proposed by Cook 
and colleagues (2003) using the following formula: Body Iron (mg/kg) = - 
[log(TfR/Ferritin ratio) - 2.8229]/0.1207 (Cook et al 2003).  
Plasma ferritin, TfR, and the ratio of TfR to plasma ferritin TfR/Ft (TfR in mg/L 
and Ft in µg/L) were used to assess iron deficiency in children. A ferritin cut-off point of 
12 µg/L was used to define iron deficiency in absence of inflammation 
(WHO/UNICEF/UNU 2001). Normal range for TfR was between 2.9-8.3 µg/ml as defined 
by the assay. An AGP concentration ≥1.2 was used to indicate the presence of 
inflammation (Paracha et al 2000, Wieringa et al 2002). Based on values of plasma 
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ferritin, TfR, TfR/ferritin, AGP, and Hb, children were classified into four groups 
(described in chapter 5): iron sufficient and not anemic (n=55), iron deficient but not 
anemic (n=13), iron deficiency anemia (n=9), and children with anemia of chronic 
disease (n=15).  
Cognitive function was assessed in children using components of the Peabody 
Picture Vocabulary Test-IV (PPVT-IV) and of the Kaufman Assessment Battery for 
Children (KABC-II).   The children were tested on two of the five scales of KABC-II: 
sequential and simultaneous processing.  The core subtests on the K-ABC-II sequential 
scale included: number recall (memory span) and word order (memory span and 
working memory). The core subtests on the K-ABC-II simultaneous scale included: 
conceptual thinking (visualization and induction), face recognition (visual memory), 
triangles (spatial relations and visualization), and pattern reasoning (induction and 
visualization). In addition, the hand movement which is a supplementary test was also 
administered to children (it measures memory span and visual memory).  The non 
verbal index K-ABC-II (NVI) is used to assess processing and cognitive abilities of children 
using both core and supplementary subtests that can be communicated with gestures 
and responded to without speaking.  
Raw scores for PPVT-IV were reported and then transformed into the 
corresponding standard scores for each age group. For K-ABC-II, raw scores for the 
seven subtests (conceptual thinking, face recognition, number recall, triangles, word 
order, pattern reasoning, and hand movement) were reported, and then transformed 
into the corresponding scaled scores for each age group. Then the sum of the scaled 
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scores for the three K-ABC-II scales was calculated. Sequential K-ABC-II = (number recall 
+ word order) for all children. For children < 5years of age: NVI = (conceptual thinking + 
face recognition + triangles + hand movement), and simultaneous K-ABC-II = (conceptual 
thinking + face recognition + triangles). For children ≥ 5 years of age: NVI = (conceptual 
thinking + face recognition + triangles + hand movement + pattern reasoning), and 
simultaneous K-ABC-II = (conceptual thinking + triangles + pattern reasoning). Scaled 
scores for four children were not added for NVI and simultaneous K-ABC-II because 
those children were not tested on story completion (part of the NVI for this age group), 
and rover (part of the simultaneous K-ABC-II for this age group). Finally, the sum of the 
scaled scores for the three K-ABC-II scales (NVI, simultaneous, and sequential) was 
transformed to the corresponding standard score for each age group.  
Anthropometric data for children were expressed as z-scores based on the WHO 
(World Health Organization) 2007 reference using AnthroPlus, version 1.0.2 (WHO 
2009).Variables that had skewed distribution (ferritin, TfR, and TfR/Ferritin, AGP and Hb) 
were transformed to logarithms, and geometric means ± 1SD were reported for those 
variables. Statistical analyses were conducted using the Statistical Package for the Social 
Sciences (SPSS/PASW), version 18.0 (SPSS Inc, Chicago, IL, USA). Analysis of variance was 
used to compare subgroups of the participants. Stepwise multiple regression analysis 
was performed to determine the variance contributed by different socioeconomic 
variables identified in correlation analysis for the prediction of cognitive scores.  
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RESULTS 
Characteristics of study participants 
Fifty-one boys and 42 girls participated in the study with a mean ± SD age of 60.7 
± 5.4 months (Tables 6.1 & 6.2). The children's mid-upper arm circumference ranged 
from 14.0 to 19.5 cm; only four children (4.3%) had less than -2 SD for weight-for-age (-2 
z), whereas two children (2.2%) had <-2 for the height-for-age z-scores. The mean age of 
mothers was 33.9 ± 5.9 years, and each mother had 4.1 ± 1.9 children with 50% of 
mothers having 5 children or more.  A total of 18% of mothers had completed 8 years or 
less of school, 63% of mothers had completed high school, and 72% of fathers had 
completed high school. In total, 91% of mothers and only 5% of fathers did not have a 
job, and the monthly income for each family (gross income-housing) was equivalent to 
325 US$.  
Based on mothers’ report, seventy-nine children had breast fed for 13.9 ± 6.3 
months, fifty children (54%) were attending kindergarten for 5.1 ± 0.9 hr/day, all 
children watched TV for 11.0 ± 8.6 hr/wk, and 45% of children (n=42) spent 1 hr/day or 
more on TV. Mothers also reported that their children spent 24.3 ±14.4 hr/wk in active 
play, and 60% of children spent at least three hours in active play daily.  
 
Biochemical indices 
As described in Table 6.1, twenty-four children (25.8%) were anemic based on 
their hemoglobin concentrations. Plasma ferritin ranged between 1.6-160.2 µg/L with a 
mean ± SD of 21.9 ± 2.0 µg/L. Fifteen children (16%) had ferritin below 12 µg/L, and half 
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were below 22 µg/L. Mean ± SD forTfR was 5.9 ± 1.4 mg/L and 13 children (14%) had TfR 
above the normal range for the assay (2.9-8.3 mg/L). Children’s estimated mean body 
iron 3.5 ± 3.8 mg/kg and 18% of children (n=17) had an iron deficit of 0.71 mg/kg body 
weight. Twenty-eight children (30%) had AGP≥1.2 g/L. There was no significant 
difference between boys and girls for zinc or for all iron indices (ferritin, TfR, iron, and 
Hb). Plasma zinc ranged between 46.3-87.8 µg/dL with a mean of 64.6 ± 9.4 µg/dL. Fifty-
three children (56%) were below 65.0 µg/dL, and 75% had plasma zinc below 70.1 mg/L.  
 
Correlations between cognitive tests, zinc and iron indices, and socioeconomic variables  
Correlations between cognitive tests are presented in Table 6.3. No significant 
correlation was found between ferritin, TfR/ferritin, and zinc and children scores on all 
cognitive tests (Table 6.4). Transferrin receptor correlated negatively only with scores 
on conceptual thinking (r=-.23, p<.05). Quantitatively estimated iron correlated 
negatively with scores on hand movement (r=-.23, p<.05), and AGP correlated positively 
with scores on PPVT-IV. 
 Socioeconomic variables showed correlations with some of the cognitive tests. 
The hours that children spend in active play correlated negatively with non verbal index 
K-ABC-II scale (r=-.23, p<.05), sequential K-ABC-II scale (r=-.22, p<.05), triangles subtest 
(r=-.25, p<.05), and hand movement subtest (r=-.24, p<.05). Kindergarten attendance 
correlated positively with non verbal index K-ABC-II scale (r=.32, p<.01), simultaneous K-
ABC-II (r=.27, p<.05), face recognition subtest (r=.22, p<.05), and hand movement 
subtest (r=.29, p<.01).  
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Hours the child spent watching TV correlated positively only with the word order 
subtest (r=.23, p<.05). Family income (after rent deduction) correlated positively with 
PPVT-IV (r=.26, p<.005), nonverbal index of the K-ABC-II (r=.32, p<.005), the 
simultaneous K-ABC-II scale (r=.32, p<.005), the triangles subtest (r=.32, p<.005), and 
the hand movement subtest (r=.23, p<.05). Highest level of education for mothers and 
fathers correlated positively with the non verbal K-ABC-II scale (r=.28, p<.01 and r=.29, 
p<.05, respectively), the simultaneous K-ABC-II scale (r=.34, p<.005 and r=.32, p<.05, 
respectively), the triangles subtest (r=.33, p<.005 and r=.27, p<.05, respectively), and the 
hand movement subtest (r=.28, p<.05 and r=.25, p<.05, respectively), while father’s 
highest level of education (but not mothers’ highest level of education) correlated 
positively with PPVT-IV (r=.45, p<.005).  
Table 6.5 shows the correlations between socioeconomic variables. Hours of 
active play was negatively correlated with KG attendance (r=-.21, p<.05) and with 
father’s education (r=-.27, p<.05). Kindergarten attendance correlated positively with 
income (r=.41, p<.01), mother’s education (r=.25, p<.05), and father’s education (r=.33, 
p<.01). Finally, both fathers’ education and mothers’ education were positively 
correlated with each other(r=.35, p<.01), and with their income (r=.43, p<.000 for 
mothers, and r=.51, p<.000 for fathers). 
 
Performance of children on cognitive tests and iron and zinc indices 
Means ± SD of PPVT-IV and K-ABC-II scales and subtests are reported in Table 
6.6. Children’s scores on PPVT-IV ranged between 47-118. Scores for 21 children were 
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below 2SD, scores for 37 children were below average, twenty-six children were within 
the normal range, and only one child scored above average (Table 6.7). Analysis of 
variance showed no significant difference in the means of all iron and zinc indices for 
the children in the three groups: lower extreme, below average, and normal range. Also 
no significant difference was found in the means of iron and zinc indices for children 
whose scores fell within or above the normal range (n=27), and those whose scores 
were below normal range (n=58).  
In the nonverbal index of the K-ABC-II, seven children scored <-2SD, scores for 34 
children were below average, scores for 40 children were within the normal range, and 
only one child scored above average (Table 6.8). There was no significant difference in 
the means of all iron and zinc indices between the three groups. Although zinc was 
slightly higher in the group of children who scored in the normal range (65.6 ± 9.9 µg/dl) 
than both groups who scored below average (62.2 ± 8.7µg/dl) and in the lower extreme 
(62.2 ± 8.7µg/dl), the difference was not significant.  
On the simultaneous K-ABC-II scale, more children scored in the normal range 
(n=43), scores for 35 children were below average, and 3 children scored in the lower 
extreme (<-2SD) (Table 6.9). Only TfR showed a significant difference between those 
children who scored in the lower extreme (9.3 ± 1.7 mg/L) than children who scored 
below average (5.8 ± 1.6 mg/L), and those who scored within the normal range (5.7 ± 
1.4 mg/L). Ferritin and estimated body iron were also lower in the three children who 
scored in the lower extreme but the difference was not significant.    
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On the Sequential K-ABC-II, more children were within the normal range (n=54), 
thirty children were below average, two children scored in the lower extreme, and no 
score was above average (Table 6.10). Zinc was lower in the two children who scored in 
the lower extreme, but the difference was not significant. Ferritin was lower and TfR 
was higher in the same group but also the difference was not significant.  
For the eight K-ABC-II subtests (conceptual thinking, face recognition, triangles, 
word order, pattern reasoning, number recall, and hand movement), means for all iron 
and zinc indices were compared for children below the 20th percentile and those above 
the 80th percentile using the students’t-test (Table 6.11). No significant difference was 
found in all iron and zinc indices between the two groups.  
Children’s performance on cognitive tests was evaluated in the children who are 
grouped based on iron status into four groups:  iron sufficient and not anemic, iron 
deficient but not anemic, children with iron deficiency anemia, and children with 
anemia of chronic disease Children’s performance on all cognitive tests showed no 
significant difference between children with different iron status (Table 6.12).  
Children’s performance on cognitive tests was also evaluated in the children who 
were grouped based on zinc status into two groups: those with plasma zinc < 65.0 µg/dL 
(n= 37), and those with zinc ≥ 65.0 µg/dL (n= 49). No significant difference was found in 
children’s performance between the two groups on all cognitive tests. However, when a 
lower cutoff for zinc was used (57.0 µg/dL), the cutoff for zinc deficiency recommended 
by the IZiNCG for non-fasting afternoon zinc samples, there was a trend of lower scores 
on most of the cognitive tests for children who had plasma zinc < 57.0 µg/dL compared 
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to children who had plasma zinc ≥57.0 µg/dL, but the difference was not statistically 
significant except for number recall subtest. Children who had plasma zinc ≥57.0 µg/dL 
had significantly higher score on number recall subtest (9.9 ± 2.3) compared to children 
who had plasma zinc < 57.0 µg/dL (8.5 ± 2.4) as shown in Table 6.13.  
 
Performance of children on cognitive tests and socioeconomic variables 
There was no significant difference between girls and boys on all cognitive tests 
scores: PPVT-IV, and K-ABC-II scales and subtests (Table 6.14).  Also no significant 
difference was found on all cognitive tests between children who breast fed and those 
who didn’t breast fed (Table 6.15).  
Children’s performance on some cognitive tests was different for children who 
attended kindergarten (KG) and those who did not (Table 6.16).  Children attending KG 
had significantly higher scores than children not attending KG on the following tests: 
non verbal index K-ABC–II scale (89.3 ± 12.1 ѵ 81.5 ± 11.4), simultaneous K-ABC-II (90.3 ± 
11.0 ѵ 84.2 ± 11.3), word order subtest (6.1 ± 1.7 ѵ 5.9 ± 1.1), and hand movement 
subtest (9.0 ± 2.4 ѵ 7.6 ± 2.1).  
Hours spent in active play also influenced children’s performance on cognitive 
tests (Table 6.17). Children who spent more than 5 hours a day in active play had 
significantly lower scores on PPVT-IV than children who played less than 5 hours a day 
(75.8 ± 10.0 and 79.5 ± 14.6, respectively), sequential K-ABC-II subscale (82.1 ± 8.2 and 
89.0 ± 9.2, respectively), number recall subtest (8.3 ± 2.2 and 10.1 ± 2.2, respectively), 
and hand movement subtest (7.4 ± 2.0 and 8.7 ± 2.4, respectively).  
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Highest level of education fathers and mothers affected children’s performance 
on cognitive tests (Table 6.18). Children’s scores on nonverbal index K-ABC-II scale and 
simultaneous K-ABC-II scale differed significantly between children whose mothers had 
completed high school or above (88.6 ± 11.7 and 90.3 ± 10.7, respectively), and those 
children whose mothers had less than high school education (80.6 ± 11.9 and 82.6 ± 
11.3, respectively). Children’s performance on these same two scales also differed by 
fathers’ highest level of education. Children whose fathers completed high school or 
above had significantly higher scores on non verbal index K-ABC-II scale and 
simultaneous K-ABC-II scale (89.0 ± 12.4 and 91.1 ± 11.1, respectively) than children 
whose fathers had an education of less than high school (80.5 ± 10.4 and 82.6 ± 10.0, 
respectively).  
Children’s performance on PPVT-IV, the conceptual thinking subtest, and the 
face recognition subtest differed by fathers’ (but not mothers’) highest level of 
education. On the other hand, children’s performance on triangles subtest, word order 
subtest, and hand movement subtest differed by mothers’ (but not fathers’) highest 
level of education. Neither fathers’ nor mothers’ highest level of education affected 
children’s performance on the sequential K-ABC-II scale and number recall subtest 
(Table 6.18).  
Cognitive tests scores also varied by family’s income. Children living in families 
with higher income (income ≥$350) had significantly higher scores than children living in 
families with income < $350 on PPVT-IV, non verbal index K-ABC-II scale, simultaneous 
K-ABC-II scale, triangles subtest, and hand movement subtest (Table 6.19). 
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Children’s performance on conceptual thinking only differed by hours spent 
watching TV. Children who watched TV more than one hour daily (n=41) had 
significantly higher scores (9.1± 4.3) than children who watched TV for less than an hour 
a day (n=45) with mean ±SD of 7.3 ± 3.6, p<.05. 
Since socioeconomic variables were highly correlated, and these variables 
correlated with many of the scores on cognitive tests, a stepwise multiple regression 
analysis was conducted to determine the socioeconomic variables that best predict 
children’s performance on cognitive tests. PPVT-IV and K-ABC-II scales and subtests 
were simultaneously regressed on the set of six predictors: family income after rent 
deduction, mother’s highest level of education, father’s highest level of education, 
kindergarten attendance, hours spent in active play, and hours spent watching TV. The 
variances of cognitive tests scores accounted for by the predictors, the standardized and 
the unstandardized regression coefficients, along with p-value are presented in Table 
6.20. Only father’s education significantly predicted children’s scores on PPVT-IV 
(R2=.19, β=.44, and p<.000). Twenty percent of the variability in the non verbal index K-
ABC-II scale was accounted for by both mother’s education (β=.30, p<.05), and family 
income (β =.26, p<.05). Mother’s education and father’s education jointly explained 20% 
of the variability in children’s scores on the non verbal index K-ABC-II scale, while 
mothers’ education only accounted for 12% of the variability of children scores on 
triangles subtest. Hours child spend on TV accounted for 7% of the variability in children 
scores on word order subtest, and kindergarten attendance accounted for 13% of 
variability in hand movement subtest.  
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DISCUSSION 
Iron and zinc indicators didn’t show any significant correlation with any of the 
administered cognitive tests. For PPVT-IV, children’s performance fell mostly within 
normal range, below average, and lower extreme categories, and there was no 
significant difference between these three groups for all iron and zinc indicators.  For K-
ABC-II scales (non verbal index K-ABC-II, simultaneous K-ABC-II, and sequential K-ABC-II) 
most of the children were either within the normal range or below average, and few 
children were in the lower extreme. Again, no significant difference was found for all 
iron and zinc indicators between these groups.  Only the three children in the lower 
extreme in simultaneous K-ABC-II had significantly higher TfR than each of the children 
in the below average category and the normal range category, but the low number of 
children who performed in the lower extreme (n=3) doesn’t allow for a sufficient power 
to detect a statistically significant difference. For all K-ABC-II subtests (conceptual 
thinking, face recognition, number recall, triangles, word order, pattern reasoning, and 
hand movement), iron and zinc indicators didn’t differ between children below the 20th 
percentile and those above the 80th percentile.  
 When children were classified according to their iron and Hb status into four 
groups (iron sufficient and not anemic, iron deficient but not anemic, iron deficiency 
anemia, and anemia of chronic disease), and their performance on cognitive tests was 
evaluated, no significant difference was found between children with different iron 
status on all cognitive tests.  
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On the other hand, children’s performance on cognitive tests was associated 
with socioeconomic variables, namely: father’s education, mother’s education, income, 
hours the child spent on TV, and kindergarten attendance.  
This study found no association between iron status in children at 4-5 years of 
age and their performance on cognitive tests. Almost all reviews of the current 
literature on the effect of iron deficiency on children’s cognition and behavior (Beard 
2003, Grantham-McGregor and Ani 2001, Lozoff et al 2006a, McCann and Ames 2007, 
Thomas et al 2009), and reviews on the role of iron supplementation in improving 
development and cognition outcomes (Iannotti et al 2006, Sachdev et al 2005), have 
supported an association between iron deficiency anemia and poor cognitive and 
behavioral performance. Yet, a direct and unequivocal causal connection could not be 
clearly established.  
In this study, only 16% of children had ferritin < 12 µg/L and 26% were anemic. 
The low prevalence of iron deficiency among children may be a possible explanation for 
the lack of an association between iron deficiency and cognitive measures. Only nine 
children had iron deficiency anemia (the latest stage of iron deficiency). If the study had 
more children in this category, this would allow for a better comparison that might have 
shown the impact of iron deficiency on children’s performance on cognitive tests. This 
agrees with Metallinos-Katsaras and colleagues (2004) who found that  although iron 
supplementation improved motor and language development, the effect on motor 
development was limited to children who were severely anemic (Hb<9.0g/dl at 
baseline). In our study none of the children had Hb below 9.0 g/dl. In addition, the study 
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of Metallinos-Katsaras and colleagues (2004) found that although iron supplementation 
resulted in improvement in selective attention among anemic children, there were no 
significant differences in cognitive outcomes at baseline between those children who 
were anemic and those with good iron status (Metallinos-Katsaras et al 2004).  
Although zinc deficiency was more prevalent among children than iron 
deficiency, neither zinc deficiency nor iron deficiency was associated with children’s 
performance on cognitive tests, except for the number recall subtest, where children 
with higher zinc status showed significantly better performance on the number recall.  
Fifty-two children (56%) had zinc below 65 µg/dL zinc, and despite the high prevalence 
of zinc deficiency only two children (2.2%) had <-2 for the height-for-age z-scores. A 
possible explanation is that zinc deficiency may have occurred recently in children’s 
lives, which means they didn’t develop the signs of chronic zinc deficiency that might 
contribute to a larger percentage of stunting among children.  Beside that, although 
more than half of the children were below the defined cut off point for zinc deficiency; 
their zinc concentration was not extremely low. Zinc concentration ranged between 
(46.3 – 64.9 µg/dL) for the zinc deficient children. Most importantly, there is absence of 
reliable measures that could sensitively measure plasma zinc. It could be that the actual 
prevalence of zinc deficiency is less than the reported figure, especially because when a 
lower cutoff for zinc deficiency was used, children’s performance on one of the subtests 
(number recall) became significantly different. These factors could explain the lack of 
any association between zinc status in children and their performance on cognitive 
tests. With that being said, the study findings are consistent with previous studies that 
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found no association between zinc status and infant and child mental development and 
behavior (Black et al 2004b, Cavan et al 1993, Gibson et al 1989, Hamadani et al 2001, 
Hamadani et al 2002, Lind et al 2004, Tamura et al 2003, Taneja et al 2005).  
A major limitation in this study is that the cognitive tests utilized in this study 
were developed for the US population, not for the population in Jordan. To overcome 
this limitation, we worked with a team of local school teachers and mothers to adapt 
the PPVT-IV and K-ABC-II subtests so that they would be culturally appropriate. All 
stimulus words and measures were translated into Arabic for training and 
administration.  All cognitive measures were pretested on a group of preschoolers in 
Jordan; the cultural differences in the interpretation of some of the measures were 
evaluated and adjusted, and then cognitive measures were tested again on another 
group of preschoolers before administering them to the study participants.  
The study of cognitive psychology and micronutrients is an emerging research 
area. The exact biological mechanisms by which zinc deficiency alters brain functions 
and relates to cognition and behavior are not yet clear. It could be that there might be 
specific cognitive defects associated with zinc deficiency that were not captured by the 
administered cognitive tests. Perhaps an important finding of this study that relates to 
populations with lower socioeconomic status in Jordan is that parent’s education and 
especially mothers’ education was an important component (more than income) of 
children performance on cognitive tests. Children whose parents had higher education 
had better performance on most of the tests than children whose parents were less 
educated.  
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This is the first study to assess the effect of iron and zinc deficiency on cognition 
in Jordan. There is an extreme lack of data not only on preschool children, but also on 
younger children, infants, and adolescents. Certainly, larger studies are needed to assess 
short-term and long-term developmental outcomes in iron deficient infants, young 
children, preschool children, school children, and adolescents in Jordan. The long term 
effects of iron and zinc deficiency may have not been captured by this study, but 
certainly rigorous randomized controlled trials of iron and zinc supplements with large 
sample size can provide detailed information and help to make firm conclusions that can 
be used to develop ways for enhancing child development in Jordan. 
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Table 6.1 
 Characteristics of the study participants 
 
 N Mean ±SD Percentile 
   25
th
  50th 75th  
Children      
Age (months) 93 60.7 ± 5.4 55.0 61.0 65.0 
Weight- for-age (z) 93 0.0 ±1.1 -0.6 0.1 0.6 
Height–for-age (z) 93 0.5 ±1.2 -0.3 0.6 1.4 
Child MUAC* (cm) 93 16.7 ± 1.2 16.0 16.7 17.5 
Ferritin (µg/L) 93 21.9 ± 2.0 14.6 21.9 31.3 
Transferrin receptor (mg/L) 93 5.9 ± 1.4 4.8 6.2 7.3 
Iron (mg/kg)** 93 3.5 ± 3.8 1.5 3.5 5.0 
Zinc (µg/dL) 93 64.6 ± 9.4 58.1 63.2 70.1 
AGP (g/L) 93 1.0 ± 1.5 0.8 1.0 1.3 
Hemoglobin (g/dL) 93 11.7 ± 1.1 11.3 11.6 12.2 
Months child breast fed 79 13.9 ± 6.3 10.0 14.0 18.0 
Child’s order between siblings 93 3.1 ±1.8 2.0 3.0 4.0 
Hours spent in KG(hr/d) 50 5.1 ± 0.9 4.4 5.0 6.0 
Hours spent on TV (hr/wk) 93 11.0 ± 8.6 5.5 7.0 14.0 
Hours spent in active play (hr/wk) 93 24.3 ±14.4 14.0 21.0 33.8 
      
Mothers      
Age (years) 93 33.9 ± 5.9 29.0 35.0 38.0 
Number of  pregnancies 93 4.8 ± 2.5 3.0 4.0 6.0 
Number of children 93 4.1 ± 1.9 3.0 4.0 5.0 
Income (USD/month) *** 92 325 ± 272 174 254 353 
Years of schooling 92 10.7 ± 2.3 9.0 12.0 12.0 
Number of household members 93 6.3 ±2.2 5 6 7 
*MAUC: Mid-upper arm circumference. 
** Iron measured quantitatively using Cook and Colleagues method 
***Income is defined as total monthly family income after rent deduction in US $. 
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Table 6.2 
 Characteristics of the study population- qualitative variables 
 
 
Variable 
 
N (%) 
Children’s gender (Total= 93)  
Male 51 (54.8%) 
Female 42 (45.2%) 
Child go to KG (Total= 93)  
No 43 (46.2%) 
Yes 50 (53.8%) 
Child breast fed (Total= 93)  
No 14 (15.1%) 
Yes 79 (84.9%) 
Mothers’ marital status (Total= 93)  
Currently married 74 (79.6%) 
Separated 2 (2.2%) 
Widowed 17 (18.3%) 
Mothers’ education (Total= 92)  
Secondary education or less 33 (35.9%) 
High school completed 33 (35.5%) 
College/University completed 26 (28.0 %) 
Mothers’ work status (Total= 93)  
Working 8 (8.7%) 
Not working 85 (91.4%) 
Fathers’ education (Total= 76)  
Secondary education or less 21 (27.6%) 
High school completed 34 (44.7%) 
College/University completed 21 (27.6%) 
Fathers’ work status (Total=76)  
Working 72 (94.7%) 
Not working 4 (5.2%) 
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Table 6.5 
Correlations between socioeconomic variables  
 
 Hours in 
active play 
KG  
attendance 
Hours  
watch TV 
 
Income 
Mothers’ 
 education 
      
Hours in active play 
 
     
KG attendance -.21*     
Hours  watch TV .13 -.03    
Income -.17 .41
††
 .07   
Mothers’ education -.16 
.25* .17 .43
¥
  
Fathers’ education -.27* .33
††
 .07 .51
¥
 .35
††
 
¥ 
Sig. at p<.000,
 †
Sig. at p<.005,
 ††
 Sig. at p<.01, *Sig. at p<.05 
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Table 6.6 
 Descriptive statistics of cognitive tests 
 
 
Test 
 
N 
 
Mean ± SD 
 
Percentile 
 
Min - Max 
   25th  50th 75th   
PPVT-IV  
 
85 78.6 ± 13.7 69.5 78.0 87.0 47 – 118 
K-ABC-II Scales: 
 
      
Non verbal index K-ABC-II  
 
82 85.7± 12.3 75.5 84.5 94.3 62 - 118 
Simultaneous K-ABC-II  
 
82 87.5 ± 11.5 80.0 85.0 97.0 68 – 116 
Sequential K-ABC-II 
 
86 78.2 ± 9.5 79.3 88.0 94.0 68 – 106 
K-ABC-II Subtests: 
 
      
Conceptual thinking 
 
86 7.9 ± 2.6 6.0 8.0 9.0 1 – 15 
Face recognition 
 
82 8.1 ± 2.9 6.0 8.0 10.0 2 – 15 
Number recall 
 
86 9.6 ± 2.3 8.0 10.0 11.0 5 – 14 
Triangles 
 
86 7.8 ± 2.7 6.0 7.0 9.0 2 – 16 
Word order 
 
86 6.0 ± 1.5 5.0 6.0 7.0 3 - 10 
Pattern reasoning  
 
50 8.9 ± 1.6 8.0 9.0 10.0 5 – 12 
Hand movement  
 
85 8.4 ± 2.3 7.0 8.0 10.0 4 - 14 
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Table 6.11 
Iron and zinc indices of children classified by subtest performance  
 (below 20th percentile versus above 80th percentile) 
   Iron and zinc indices (Mean ±SD) 
  
 
Subtest 
  20
th 
percentile 
 80
th 
percentile 
 
 
Conceptual thinking  
     
(n: lower=17, upper=17) Hb (g/dL)  11.8 ± 1.1  11.5 ± 1.1  
 Ferritin (µg/L)  17.2 ± 2.6  23.2 ± 2.0  
 TfR (µg/mL)  5.4 ± 1.6  6.7 ± 1.4  
 TfR/Ferritin  0.3 ± 2.3  0.3± 2.5  
 Iron (mg/kg)  3.0 ± 3.0  2.7 ± 3.3  
 Zinc (µg/dL)  65.1 ± 9.5  65.5 ± 8.9  
 AGP (g/L)  0.9 ± 1.7  1.2 ± 1.4  
Face recognition       
(n: lower=17, upper=16) Hb (g/dL)  11.9 ± 1.1  11.8 ± 1.1  
 Ferritin (µg/L)  20.1 ± 1.9  23.8 ± 1.8  
 TfR (µg/mL)  4.7 ± 1.5  6.4 ± 1.4  
 TfR/Ferritin  0.2 ± 2.4  0.3 ± 1.9  
 Iron (mg/kg)  3.9 ± 3.1  3.3 ± 2.3  
 Zinc (µg/dL)  62.4 ± 2.4  68.1 ± 2.3  
 AGP (g/L)  7.8 ± 8.0  7.8 ± 12.4  
Number recall       
(n: lower=17, upper=18) Hb (g/dL)  11.8 ± 1.1  11.6 ± 1.1  
 Ferritin (µg/L)  28.9 ± 1.8  24.6 ± 2.1  
 TfR (µg/mL)  5.1 ± 1.5  6.1 ± 1.4  
 TfR/Ferritin  0.2 ± 1.9  0.2 ± 2.1  
 Iron (mg/kg)  4.7 ± 2.3  5.0 ± 6.6  
 Zinc (µg/dL)  62.0 ± 10.2  65.5 ± 10.8  
 AGP (g/L)  1.2 ± 1.5  1.1 ± 1.5  
Triangles      
(n: lower=18, upper=17) Hb (g/dL)  11.9 ± 1.1  11.6 ± 1.1  
 Ferritin (µg/L)  26.8 ± 2.2  22.7 ± 1.6  
 TfR (µg/mL)  6.1 ± 1.5  5.3 ± 1.3  
 TfR/Ferritin  0.2 ± 2.2  0.2 ± 1.7  
 Iron (mg/kg)  3.8 ± 2.9  3.7 ± 1.9  
 Zinc (µg/dL)  66.1 ± 8.7  65.6 ± 7.4  
 AGP (g/L)  1.1 ± 1.6  1.1 ± 1.4  
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Table 6.11-continued 
Iron and zinc indices of children classified by subtest performance  
 (below 20th percentile versus above 80th percentile) 
   Iron and zinc indices 
 (Mean ± SD) 
 
Subtest 
  20
th 
percentile 
 80
th 
percentile 
 
 
Word order 
 
 
 
 
 
(n: lower=18, upper=17) Hb (g/dL)  11.8 ± 1.1  11.8 ± 1.1  
 Ferritin (µg/L)  26.7 ± 1.9  21.0 ± 2.0  
 TfR (µg/mL)  5.7 ± 1.6  6.9 ± 1.3  
 TfR/Ferritin  0.2 ± 2.2  0.3 ± 2.1  
 Iron (mg/kg)  4.1 ± 2.9  2.6 ± 2.6  
 Zinc (µg/dL)  65.3 ± 9.9  62.9 ± 7.4  
 AGP (g/L)  1.1 ± 1.7  1.1 ± 1.4  
Pattern reasoning      
(n: lower=10, upper=10) Hb (g/dL)  11.9 ± 1.1  11.9 ± 1.1  
 Ferritin (µg/L)  24.5 ± 2.2  20.1 ± 1.5  
 TfR (µg/mL)  6.5 ± 1.6  7.1 ± 1.3  
 TfR/Ferritin  0.3 ± 2.5  0.3 ± 1.5  
 Iron (mg/kg)  3.3 ± 3.4  1.5 ± 2.8  
 Zinc (µg/dL)  67.5 ± 7.1  63.0 ± 5.4  
 AGP (g/L)  1.4 ± 1.3  1.1 ± 1.5  
Hand movement      
(n: lower=18, upper=17) Hb (g/dL)  11.8 ± 1.1  11.7 ± 1.1  
 Ferritin (µg/L)  26.0 ± 2.0  16.1 ± 2.3  
 TfR (µg/mL)  5.5 ± 1.5  5.6 ± 1.3  
 TfR/Ferritin  0.2 ± 2.2  0.3 ± 2.4  
 Iron (mg/kg)  5.5 ± 6.3  2.3 ± 3.2  
 Zinc (µg/dL)  66.3 ± 11.2  62.9 ± 7.8  
 AGP (g/L)  1.1 ± 1.5  1.1 ± 1.4  
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Table 6.12 
Mean scores of cognitive tests for children iron status groups  
  G1:  
Iron 
sufficient, 
not anemic 
Mean ±SD 
 G2:  
Iron 
deficient, not 
anemic (ID) 
 Mean ±SD 
 G3:  
Iron deficiency 
anemia 
(IDA) 
Mean ±SD 
 G4:  
Anemia of 
chronic 
disease (ACD) 
 Mean ±SD 
  (n=55)  (n=13)  (n=9)  (n=15) 
Ferritin (µg/L)  27.2 ± 1.7  11.3 ± 2.3  10.0 ± 1.2  24.7 ± 1.4 
TfR (µg/mL)  5.3 ± 1.4  7.5 ± 1.5  7.2 ± 1.4  6.4 ± 1.4 
TfR/Ft  0.2 ± 1.8  0.7 ± 1.8  0.7 ± 1.4  0.3 ± 1.5 
AGP (g/L)  1.0 ± 1.6  1.0 ± 1.4  1.1 ± 1.3  1.0 ± 1.4 
Hb (g/dL)  12.1 ± 1.1  12.0 ± 1.0  10.7 ± 1.1  11.0 ± 1.0 
Zinc (mg/L)  65.2 ± 9.0  63.3 ± 8.6  64.4 ± 11  63.9 ± 12 
PPVT-IV  77.0 ± 14.2 
(n=49) 
 
 
80.9 ± 10.1 
(n=13) 
 
 
78.3 ± 13.1 
(n=8) 
 
 
82.8 ± 15.6 
(n=14) 
 
Non verbal index K-ABC-II 
 
84.4 ± 12.9 
(n=48) 
 
 
86.1 ± 13.9 
(n=12) 
 
 
87.6 ± 8.7 
(n=7) 
 
 
89.5 ± 10.9 
(n=14) 
 
Simultaneous K-ABC-II 
 
87.1 ± 11.7 
(n=48) 
 
 
86.6 ± 13.5 
(n=12) 
 
 
85.9 ± 9.5 
(n=7) 
 
 
90.9 ± 10.5 
(n=14) 
 
Sequential K-ABC-II 
 
85.8 ± 9.3 
(n=51) 
 
 
90.6 ± 8.2 
(n=12) 
 
 
90.4 ± 7.6 
(n=8) 
 
 
88.4 ± 11.5 
(n=14) 
 
Conceptual thinking 
 
7.6 ± 2.4 
(n=51) 
 
 
9.2 ± 3.0 
(n=12) 
 
 
7.6 ± 3.6 
(n=8) 
 
 
7.8 ± 2.3 
(n=14) 
 
Face recognition 
 
7.7 ± 3.1 
(n=48) 
 
 
7.7 ± 2.4 
(n=12) 
 
 
9.3 ± 3.4 
(n=7) 
 
 
9.3 ± 2.0 
(n=14) 
 
Number recall 
 
9.2 ± 2.2 
(n=51) 
 
 
10.1 ± 2.5 
(n=12) 
 
 
10.8 ± 1.7 
(n=8) 
 
 
10.1 ± 2.8 
(n=14) 
 
Triangles 
 
7.9 ± 2.8 
(n=51) 
 
 
7.1 ± 2.5 
(n=12) 
 
 
6.8 ± 1.4 
(n=8) 
 
 
8.8 ± 2.8 
(n=14) 
 
Word order 
 
5.9 ± 1.5 
(n=51) 
 
 
6.7 ± 1.3 
(n=12) 
 
 
6.0 ± 1.2 
(n=8) 
 
 
5.9 ± 1.7 
(n=14) 
 
Pattern reasoning  
 
8.9 ± 1.7 
(n=27) 
 
 
9.2 ± 1.9 
(n=5) 
 
 
8.4 ± 1.6 
(n=7) 
 
 
9.1 ± 1.1 
(n=11) 
 
Hand movement 
 
8.3 ± 2.4 
(n=50) 
 
8.4 ± 2.3 
(n=12) 
 
9.0 ± 2.0 
(n=8) 
 
8.3 ± 2.5 
(n=14) 
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Table 6.13 
 Mean scores of cognitive tests by zinc status 
 Plasma zinc 
  
≥ 57.0  µg/dL 
 
  
< 57 µg/dL 
 
 Mean ± SD  Mean ± SD 
    
PPVT-IV  
 
78.5 ± 14.6 
(n=67) 
 
 79.2 ± 9.6 
(n=18) 
Non verbal index K-ABC-II 
 
86.0 ± 12.8 
(n=64) 
 
 84.4 ± 10.8 
(n=18) 
Simultaneous K-ABC-II 
 
88.0 ± 12.0 
(n=64) 
 
 85.7 ± 9.4 
(n=18) 
Sequential K-ABC-II 
 
88.2 ± 9.1 
(n=68) 
 
 83.4 ± 10.3 
(n=18) 
Conceptual thinking 
 
7.9 ± 2.5 
(n=68) 
 
 7.6
 
± 2.3 
(n=18) 
Face recognition 
 
8.0 ± 2.9 
(n=64) 
 
 8.3
 
± 2.8 
(n=18) 
Number recall 
 
9.9
 a 
± 2.3 
(n=68) 
 
 8.5
b
 ± 2.4 
(n=18) 
Triangles 
 
7.8 ± 2.7 
(n=68) 
 
 7.8 ± 2.4 
(n=18) 
Word order 
 
6.1 ± 1.5 
(n=68) 
 
 5.8
 
± 1.4 
(n=18) 
 
Pattern reasoning  
 
9.0 ± 1.7 
(n=37) 
 
 8.0 ± 0.9 
(n=13) 
Hand movement  8.5 ± 2.4 
(n=67) 
 8.1 ± 2.3 
(n=18) 
a,b 
Sig.at p<.05 
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Table 6.14 
 Mean scores of cognitive tests by sex  
  Gender 
  Males Females 
  Mean ±SD Mean ±SD 
    
PPVT-IV (M=47, F=38)  79.5 ± 12.9 77.6 ± 14.7 
Non verbal index K-ABC-II (M=46, F=36)  84.4 ± 11.6 87.3 ± 13.2 
Simultaneous K-ABC-II (M=46, F=36)  86.7 ± 10.9 88.6 ± 12.2 
Sequential K-ABC-II (M=48, F=38)  86.7 ±9.8 87.8± 9.1 
Conceptual thinking (M=48, F=38)  7.7 ± 2.9 8.1± 2.2 
Face recognition (M=46, F=36)  7.4 ± 2.8 9.0 ± 2.8 
Number recall ( M=48, F=38)  9.4 ± 2.4 9.8 ± 2.3 
Triangles (M=48, F=38)  7.8 ± 2.7 7.8 ± 2.6 
Word order (M=48, F=38)  6.0 ± 1.5 6.0 ± 1.4 
Pattern reasoning ( M=32, F=18)  9.0 ± 1.5 8.8 ± 1.7 
Hand movement ( M=47, F=38)  8.5 ± 2.1 8.2 ± 2.6 
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Table 6.15 
 Mean scores of cognitive tests by breast feeding history 
  Did the child breast fed? 
  Yes No 
   
Mean ±SD 
 
Mean ±SD 
    
PPVT-IV (Yes=73, No=12)  79.0 ± 14.1 76.0 ± 11.2 
Non verbal index K-ABC-II (Yes=70, No=12)  86.0 ± 12.3 83.5 ± 12.8 
Simultaneous K-ABC-II (Yes=70, No=12)  88.2 ± 11.6 83.4 ± 10.0 
Sequential K-ABC-II (Yes=74, No=12)  87.3 ± 9.6 86.9 ± 9.3 
Conceptual thinking (Yes=74, No=12)  8.0 ± 2.7 7.3 ± 1.8 
Face recognition (Yes=70, No=12)  8.1 ± 2.9 8.2 ± 2.8 
Number recall (Yes=74, No=12)  9.7 ± 2.4 9.2 ± 2.2 
Triangles (Yes=74, No=12)  7.9 ± 2.7 7.1 ± 2.3 
Word order (Yes=74, No=12)  6.0  ± 1.4 6.3 ± 1.7 
Pattern reasoning (Yes=43, No=7)  9.0 ± 1.6 8.7 ± 0.8 
Hand movement (Yes=73, No=12)  8.3 ± 2.2 8.5 ± 3.0 
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Table 6.16 
 Mean scores of cognitive tests by kindergarten attendance 
  
Kindergarten attendance 
 Yes 
 
 
No 
 
 Mean ±SD  Mean ±SD 
    
PPVT-IV (Yes=47, No=38) 
 
81.2
 
± 15.2  75.6
 
± 11.0 
Non verbal index K-ABC-II (Yes=44, No=38) 
 
89.3
a
 ± 12.1  81.5
b
  ± 11.4 
Simultaneous K-ABC-II (Yes=44, No=38) 
 
90.3
c
 ± 11.0  84.2
d
 ± 11.3 
Sequential K-ABC-II (Yes=44, No=38) 
 
88.2
 
± 10.2  86.1 ± 8.5 
Conceptual thinking (Yes=48, No=38) 
 
8.3
 
± 2.9  7.3 ± 2.1 
Face recognition (Yes=44, No=38) 
 
8.7
 
± 2.7  7.4 ± 3.0 
Number recall (Yes=44, No=38) 
 
9.9
 
± 2.4  9.3
 
± 2.2 
Triangles (Yes=44, No=38) 
 
8.4
 
± 2.8  7.0
 
± 2.2 
Word order (Yes=44, No=38) 
 
6.1
c
 ± 1.7  5.9
d
 ± 1.1 
Pattern reasoning (Yes=44, No=38) 
 
8.7 ± 1.6  9.6 ± 1.3 
Hand movement (Yes=44, No=38) 9.0
a
 ± 2.4  7.6
b
 ± 2.1 
a,b 
Sig. at p<.005, 
c,d 
Sig. at p<.05 
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Table 6.17 
 Mean scores of cognitive tests by children’s hours of active play 
 hours child spend in active play 
 ≥ 5 hr/day 
 
 < 5 hr/day 
 
 Mean ± SD  Mean ± SD 
    
PPVT-IV  
 
75.9
d
 ± 10.0 
(n=21) 
 
 79.5
c
 ± 14.6 
(n=60) 
Non verbal index K-ABC-II 
 
81.3
b
 ± 12.2 
(n=22) 
 
 87.3
a
 ± 12.1 
(n=60) 
Simultaneous K-ABC-II 
 
85.4 ± 12.7 
(n=22) 
 
 88.3 ± 11.0 
(n=64) 
Sequential K-ABC-II 
 
82.1 ± 8.2 
(n=22) 
 
 89.0 ± 9.3 
(n=64) 
Conceptual thinking 
 
7.2 ± 2.1 
(n=22) 
 
 8.1
 
± 2.7 
(n=64) 
Face recognition 
 
7.2 ± 2.7 
(n=22) 
 
 8.4
 
± 2.9 
(n=60) 
Number recall 
 
8.3
b 
± 2.2 
(n=22) 
 
 10.1
a
 ± 2.2 
(n=64) 
Triangles 
 
7.9 ± 2.7 
(n=22) 
 
 7.8 ± 2.7 
(n=64) 
Word order 
 
5.6 ± 1.1 
(n=22) 
 
 6.2
 
± 1.4 
(n=54) 
 
Pattern reasoning  
 
9.1 ± 1.4 
(n=11) 
 
 8.9 ± 1.6 
(n=39) 
Hand movement  7.4
d
 ± 2.0 
(n=22) 
 8.7
c
 ± 2.4 
(n=63) 
a,b 
Sig. at p<.005, 
c,d 
Sig. at p<.05 
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Table 6.18 
 Mean scores of cognitive tests by parental level of education 
  Mothers’ highest level of  
education 
 Fathers’ highest level of  
education 
  High school 
 or above 
 
Less than 
 high school 
 
 High school 
 or above 
 
Less than  
high school 
  Mean ± SD Mean ± SD  Mean ± SD Mean ± SD 
       
PPVT-IV   80.6
 
± 13.5  
(n=52)  
 
75.0
 
± 13.4 
(n=30) 
 82.2
 a
 ± 12.6 
(n=74) 
72.6
 b
 ± 10.9 
(n=20) 
Non verbal index K-ABC-II 
 
 88.6
a
 ± 
11.7 
(n=52) 
 
80.6
b
± 11.9 
(n=30) 
 89.0
 c
 ± 12.4 
(n=47) 
80.5
 d
 ± 10.4 
(n=20) 
Simultaneous K-ABC-II 
 
 90.3
a
 ± 
10.7 
(n=56) 
 
82.6
b
 ± 
11.3 
(n=30) 
 91.1
 a
 ± 11.1 
(n=51) 
82.6
 b
 ± 10.0 
(n=20) 
Sequential K-ABC-II 
 
 88.0
 
 ± 9.6 
(n=55) 
 
85.8
 
 ± 9.2 
(n=30) 
 88.2
 
 ± 9.9 
(n=50) 
84.1
 
 ± 9.6 
(n=20) 
Conceptual thinking 
 
 8.2
 
 ± 9.6 
(n=56) 
 
7.3
 
 ± 9.2 
(n=30) 
 8.4
 
 ± 2.7 
(n=51) 
7.0
 
 ± 1.9 
(n=20) 
Face recognition 
 
 8.3 ± 2.7 
(n=52) 
 
7.8 ± 3.2 
(n=30) 
 8.6
 g
 ± 3.0 
(n=47) 
7.1
 f
 ± 2.2 
(n=20) 
Number recall 
 
 9.6 ± 2.4 
(n=56) 
 
9.6 ± 2.3 
(n=30) 
 9.8 ± 2.4 
(n=51) 
8.9 ± 2.5 
(n=20) 
Triangles 
 
 8.4
c
 ± 2.7 
(n=56) 
 
6.7
d
 ± 2.2 
(n=30) 
 8.42
 
 ± 3.0 
(n=51) 
7.1
 
 ± 2.0 
(n=20) 
Word order 
 
 6.3
g
 ± 1.5 
(n=56) 
 
5.6
f
 ± 1.3 
(n=30) 
 6.2
 
 ± 1.5 
(n=51) 
5.7
 
 ± 1.2 
(n=20) 
Pattern reasoning  
 
 8.7 ± 1.6 
(n=35) 
 
9.3 ± 1.3 
(n=15) 
 8.6
 
 ± 1.5 
(n=33) 
9.4
 
± 1.5 
(n=9) 
Hand movement   8.8
g
 ± 2.4 
(n=56) 
7.5
f
 ± 1.9 
(n=29) 
 8.7 ± 2.3 
(n=50) 
7.8 ± 2.5 
(n=20) 
a,b 
Sig. at p<.005, 
c,d 
Sig. at p<.01, 
g,f 
Sig. at p<.05 
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Table 6.19 
 Mean scores of cognitive tests by family income after rent deduction 
  
Family income after rent deduction 
  
Income ≥ $ 350  
 
  
Income < $ 350 
 
 Mean ± SD  Mean ± SD 
    
PPVT-IV  84.5
 g
 ± 13.9 
(n=23) 
 
 76.2
f
 ± 13.0 
(n=61) 
Non verbal index K-ABC-II 
 
92.8
c
 ± 13.4 
(n=20) 
 
 83.5
 d
 ±11.2 
(n=61) 
Simultaneous K-ABC-II 
 
94.8
c
 ± 12.2 
(n=20) 
 
 85.2
d
 ± 10.4 
(n=61) 
Sequential K-ABC-II 
 
87.9 ± 10.2 
(n=24) 
 
 86.9 ± 9.3 
(n=61) 
Conceptual thinking 
 
8.2 ± 3.1 
(n=24) 
 
 7.7
 
± 2.4 
(n=61) 
Face recognition 
 
8.9 ± 3.1 
(n=20) 
 
 7.8
 
± 2.8 
(n=61) 
Number recall 
 
9.7 ± 2.5 
(n=24) 
 
 9.5 ± 2.3 
(n=61) 
Triangles 
 
9.5
a
 ± 3.5 
(n=24) 
 
 7.1
b
 ± 1.9 
(n=61) 
Word order 
 
6.2
 
± 1.7 
(n=24) 
 6.0
 
± 1.4 
(n=51) 
 
Pattern reasoning  
 
8.5 ± 1.8 
(n=18) 
 
 9.2 ± 1.3 
(n=61) 
Hand movement  9.4
g
 ± 2.0 
(n=23) 
 8.0
f
 ± 2.3 
(n=51) 
a,b 
Sig. at p<.000, 
c,d 
Sig. at p<.005, 
g,f 
Sig. at p<.05 
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Table 6.20 
Stepwise regression of children’s performance on cognitive tests in relation to 
socioeconomic variables 
Model Summary   Coefficients 
 
 
 
R2 
 
∆R2 
 
p-
value 
  
Variables 
 
B 
 
SE 
 
β 
 
p-
value 
Test# 1: PPVT-IV,  
(N=69) 
        
Father education .19 .19 .000  Father education 4.0 1.0 .44 .000 
     Income   .13 .316 
     Mother 
education 
  .14 .229 
     KG attendance   .08 .491 
     Hours in active 
play 
  -.02 .873 
     Hours on TV   .11 .305 
Test# 2: Non verbal index K-ABC-II  
(N=66) 
       
Mother education .14 .14 .002  Mother 
education 
3.0 1.2 .30 .014 
Mother education, income .20 .06 .031  income .02 .01 .26 .031 
     Father education   .14 .272 
     KG attendance   .13 .314 
     Hours in active 
play 
  -.13 .279 
     Hours on TV   .08 .515 
Test# 3: Simultaneous K-ABC-II,  
(N=66) 
        
Mother education .14 .14 .002  Mother 
education 
2.9 1.1 .31 .011 
Mother education, Father 
education 
.20 .06 .039  Father education 2.1 1.0 .25 .039 
     income   .15 .248 
     KG attendance   .08 .504 
     Hours in active 
play 
  -.08 .513 
     Hours on TV   .02 .898 
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Table 6.20-continued 
Stepwise regression of children performance on cognitive tests in relation to 
socioeconomic variables 
Model Summary   Coefficients 
 
 
 
R2 
 
∆R2 
 
p-
value 
  
Variables 
 
B 
 
SE 
 
β 
 
p-
value 
Test # 8: Triangles,  
(N=70) 
        
Mother education .12 .12 .003  Mother 
education 
.79 .26 .35 .003 
     income   .21 .084 
     Father education   .18 .126 
     KG attendance   .18 .143 
     Hours in active 
play 
  -
.002 
.983 
     Hours on TV   -.02 .877 
Test# 9: Word order, 
 (N=70) 
        
Hours on TV .07 .07 .032  Hours on TV .04 .02 .26 .032 
     income   .08 .511 
     Mother 
education 
  .20 .087 
     Father education   .15 .209 
     KG attendance   .16 .180 
     Hours in active 
play 
  -.16 .168 
Test # 11: Hand movement, 
 (N=69) 
        
KG attendance .13 .13 .003  KG attendance 1.7 .54 .36 .003 
     income   .08 .571 
     Mother 
education 
  .21 .080 
     Father education   .17 .161 
     Hours in active 
play 
  -.15 .210 
     Hours on TV   .04 .717 
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CHAPTER VII 
 
 
CONCLUSION 
 
This study had three objectives corresponding to the three manuscripts in the 
dissertation. The 1st objective was to assess vitamin D status in women of childbearing 
age and their preschool children in Jordan during the summer. The study found a high 
prevalence of vitamin D deficiency among women of childbearing age (48.9% had 
25(OH) D <25.0 nmol/L, and 97.8% had 25(OH) D <50.0 nmol/L), and to a lesser extent 
among their children (39% had 25(OH) D <50.0 nmol/L). Natural foods rich in vitamin D 
are not commonly consumed by the larger population in Jordan, and there are no 
governmental regulations that mandate vitamin D fortification for the processed milk 
and milk products produced in Jordan. Unfortunately, there still are no recommended 
dietary guidelines concerning vitamin D intake in the Middle East and North Africa 
region (MENA), despite the high prevalence of vitamin D deficiency. 
Despite the abundant sunlight during summer, the vitamin D status is a concern 
for young mothers and children in Jordan. Nutrition education programs should be 
implemented to inform women about the consumption of vitamin D fortified milk 
products as well as the importance of sufficient exposure to sunlight to attain optimal 
vitamin D status for themselves and their children. There is a need to assess vitamin D
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status at the national level so that strategies for vitamin D fortification and 
supplementation are developed and implemented. 
The 2nd objective of the study was to determine the prevalence of iron and zinc 
deficiency in mothers and their preschool children, and to evaluate the diagnostic 
efficiency of serum TfR and different TfR/ferritin ratios in identifying iron deficiency in 
women of child-bearing age and preschool children in Jordan. The study found 
widespread co-existing micronutrient deficiencies among mothers and to a lesser extent 
among children based on low values for hemoglobin, ferritin, and zinc. Besides, there 
was a high prevalence of inflammation among study participants and especially among 
women. Flour fortification with iron has been implemented in Jordan few years ago and 
still anemia and iron deficiency are a concern for mothers in Jordan. Given that there 
are no estimates of the national prevalence and distribution of zinc deficiency in Jordan, 
and that no previous study has assessed plasma zinc in the region, the high prevalence 
of zinc deficiency among study participants (58% and 56% among women and children, 
respectively) is alarming. There is a need to assess zinc status on the national level to 
provide information for developing a national public health policy that ensures 
fortification of staple foods with zinc. Along with food fortification, there is a need to 
conduct studies to examine the availability of zinc in the local diet.  
An important finding in this study was the high prevalence of overweight (37%) 
and obesity (40%) among women. This could be explained by sedentary life style and 
high number of pregnancies. This highlights the need for the implementation of 
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nutrition education and health awareness programs that stimulate behavior change and 
promote healthy lifestyles especially in women.   
The 3rd aim of the study was to examine any association between socioeconomic 
variables, measures of iron and zinc status, and children’s performance on tests of 
cognitive functions. Although zinc deficiency was more prevalent among children than 
iron deficiency, children’s performance on only one subtest was affected by their zinc 
status, while for the rest of cognitive tests neither zinc deficiency nor iron deficiency 
was associated with children’s performance on any of the administered cognitive tests. 
An important finding of this study that relates to populations with lower socioeconomic 
status in Jordan and developing countries is that parent’s education and especially 
mothers’ education was an important component of children performance on cognitive 
tests. Women’s education may not only improve their lives but also the lives of their 
children.  
The interaction between cognitive psychology and micronutrients is an emerging 
research area. This is the first study to assess the effect of iron and zinc deficiency on 
cognition in Jordan. Certainly, larger studies are needed to assess short-term and long-
term developmental outcomes in iron deficient infants, young children, preschool 
children, school children, and adolescents in Jordan. The long term effect of iron and 
zinc deficiency may not have been captured by this study, but certainly rigorous 
randomized controlled trials of iron and zinc supplements with larger sample size can 
provide detailed information and help to make firm conclusions that can be used to 
develop means to enhance child development in Jorda
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